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Aim of the thesis 
Aim of the thesis 
The function of the three Kindlin proteins is unknown. Recently, mutations in the human 
FERMT1 gene, coding for the Kindlin-1 protein, were shown to cause Kindler Syndrome, a 
rare autosomal recessive skin blistering disease. In addition to the skin blister phenotype, 
several other abnormalities have been reported, although a clear genotype to phenotype 
correlation is not evident. Cell-culture based work on Kindlin-1 and Kindlin-2 demonstrated 
an important role of these proteins in integrin-mediated cell adhesion and adhesion 
strengthening by the actin cytoskeleton. No functional data on Kindlin-3 have been reported, 
although the high homology to the other Kindlins suggests that they share similar functions, 
at least at integrin adhesion sites. 
The overall goal of this thesis was to describe the consequences of loss of each Kindlin 
protein in mice. Four major aims were defined for addressing these tasks; first, 
characterisation of the spatial and temporal expression pattern of the three Kindlin mRNAs 
and proteins. Second, generation of mouse strains deficient for each Kindlin. Third, analyses 
of their phenotypes and comparison of the Kindlin-1 knockout phenotype in mice with the 
human Kindler Syndrome. Fourth, identification of the molecular basis for the phenotypes.  
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Summary 
Summary 
The Kindlin protein family comprises three members (Kindlin-1-3). The proteins share a 
common domain architecture consisting of a central FERM domain harbouring a pleckstrin 
homology domain insertion. Both domains point to a membrane localisation of the Kindlins. 
Previous in vitro studies identified Kindlin-1 and Kindlin-2 as important players in mediating 
cell substrate adhesion by linking integrins to the actin cytoskeleton. Mutations in the human 
Kindlin-1 cause a rare inheritable skin blistering disease called Kindler Syndrome. 
The first aim of this study was to characterise the expression pattern and subcellular 
localisation of all three Kindlins during murine development and in adult tissues. This was 
addressed in Paper I. The analysis revealed a differential expression pattern of the three 
Kindlins. Kindlin-2 is ubiquitously expressed, while Kindlin-1 is predominantly expressed in 
epithelia and Kindlin-3 exclusively in hematopoietic cells. In addition to its previously 
characterized localisation in focal contacts, Kindlin-2 also localizes to keratinocyte cell-cell 
contacts upon differentiation. Finally, the studies revealed that Kindlin-3 localizes to 
podosomes, which are specialised cell-matrix adhesions of hematopoietic cells. 
The second aim was to directly test the function of Kindlins by individually disrupting the 
Kindlin genes in mice. Therefore three individual constitutive knockout mouse lines were 
successfully established as described in Papers II, IV and VII.  
The third aim was to analyse the individual knockout phenotypes, and in particular to 
compare the phenotype of the Kindlin-1 knockout to the Kindler Syndrome. As expected from 
the different expression patterns the phenotypes of the Kindlin knockout mice were diverse. 
Kindlin-2 is the only Kindlin expressed already in embryonic stem (ES) cells. Disruption of the 
Kindlin-2 gene results in lethality around embryonic day (E) 5.5-6.5. In vitro studies with 
embryoid bodies (EBs) demonstrated that loss of Kindlin-2 abrogates integrin activation 
(inside-out signalling) leading to detachment of primitive endoderm and epiblast from the 
basement membrane (BM) and finally to the deterioration of the EBs (Paper II).  The study 
also identified Kindlin-2 as an important regulator of integrin outside-in signalling. This was 
shown as Mn2+ treated Kindlin-2 deficient primitive endoderm cells were unable to spread 
and to recruit integrin linked kinase (ILK) into focal adhesions (FAs).  A general overview 
about the function of ILK its association with other proteins and its role during development is 
reviewed in Paper III. 
Kindlin-3 deficient mice were born although a few displayed embryonic lethality due to severe 
bleedings. The newborn mice died within one week after birth due to severe haemorrhages 
and anaemia (Papers IV and V).  In Paper IV we showed that Kindlin-3 deficient platelets 
are unable to activate integrins resulting in an inability of them to adhere to injured vessel 
walls and to form thrombi.  
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Apart from this platelet defect, these mice develop a severe anaemia, which was analyzed 
with stable isotope labelling of the entire mouse proteome. These studies revealed that 
Kindlin-3 deficient erythrocytes have structural defects caused by an almost complete 
absence of ankyrin-1, band 4.1, adducin-2, and dematin from their membrane fractions. 
Thus, Kindlin-3 is an important structural element for the membrane cytoskeleton of 
erythrocytes (Paper V).  
Importantly, we could identify mutated Kindlin-3 to cause Leukocyte Adhesion Deficiency-III 
(LAD-III) syndrome. LAD-III is characterised by an inability of leukocyte β2 integrin to become 
activated and patients (Paper VI). 
Deletion of Kindlin-1 resulted in early postnatal lethality due to a severe ulcerative colitis (UC) 
triggered by shear stress-induced detachment of the colonic epithelium (Paper VII). The 
epithelial detachment was caused by an integrin activation defect. Interestingly, although co-
expressed in colonic epithelial cells, Kindlin-2 was unable to compensate for loss of Kindlin-1 
due to its localisation to cell-cell contacts. Additional analysis of the murine skin showed no 
signs of epidermolysis but a progressive skin atrophy which is also seen in Kindler Syndrome 
patients (Paper VII).  Thus this study showed that complete loss of Kindlin-1 results in severe 
intestinal complications and some but not all described skin symptoms. Recent data from 
patients demonstrate that complete loss of Kindlin-1 can result in UC preceding 
epidermolysis in humans. Thus, these data showed that Kindlin-1-/- mice model the most 
severe form of Kindler Syndrome. 
In primary human keratinocytes Kindlin-1 and Kindlin-2 can form a ternary complex with 
Migfilin, a LIM domain containing protein (Paper VIII), although neither Kindlin-2 nor Migfilin 
localisation was depending on the presence of Kindlin-1. We identified Kindler Syndrome 
patients that, in addition to reduced Kindlin-1 levels, had also reduced Kindlin-2 and Migfilin 
immunostaining, suggesting that abnormal levels of Kindlin-1 associated proteins may lead 
and/or contribute to Kindler Syndrome. Furthermore, we identified a novel mutation in the 
FERMT1 gene, which affects splicing of exon 13 and gives rise to a severe form of Kindler 
Syndrome (Paper IX).  
The fourth aim addressed the molecular mechanism underlying the Kindlin defects. The 
studies revealed that Kindlins share a common binding site at integrins cytoplasmic domains. 
Kindlins bind the membrane distal NxxY motif within the cytoplasmic domain of β1 and β3 
integrins. In addition these studies demonstrated for the first time that Talin requires integrin 
bound Kindlins to trigger integrin activation (Papers II, IV and VII). 
 
In summary, Kindlin proteins are essential triggers of integrin affinity. The individual 
phenotypes of Kindlin deficient mice reflect the spatial and temporal expression pattern of 
these proteins, rather than different functions. Our studies underlined the important role of 
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Talin in integrin activation. However, we introduced the Kindlin proteins as essential 
elements in this process. The exact mechanism of how Kindlins assist Talin in integrin 
activation and the identification of additional functions will be challenging tasks for future 
studies. 
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Kindlins 
The Kindlin family of proteins consists of three members (Kindlin-1, -2 and -3) in mice and 
men. They share an evolutionary conserved gene and protein structure. Kindlin-2, formerly 
named Mig-2 (mitogen inducible gene 2/PLEKHC1) was the first described family member. It 
was discovered in a differential cDNA library screen for mitogen induced genes [1]. More 
recently, two other family members have been described; URP1 (Unc-112 related protein 1; 
Kindlin-1) and URP2 (Kindlin-3) [2]. Blast searches identified one Kindlin orthologue 
(Uncoordinated protein 112 (UNC-112)) in C.elegans and two (fermitin-1 and -2) in 
Drosophila. 
 
Kindlin proteins have a common domain composition but there are some differences on the 
DNA and protein level. A phylogenetic tree illustrates the relationship between the three 
proteins in comparison to the C. elegans orthologue UNC-112. As shown in figure 1, Kindlin-
1 and Kindlin-2 are slightly closer related to each other than to Kindlin-3. However, despite 
some areas of variability especially at the N-terminus and within the FERM (Band 4.1, ezrin, 
radixin, moesin) domain at the border between the F2 and F3 subdomain, the amino acid 
sequence is highly conserved (see figure 2). 
Kindlin-1 
Kindlin-2 Mouse 
Kindlin-3 
C. elegans UNC-112 
 
Figure 1: A phylogenetic tree of Kindlins. 
 
In comparison to other FERM domain containing proteins, the Kindlin FERM domain has 
been found to share closest homology with the FERM domain of Talin. Talin is a large 
(~250kDa) cytoskeletal protein with an important role in the regulation of integrins, a family of 
heterodimeric transmembrane receptors important for binding to extracellular matrix 
components (ECM). Both Talin and integrins will be discussed in more detail below. 
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Figure 2: Murine Kindlin protein alignment. NLS; nuclear localisation signal. **** indicates a 
NPXY motif in Kindlin-1 and Kindlin-2. PH; pleckstrin homology domain. 
 
Kindlin gene and protein structure 
Analysis of the exon/intron organization of the genes and the protein domains revealed a 
common structure, indicating that the three Kindlins recently separated in evolution. The 
genes consist of fifteen exons with the translation start codon in exon 2. Murine Kindlin 
proteins (1-3) have a length of 677, 680 and 665 amino acids, respectively. They are 
composed of a central FERM domain whose F2 subdomain contains a pleckstrin homology 
(PH) domain (see figure 3) [2].  In addition, Kindlin-2 has a nuclear localisation signal in the 
N-terminus of the protein that is neither present in Kindlin-1 nor in Kindlin-3. 
 
 
 
Figure 3: Kindlin protein structure; F1, F 2 and F3 are the subdomains of the FERM domain and 
PH is indicating the pleckstrin homology domain.  
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FERM domains 
FERM domain-containing proteins (81 in mice; http://smart.embl-heidelberg.de) constitute a 
heterogeneous family of membrane proteins that function as membrane-cytoskeleton linkers 
[3]. The FERM domain itself is around 200-300 amino acids (in Talin [4] and Band 4.1 [5], 
respectively) long. It was initially identified in Band 4.1 from erythrocyte ghosts [5].  Diverse 
studies on FERM domain containing proteins like Band 4.1, Merlin, protein phosphatases 
and Talin, unravelled an important role of this domain in membrane localising proteins [3]. 
Furthermore, Ezrin, Radixin, Moesin (ERM proteins) [6,7,8,9,10,11] and Talin [4] have been 
shown to mediate the linkage of transmembrane receptors with the actin cytoskeleton. 
FERM domains are divided into three subdomains, F1-F3. The first subdomain has a 
ubiquitin fold, the second an α-helix bundle structure, and the third subdomain was classified 
as a pleckstrin homology (PH)-like or phospho tyrosine binding (PTB) domain, which belongs 
to the PH domain superfold family [12,13,14].  ERM proteins and Talin use the PTB domain 
for binding adhesion molecules. Although they share a similar function, the sequence 
homology can be variable with only 24% homology between ERM proteins and Talin. 
PH/PTB superfamily 
The PH/PTB domain superfold family is characterised by a common core fold, where two 
nearly orthogonal β sheets form a β sandwich with an α-helix capping off at one closed 
corner [14,15]. 
PTB domains are found in around 50 proteins in mice and man (http://smart.embl-
heidelberg.de). This domain was initially identified in the Src homology 2 domain adaptor 
protein Shc, to mediate the binding of Shc to an NPXpY motif in activated receptor tyrosine 
kinases, such as the epidermal growth factor (EGF) receptor [16].  Interestingly, this 
recognition motif differs fundamentally from those of SH2 domains. In contrast to SH2 
domains, the amino acids N-terminally to the tyrosine define the specificity of the PTB 
domains. In addition, several other PTB domain containing proteins including Talin [17] or 
ICAP1α [18] either bind with the same or higher affinity to an unphosphorylated NPXY motif, 
indicating that the majority of PTB domains do not specifically interact with phosphorylated 
tyrosine residues.  
PH domains are also short (~120 amino acids) modules with a common fold. They consist of 
very diverse sequences and are present in around 250 human proteins (http://smart.embl-
heidelberg.de). Although they share a common core fold, PH domains have a variety of 
binding abilities [19]. Known ligands include structurally diverse proteins, phosphoinositides, 
and inositol polyphosphates/pyrophosphates [20].  
The main function of PH domains is to bind membrane phosphoinositides [21,22]. There are 
three potential phosphatidylinositol (PtdIns) phosphorylation sites; PtdIns(3), PtdIns(4) and 
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PtdIns(5) that refer to the position of the phosphate group on the D-myoinositol ring. These 
three sites can be phosphorylated in each combination resulting in mono, bi-, and tri-
phosphorylated PtdIns in a synergism of different kinases like phosphoinositide 3-kinase 
(PI3K) and lipid phosphatases such as phosphatase and tensin homolog (PTEN) [15]. The 
bulk cellular levels of phosphoinositides are typically relatively low with <1% of total 
phospholipids [23] and the different phosphoinositides show distinct subcellular localisations. 
PtdIns(4)P, PtdIns(4,5)P2 (present at significant steady state levels), PtdIns(3,4,5)P3 and 
PtdIns(3,4)P2 (after receptor stimulation) can be found at the plasma membrane. In addition, 
PtdIns(4)P and PtdIns(4,5) are also found at the Golgi. PtdIns(3)P is mainly present at the 
endosome and in the nucleus, and PtdIns(3,5) is involved in vacuolar sorting. The spatial and 
temporal localisation of PtdIns(5)P is poorly understood, but a nuclear localisation has been 
suggested [15]. Thus, the specificity of a PH domain can be important for the subcellular 
localisation and targeting of the host protein. 
The role of UNC-112 in C. elegans 
First functional data on Kindlin proteins came from the C. elegans orthologue UNC-112. The 
name UNC-112  comes from a disorganized body wall muscle leading to paralysis in adult 
worms and uncoordinated movement in homozygous animals for the r367 allele of unc-112 
[24]. 
C. elegans has four muscle cell quadrants separated from the epidermis via a BM, which is 
composed of ECM such as Perlcecan/UNC-52. The BM is essential for the development of 
M-lines and dense bodies (see figure 4). Due to space limitations in the eggshell the embryo 
has to fold back upon itself twice during embryonic development, resulting in the formation of 
the two- and threefold stages of embryogenesis [25].  
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Figure 4:  Localization and arrangement of dense bodies and M-lines. Scheme shows the 
localization and arrangement of dense bodies and M-lines in C. elegans body wall muscle and 
fibrous organelles in the epidermis [26]. 
 
Therefore, embryonic movement starts before the twofold stage [26]. Force transduction 
within the muscle is accomplished through anchorage of actin and myosin filaments to the 
muscle cell membrane via linkage to PAT2/α integrin and PAT3/β integrin heterodimers. 
During sarcomere assembly, actin (thin bundles) and myosin (thick filaments) link to the cell 
body through dense bodies and M-lines, respectively (see figure 4). 
Interestingly, the unc-112 r367 phenotype can be suppressed by null mutations in a novel 
protein called dim-1 with unknown function [27]. However, null mutants of unc-112 show a 
much more severe phenotype compared to the r367 allele and display a paralyzed, arrested 
elongation at twofold stage (PAT) phenotype. A PAT phenotype indicates that the missing 
gene products are essential for the formation of a functional embryonic body wall muscle 
[28,29].  The unc-112 phenotype belongs like the unc-52 (perlecan), pat-2 (α integrin) and 
pat-3 (β integrin) phenotypes to the most severe variant of PAT phenotypes [28]. Rogalski 
and co-workers could show that GFP-tagged UNC-112 localises with PAT-3 to the basal cell 
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membrane in regions of contact with adjacent muscle cells, and to dense bodies and M-lines. 
They demonstrated that in UNC-112 deficient worms PAT-3/β integrin is localised to the 
plasma membrane but cannot be properly organised in dense bodies and M-lines. Deletion 
of UNC-112 did not alter localisation of UNC-52 or the PAT-3 association of DEB-1 (vinculin) 
[29].  
Conversely, it was shown that UNC-112 recruitment to the plasma membrane is dependent 
on PAT-3 and PAT-4 (ILK). The PAT-4 mammalian orthologue ILK has been reported to be 
an important mediator of integrin signalling and actin organisation [30,31]. Moreover, the 
proper localisation of PAT-4 itself seems also to be depending on UNC-112. This 
dependence may be achieved by direct interaction, as both proteins interact with each other 
in a yeast two hybrid assay. A more detailed analysis revealed that the first 31 amino acids of 
UNC-112 bind to a region in the pseudokinase domain of PAT-4, partly overlapping with the 
binding site of PAT-6/parvin [32,33].  
These data position UNC-112/ Kindlin as an important regulator of integrin clustering and 
integrin linkage to the actin cytoskeleton. The observations were further corroborated by 
RNAi studies in post-embryonic stages, where depletion of UNC-112 resulted in sterility due 
to defective ovulation and in migration defects of the distal tip cells that form the gonads. The 
sterility was caused by an inability of the mature oocytes to enter the spermatheca, which in 
turn was due to a greatly reduced contractility of the gonad sheath [34]. Thus, UNC-112 is an 
important regulator of actin mediated cell contractility. More recently, UIG-1 (UNC-112 
interacting guanine nucleotide exchange factor-1) was identified to bind to UNC-112 and to 
co-localise with UNC-112 at dense bodies. The consequences of this binding remain to be 
elucidated but the findings raise the possibility that UNC-112 additionally functions as a 
signalling scaffold [35]. 
Taken together, these first functional data on UNC-112/Kindlin confirmed the functional 
predictions based on the domain architecture. UNC-112 could be defined as an important 
regulator of integrin function. 
Integrins 
Integrins are heterodimeric surface receptors consisting of an α and a β subunit [36]. They 
mediate the connection between extracellular matrix components or cellular counter 
receptors and the actin cytoskeleton or intermediate filaments, which led to the name 
“integrin” [37]. This functional property allows them to regulate cell migration, proliferation, 
survival and polarity [38]. With increasing complexity of the organism the number of integrin 
receptors is raising. In C. elegans the integrin family consists of two members, which result 
from the combination of two α integrin subunits (PAT-2 and INA-1 [39]) and one β integrin 
subunit (PAT-3).  The Drosophila melanogaster genome codes for five integrins composed 
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out of five α and one β subunits [40]. In mammals the combination of 18 α and 8 β subunits 
gives rise to at least 24 distinct integrins. The globular head domains of the α and β subunit 
form the ligand binding domain. Accordingly, the ligand specificity depends on both subunits. 
Among this large family the twelve β1 integrins are the largest subclass (see figure 5). 
 
Figure 5: The mammalian integrin family.  Integrins are heterodimers composed of an α and a β 
subunit. The figure depicts the mammalian subunits and their αβ associations. The 
heterodimers can be grouped in several subfamilies based on evolutionary relationships 
(colouring of subunits), ligand specificity and, in the case of β2 and β7 integrins, restricted 
expression on white blood cells. α subunits with gray hatching or stippling have inserted I/A 
domains. Such α subunits are restricted to chordates, as are α4 and α9 (green) and subunits 
β2-β8. In contrast, α subunits with specificity for laminins (purple) or RGD (blue) are found 
throughout the metazoa and are clearly ancient. Asterisks denote alternatively spliced 
cytoplasmic domains. [36]. 
 
Integrins can be grouped into five classes; (i) RGD peptide recognizing integrins that bind 
molecules like fibronectin, vitronectin and others through an RGD motif; (ii) Laminin 
receptors; (iii) collagen receptors; (iv) leukocyte specific receptors that bind Ig-superfamily 
cell-surface counter-receptors such as VCAM-1 and mediate heterotypic cell-cell adhesion 
and (v) two related integrins (α4β1 and α9β1) that recognise both ECM proteins such as 
fibronectin and Ig-superfamily counter-receptors [36,41]. All integrins, with the exception of 
α6β4 integrin, which is connected to intermediate filaments, link to the actin cytoskeleton. In 
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addition, the α6β4 integrin differs from all the others with a much larger cytoplasmic domain 
consisting of 1072 amino acids. 
Integrin function in vivo 
Integrins have multiple functions, which are reflected by the diversity of phenotypes observed 
in mice lacking individual α or β subunits (see figure 6). This diversity originates from the 
different spatial and temporal expression pattern and the ligand binding specificity of 
individual integrins. There is an overwhelming literature on the in vivo function of the 
individual integrin subunits reviewed in [36,42]. Thus, only selected information will be 
provided here. An overview about the function of integrins during pre- and peri-implantation 
development, in skin, the intestine and platelets, is important to better understand the 
consequences of loss of Kindlin-1-3. Furthermore the focus will be on β1 and β3 integrins, 
which have been shown in this thesis to associate with Kindlins [43,44]. 
 
Figure 6: Phenotypes of integrin knockout mice during development. Diagram shows the 
embryonic and perinatal lethal phenotypes of single and double integrin–null mutant mice. The 
earliest lethal phenotype is observed in β1-deficient mice at E5.5. Studies of double α5/αv-null 
and α3/α6-null mice revealed a redundant and/or compensatory function for α5/αv during early 
mouse development and for α3/α6 in several organs and tissues including brain, and lung [42]. 
 
Murine pre- and peri-implantation development 
The pre-implantation development of mammals encompasses the period from fertilization to 
implantation. It is characterized by three distinct phases: (i) fertilization and followed by cell 
divisions; (ii) the establishment of cell polarity and compaction into a morula, (iii) lineage 
differentiation in blastocysts and implantation (figure 7) [45,46].  In mice the blastocyst 
develops around day E3.5 and is composed of three cell types, the outer terminally 
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differentiated epithelial trophectoderm, the primitive endoderm covering the inner cell mass. 
The trophectoderm mediates the first contact with the luminal epithelium of the uterus while 
the inner cell mass gives rise to the embryo proper. The primitive endoderm differentiates 
from the inner cell mass and further differentiates into visceral and parietal endoderm. Both 
cell types are separated via a BM from the inner cell mass and trophectoderm, respectively. 
After implantation inner cell mass cells adjacent to the BM differentiate into epiblast while the 
remaining inner cell mass cells undergo apoptosis, which leads to cavitation and formation of 
the pro-amniotic cavity. 
 
 
 
Figure 7: Pre-implantation development in mice. After fertilization in the oviduct the embryo 
proliferates and forms the morula. At this stage the embryo enters the uterine lumen and 
further develops into a blastocyst. The blastocyst is characterised by a cavity (blastocoel) and 
two different cell types, the inner cell mass and the trophectoderm, which will give rise to the 
trophoblast cells. In order to implant the blastocyst has to hatch from the outer shell called 
zona pellucida and further differentiate to form the epiblast and the primitive endoderm. At this 
stage the trophectoderm attaches to the uterine lining to initiate the implantation [45]. 
 
To facilitate the analysis of these embryonic stages an in vitro model, termed embryoid 
bodies (EBs), has been established. EBs are ES cell aggregates, which mimic endoderm 
and epiblast differentiation. The development of this in vitro system is limited partially due to 
the fact that no trophectoderm is formed. This is also responsible for peripheral aggregates 
of the parietal endoderm [47,48]. 
The role of integrins during pre- and peri-implantation development 
Several in vitro studies suggested a role of integrins in the interaction of the blastocyst with 
the luminal epithelium [49,50]. It has been shown that especially αvβ3 and αvβ5 integrins are 
expressed on the apical pole of the luminal epithelium [51] but also on the epithelial surface 
of blastocysts [52,53]. Furthermore, studies using arginine-glycine-aspartic acid (RGD) 
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blocking peptides or blocking antibodies against αvβ3 suggested that implantation in the 
mouse can be significantly reduced with these tools [54].  
In contrast to these studies, neither single knockouts of integrin subunits nor a combination 
of knockouts of different α subunits [42] led to a defect during pre-implantation so far This 
could either be the result of residual maternal mRNA, although unlikely [55], or a 
compensation by other integrins. Therefore, a double knockout of αv and β1 integrin could 
help to clarify whether integrins are important during pre-implantation (see figure 5). 
Deletion of the β1 integrin affects the largest number of integrin receptors. Thus, it is not 
surprising that constitutive deletion of β1 integrin leads to the most severe phenotype with 
lethality at the peri-implantation stage at around E5.5 [56,57].  In vitro analysis with β1 
integrin-deficient EBs revealed that the mutant endoderm is unable to secrete sufficient 
laminin α1 chains and thus fail to deposit a BM, to differentiate an epiblast and to cavitate 
[58]. Laminin α1 is required to form a functional heterotrimeric laminin [59], which in turn is a 
prerequisite for the formation of a BM [47]. Reconstitution of β1 integrin deficient EBs with 
laminin-111 permitted BM formation and epiblast differentiation although detachment of the 
outer endodermal layer was still present [60]. The important role of β1 integrin was further 
highlighted by the analysis of chimeric β1 integrin deficient mice, showing impaired 
recruitment of haematopoietic progenitor cells into the foetal liver and no homing of adult 
haematopoietic stem cells into the bone marrow [61,62] despite normal differentiation in vitro 
and in vivo [42]. 
Skin 
The skin is a complex organ consisting of more than 20 cell types. Its main functions are  
protection from water loss, temperature change, radiation, trauma and infections [63]. The 
skin is composed of three different layers. The outermost layer consists of a squamous 
stratified epithelial layer (epidermis).  The dermis is separated from the epidermis via a BM 
and is mainly consisting of ECM secreting fibroblasts of mesodermal origin. The subcutis is 
the third layer where the adipocytes reside. 
The epidermis itself consists of several layers of keratinocytes (see figure 8) that provide a 
physical barrier to the outside of the body. The basal keratinocytes face on their basal side 
the BM and contain the proliferative cell pool within the epidermis. 
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Figure 8: The epidermal architecture is shown in this schematic, illustrating the basement 
membrane at the base, the proliferative basal layer, and the three differentiation stages: 
spinous layer, granular layer, and outermost stratum corneum. [64]. 
 
During differentiation/stratification keratinocytes move upwards, withdraw from the cell cycle, 
downregulate their integrin expression and finally de-nucleate. Thereby these cells give rise 
to the spinous and granular layers and finally to the production of dead corneocytes of the 
stratum corneum that eventually shed from the epidermal surface [65]. 
The role of integrins in the epidermis 
The major integrins expressed in normal epidermis are the α6β4 and α3β1 integrin that bind 
laminins and α2β1 which is a collagen binding integrin [66]. Integrin expression is restricted 
to the basal keratinocytes (figure 8). 
Genetic deletion of either the α6 or the β4 integrin in mice results in loss of 
hemidesmosomes and severe keratinocyte de-adhesion from the BM [67,68,69] leading to a 
severe early postnatal lethal skin blistering phenotype. Similarly, mutations in the human β4 
integrin cause a recessive skin blistering disease termed junctional epidermolysis bullosa 
(JEB), that is also observed upon mutation of the main ligand laminin-332 [70]. 
The early lethality of β1 integrin-deficient mice required the establishment of a conditional 
knockout allele for the β1 integrin. Keratinocyte specific disruption of the β1 integrin gene 
during early embryonic development results in a stronger phenotype than observed in α3 
integrin-null mice, although α3β1 was believed to be the predominant keratinocyte β1 
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containing integrin [71,72]. The phenotype is characterised by reduced cell proliferation, 
extensive skin blistering, altered BM assembly and a failure of hair follicle keratinocytes to 
remodel the BM and invaginate into the dermis [65].  This indicates that other β1 integrin 
containing receptors such as α2β1 integrin have important functions in skin homeostasis as 
well. Later skin-specific β1 integrin deletion, around birth, results in hair-loss, epidermolysis 
and a reduced proliferation rate of basal keratinocytes. The role of other integrins is less 
clear. αvβ6 integrin, for example, is expressed upon injury or inflammation and known to bind 
TGF-β1 in its latent form. Deletion of the β6 integrin subunit does not alter wound healing, but 
leads to a local reduction of activated TGF-β1 [73,74]. 
Intestine 
The intestine, composed of the small intestine, the caecum and the colon, is part of the 
gastrointestinal tract that in addition includes the pharynx, oesophagus and stomach. 
Developmentally, the pharynx, oesophagus and stomach are formed from the foregut, while 
the small intestine, the caecum and the colon arise from the midgut and hindgut, respectively 
[75]. The intestinal epithelium like the epithelium in the skin provides a barrier to the outside 
of the body [76].   
In mice, the gut epithelium can be first identified at E7.5 as a single layer of proliferative, 
endodermal cells, followed by the formation of a pseudostratified epithelium within the next 
days [77].  While the oesophagus is lined by a stratified epithelium, parts of the stomach and 
the whole intestine (small intestine and colon) are covered by a single epithelial cell layer. 
The surface of the small intestine is increased by numerous evaginations (villi) and 
invaginations (crypts). In contrast, the colon lacks villi and the crypts are thus connected to a 
flat surface epithelium (see figure 9).  
The villi in the small intestine increase the surface of the small intestine to maximise nutrient 
and water resorption. The main function of the colon is the thickening of the stool, making a 
large surface dispensable. Thus the intestinal epithelium has a bi-functional role; on one side 
it has to function as a barrier to a massive bacterial load, but on the other side it has to 
permit passage of nutrients and water into the body. 
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Figure 9: Instestinal architecture. (A) The small intestine is characterised by large villi 
surrounded by stem cell containing crypts. The stem cells (dark blue) reside above the Paneth 
cells (yellow). The stem cells give rise to progenitor cells that further proliferate and occupy 
the remainder of the crypt. Differentiated cells (green) move upwards and populate the villus. 
(B) The colon lacks villi and instead has a flat surface epithelium. The putative stem cells (dark 
blue) reside at the crypt bottom and the progenitor cells occupy two-thirds of the crypt. The 
differentiated cells (green) populate the remainder of the crypt and the flat surface epithelium 
[78]. 
 
In order to achieve this multiple functions the intestinal epithelium differentiates into different 
specialised cell types: goblet cells, enterocytes, entero-endocrine cells and Paneth cells. 
While the goblet cells, enterocytes and entero-endocrine cells populate the villi the Paneth 
cells reside at the bottom of the crypts. The cells migrate within three days upwards from the 
crypts to the villus tips where they finally undergo apoptosis and are shed into the intestinal 
lumen [76,79,80]. Within the crypts there is a clearly defined positioning of the stem cells. 
While the stem cells are positioned at the crypt  mid in the  small intestine [81] and 
descending colon [82] they can be found in the crypt base of the ascending colon [83]. The 
stem cells slowly proliferate and give rise to progenitor cells that then further differentiate. 
Therefore, the intestine is an excellent tissue to investigate processes such as stem cell 
function, host defence, differentiation, cell migration and apoptosis.  
The role of integrins in the intestine 
The vast majority of studies on the function of intestinal integrins were performed in cell 
culture. Several studies, however, investigated the expression pattern of different integrins 
along the crypt villus axis, primarily in humans.  
These studies revealed expression of β1, β4, α2 integrins predominantly in the crypts and α3 
integrin on the villi. α6 and αv integrins expression is uniformly distributed from the crypts to 
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the villi tips, whereas α5 and α7 integrin show a very restricted expression pattern. α5 
integrin is only found at the crypt base and α7 integrin at the interface between the crypt and 
the villus. α6β4 integrins cluster into keratin linked hemidesmosomes that can be found in a 
regressing gradient from the crypts to the villi. In contrast to basal keratinocytes, intestinal 
epithelial cells lack major hemidesmosomal proteins like BP230 and BP180 and thus form so 
called type II hemidesmosomes [84].  In addition intestinal hemidesmosomes have a distinct 
role in mediating cell adhesion in comparison to the skin. This is best illustrated as mice 
lacking the intracellular domain of the β4 integrin develop severe epidermolysis but no 
intestinal epithelial detachment. However IECs show a severe proliferation defect due to an 
altered cell cycle control [85]. 
Initial data on ECM proteins showed a differential expression pattern of collagen IV isoforms 
[86,87], laminin 111, laminin 211  [88,89,90] and laminin-332 [91]. Laminin 111 is present in 
the villus while laminin 211 in crypts. Laminin-332, initially believed to be solely present in the 
BM of stratified epithelia, is expressed in an increasing gradient from the upper crypt to the 
villus tip [91]. These data suggested a relation between the integrin expression, the BM 
composition and the differentiation state of the intestinal epithelium [92].  
A detailed genetic analysis of the intestinal epithelium was limited due to the lack of specific 
Cre lines. The recent establishment of a Cre line using the villin promoter that is specifically 
activated in the intestinal epithelium [93], allowed the conditional deletion of genes in the 
intestine. The intestinal epithelial specific deletion of the β1 integrin with this villin-Cre strain 
did not result in altered epithelial adhesion, but in crypt expansion due to increased 
proliferation which was linked to reduced hedgehog expression [94].  
These data indicated that intestinal integrins have an important role in tuning stem cell and 
progenitor cell proliferation and differentiation. The absence of adhesion defects, especially 
in β1 deficient mice, suggests that αv containing integrins (see figure 5) might compensate. 
Deletion of individual α integrin subunits might provide further insights into the role of 
integrins in intestinal epithelial cell migration proliferation and differentiation. 
Platelets 
Platelets mediate primary haemostasis and are small anuclear cell fragments that arise from 
megakaryocyte cytoplasmic extensions called proplatelets (see figure 10). They are sheared 
from their transendothelial stems by flowing blood. [95,96]. Megakaryocytes are large 
polyploid cells of at least 16N in rodents and men that reside in the bone marrow of adults 
[97,98]. Polyploidy is achieved by endomitosis [97] and is required to produce enough 
templates for the high rate of transcription and translation. The production of secretory 
granules, like α- and dense granules, is a prerequisite for thrombopoiesis.  
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Figure 10: Formation of proplatelets. Shown is a cultured murine megakaryocyte stained for β 
tubulin. Long pseudopodia end with proplatelets (arrow) [95].  
 
Secretory granules originate from the Golgi complex [99] and acquire their content by a 
combination of synthesis, endo- and pinocytosis [100,101]. Several critical components of 
platelet function are incorporated into α- and dense granules, like P-selectin, αIIbβ3 integrin, 
van Willebrand Factor (vWF) and granulophysin, respectively [99]. 
The physiologic function of platelets is to seal injured blood vessels. This process has to be 
tightly controlled as abnormal platelet activation can lead to pathological thrombus formation 
causing myocardial infarction or stroke. 
Therefore, a tightly regulated signalling cascade is initiated once a platelet encounters an 
injury in the blood vessel wall (see figure 11). The first step in this haemostatic cascade is 
the interaction of platelets with the ECM. At sites of high shear stress, like in small arteries 
and arterioles, the initial tethering is mediated by the platelet receptor glycoprotein (GP)Ib 
and vWF bound to BM collagens [102]. This interaction has a very high off rate and is not 
able to mediate stable adhesion. Therefore in a next step an interaction between collagen 
and the immunoglobulin superfamily receptor GPVI forms. The low affinity interaction is not 
sufficient for stable platelet adhesion. However, it leads to a signalling cascade in platelets 
resulting in the activation of integrins enabling them to bind their ligands. Furthermore, GPVI 
binding triggers the release of secondary mediators ADP and thromboxane A2 (TXA2) from 
granules, which together with thrombin activates heterotrimeric G protein coupled receptors 
leading to full platelet activation. These cells are characterised by shape change, secretion 
due to degranulation and aggregation upon integrin activation [96,103]. 
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Figure 11: Schematic of platelet adhesion and aggregation on the ECM. Initial platelet contact 
is mediated via a GPIb/ vWF interaction. This results in platelet tethering and GPVI/ collagen 
interactions. The binding of GPVI to collagen induces integrin activation and release of ADP 
and TXA2. In parallel, tissue factor (TF) induces thrombin formation which also leads to platelet 
activation. [96] 
 
The role of integrins in platelets 
Platelets express five different integrin receptors namely, α2β1, α5β1, α6β1, αIIbβ3 and 
αvβ3 integrin. Initially it was believed that α2β1 integrin is the main platelet collagen receptor 
mediating firm adhesion. Studies in α2 and β1 integrin deficient mice, however, showed no 
major haemostatic defect. These data revealed that α2β1 integrin only supports adhesion to 
fibrillar collagen whereas the main collagen adhesion molecule is GPVI [104,105,106].  GPVI 
mediates only low affinity adhesion, thus it is believed that other receptors, most notably 
αIIbβ3 integrin, mediate shear resistant attachment to the ECM [96,102]. 
αIIbβ3 integrin binds an RGD sequence (see figure 5) present in proteins such as fibrinogen, 
its cleavage product fibrin, vWF, fibronectin, thrombospondin and vitronectin. Among those 
ligands fibrinogen is especially important as it has two binding sites for the αIIbβ3 integrin. 
Thus, it can serve as a bridge to connect two platelets and thus mediates their aggregation.  
αIIbβ3  integrin is the most abundant glycoprotein on the platelet surface [107], and lack or 
dysfunction of αIIbβ3 integrin results in Glanzmann thrombasthenia in humans [108]. This 
inheritable disorder is characterised by a failure of platelets to aggregate. The severity of the 
observed bleeding defects varies among patients [109]. Similarly mice lacking the β3 integrin 
subunit have absent platelet aggregation, reduced clot retraction and greatly reduced 
fibrinogen uptake into platelets [110]. The role of the other integrins present in platelets is 
less well described. Recent reports suggest, that these integrins might modulate platelet 
response by the nature of the exposed ECM, as the laminin binding α6β1 integrin for 
instance enhances platelet spreading through GPVI [111].  
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Taken together integrins have a variety of different functions. They primarily mediate a 
connection between the extracellular environment and the cellular cytoskeleton. Thereby 
they provide a mechanical link but also provide a signalling platform sensing the cellular 
surrounding. The essential role of integrins in cellular adhesion is underlined by (i) the severe 
most often lethal phenotypes upon deletion of key integrin subunits or (ii) the expression of 
compensating integrins to overcome the potential loss of one integrin subunit.  
Integrin activation (Inside-out signalling)  
Regulating the affinity of individual integrins for their ligands is an additional regulatory step 
to modulate the function of integrins. This becomes most apparent when looking at platelets. 
Constitutive activation of αIIbβ3 integrin would be incompatible with life. Platelets would bind 
their major ligand fibrinogen, present at high levels in the plasma and aggregate leading to 
instant thrombosis. A theoretical possibility to circumvent this would be the intracellular 
storage of these receptors and the transport to the cell surface upon stimulation. This is 
indeed partially the case as αIIbβ3 integrin is stored in α-granules that fuse with the plasma 
membrane upon GPVI signalling. However, the high amounts of αIIbβ3 integrin on the 
surface of resting platelets suggest an additional regulatory step. 
Structural analysis of the extracellular domain of αvβ3 integrin [112,113,114] revealed a 
bended, v-shape conformation unable to bind immobilzed ligands like fibronectin or 
vitronectin (see figure 12A). Upon treatment with Mn2+, a known activator of integrins [115], 
or RGD peptide binding, αvβ3 extracellular domains undergo a dramatic global change in 
conformation and converted to an extended form (see figure 12B and C) [114].  These and 
other studies led to the conclusion that integrins exist in an inactive (low affinity, bended) and 
an active (high affinity, extended) conformation [116]. 
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integrin subunit can interact with each other to regulate integrin activity [36]. Studies on 
αIIbβ3 integrin showed that the αIIb cytoplasmic domain acts as negative regulator of 
activation and that deletion of it results in a constitutively active integrin [118,119]. The same 
effect could be observed upon mutation of the membrane-proximal segment in the β3 
integrin, destroying a salt bridge between R995 of αIIb and D723 of β3 integrin [120,121]. It 
was shown that the separation of the two integrin tails leads to conformational changes 
characterized by the described switchblade-like opening of the bended inactive into the 
extended active integrin [122]. Therefore changes in the intracellular binding of proteins to 
the β integrin cytoplasmic tail translate into structural changes in the extracellular part of the 
heterodimer resulting in a high affinity fold. 
Talin mediates integrin activation 
Talin-1 (mostly referred to as Talin) is a large cytoplasmic adaptor protein (~250kDa) [4] with 
a FERM domain located at the N-terminus or head region. It was shown that Talin is 
essential for integrin activation. It binds via a PTB domain encoded in the FERM domain to 
an NPLY (amino acids 744-747) motif of β3 integrin [17,123,124,125].  
 
 
Figure 13: Structural model of Talin induced integrin activation (A) αβ integrin heterodimer 
connected via a salt bridge. The talin F3 domain is shown as surface representation and 
coloured by charge. (B) The Talin F3 domain binds to the membrane distal (MD) part of the β3-
integrin tail (in red). This results in a higher order of the β3 integrin cytoplasmic tail but the αβ 
interaction remains intact. (C) The Talin F3 domain additionally interacts with a membrane 
proximal (MP) region of the β3 integrin cytoplasmic tail. This induces the destabilization of the 
αβ integrin saltbridge and the stabilization of the helical structure of the MP region. 
Furthermore the Talin F3 domain can electrostatically interact with acidic lipid head groups in 
the plasma membrane. These changes result in the separation of the integrin tails and integrin 
activation. [125] 
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Structural analysis of the β3 integrin and Talin head interaction showed that the initial PTB-
NPLY interaction does not result in separation of the integrin tails but enables Talin binding 
to more membrane proximal regions within the β3 tail [125] leading to separation of the 
integrin tails [123,124,126] (see figure 13). Recently it has been shown, that the F3 
subdomain of the FERM domain, encoding the PTB domain, is sufficient to promote β3 
integrin activation. Interestingly additional elements in the F1 domain are required to promote 
β1 integrin activation [127]. This indicates certain differences between the individual integrin 
heterodimers with regards to their activation mechanisms. The essential role of Talin in 
integrin activation is underlined by the severe adhesion and aggregation defects of Talin-1 
deficient platelets that mimic loss of β3 integrin [128].  
Apart from Talin-1 a second gene, Talin-2 has been identified, but it is not very well 
characterized. This is mainly due to the lack of Talin-1 or -2 specific antibodies and the very 
restricted expression pattern of Talin-2 [129]. However it is currently believed that Talin-2 
compensates during early embryonic development for the loss of Talin-1. This could explain 
the relatively late embryonic lethality of Talin-1 deficient mice around E8.5-9.5 [130]. In 
addition a mutational screen within the β3 integrin cytoplasmic tail identified a Y759A 
mutation in the membrane distal NxxY motif also to inhibit integrin activation, despite normal 
Talin binding. This suggests that additional proteins are involved in Talin mediated integrin 
activation [131]. 
Nevertheless, binding of Talin or the Talin head to the β integrin cytoplasmic tail induces 
integrin activation. Thus this binding event has to be tightly regulated either at the level of 
Talin or integrins [132,133]. At the level of integrins post-translational modifications of 
cytoplasmic tails could alter Talin binding. Indeed, Src family kinases phosphorylate β  
integrin cytoplasmic tail NPXY motifs [134,135] which inhibits the Talin PTB/NPXY interaction 
[136,137,138]. Whether this phosphorylation plays a role in vivo has to be elucidated. Mice 
harbouring tyrosine to phenylalanine mutations of both NxxY motifs of the β1 integrin did not 
show any abnormalities while tyrosine to alanine mutations resembled a null phenotype 
[139]. The specific effects of Talin phosphorylation on its function are not known [132]. 
However, Talin is known to form a homodimer [140], while other FERM domain containing 
proteins exhibit an autoinhibitory intramolecular binding [141]. This creates the possibility that 
the integrin binding site is masked by an intra- or intermolecular interaction. In addition 
phosphatidylinositol 4,5-bisphosphate promotes Talin binding to integrin β1 tails associated 
with a conformational change in Talin exposing the integrin binding site [142]. Finally, 
calpain-mediated cleavage of Talin was shown to release the Talin head from the rod domain 
that binds the β3 integrin cytoplasmic tail with a six-fold higher affinity than full length Talin 
[124,143]. Thus the Talin-integrin interaction is tightly regulated in order to prevent 
unintentional integrin activation. 
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Outside-in Signalling 
Activation of integrins permits ligand binding. This information is transmitted from the 
extracellular domain to the cytoplasm in a process called outside-in signalling. Diverse 
signalling events are subsequently initiated regulating processes like cytoskeletal 
strengthening, migration but also cell proliferation and apoptosis. The processes that 
regulate the number and spatial organisation of integrin-ligand bonds are best characterised 
for adhesion strengthening [116].  
Cell matrix adhesions can be divided into four groups; immature focal complexes, mature 
FAs, fibrillar adhesions and podosomes [144]. Focal complexes are ~100nm dot-like matrix 
adhesions at membrane protrusions that either disassemble or further mature. They give rise 
to larger more elongated FAs that are best distinguished from focal complexes by their 
anchorage to actin stress fibres. Fibrillar adhesions are a special form of FAs that are mainly 
composed of α5β1 integrins and are thought to be important for the parallel orientation of 
fibronectin fibres along the actin stress fibres [145]. Finally, podosomes are specialised 
adhesion structures of monocyte derived cells with a circular structure and an actin core 
[146]. 
Despite its role in integrin activation, Talin is a central element in the initial steps of focal 
complex formation. Talin has two integrin binding sites. The PTB site within the Talin head 
domain, which is crucial for integrin activation, and a lower affinity binding site in the Talin rod 
[147]. These two sites and a potential dimerisation site within the Talin rod mediate initial 
integrin clustering. In addition to its integrin binding ability Talin has three actin and vinculin 
binding sites in its rod domain [148]. Vinculin binding to Talin and its recruitment to focal 
complexes is dependent on its activation by PIP2. Local production of PIP2 is accomplished 
by Talin mediated recruitment of PIPKIγ  [149]. Therefore the proper recruitment of these 
proteins can be seen as minimal requirement for the formation of focal complexes, the 
linkage to the actin cytoskeleton and their maturation into FAs.  
In addition to these proteins a multitude of different signalling and structural proteins are 
recruited to focal adhesions that regulate cell adhesion, migration but also proliferation and 
apoptosis [38]. The multitude of signalling events concentrated at FAs is maybe best 
described by the fact that staining with anti-phospho tyrosine antibodies nicely stains FAs. In 
addition to Talin, more than 20 proteins are able to bind the cytoplasmic domain of integrins 
and thus are part of focal contacts. The vast majority of these proteins interact with different β 
integrin cytoplasmic tails rather than with the even shorter cytoplasmic tails of α integrin 
subunits. The diverse list of proteins includes actin-binding proteins, enzymes, adaptor 
proteins, transcriptional co-activators and others of unknown function [150]. Due to the short 
length of the cytoplasmic tail the in vivo relevance and co-occurrence of these interactions 
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has to be addressed in future studies as not all of these proteins can bind one cytoplasmic 
tail simultaneously. 
Kindlin function in mammalian cells  
In comparison to integrins, relatively little is known about the role of Kindlin proteins in 
mammalian cells. Kindlins were shown to be differentially expressed in lung and colon 
carcinomas. Kindlin-1 was identified to be overexpressed in colon and lung cancers, while 
Kindlin-2 was overexpressed in breast cancer [2]. Kindlin-3 is overexpressed in B-cell 
malignancies [151]. The functional consequences of this deregulated Kindlin expression 
remain to be elucidated. In addition to theses data, mutations in the FERMT1 (C20ORF42, 
KIND1) gene, encoding for Kindlin-1, uncovered the genetic cause for Kindler Syndrome 
[152,153], a very rare skin blistering disease. 
Kindler Syndrome 
The Kindler Syndrome was first described by Theresia Kindler (1890-1975) in 1954 [154]. 
She described a 14 year old girl showing a combination of epidermolysis bullosa heriditaria  
and poikiloderma congenitale [155].  
The clinical overlap with dystrophic epidermolysis bullosa [70] and hereditary acrokeratotic 
poikiloderma (Weary Syndrome) [156] makes the diagnosis of Kindler Syndrome still difficult 
[157]. This could explain the very low number (slightly above 100) of cases reported up to 
now worldwide. 
 
Figure 14: Characteristic clinical presentation of Kindler Syndrome. This patient showed 
poikiloderma on the face, neck and hands and ulceration is present on the lower lip [158]. 
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The characteristic features of this disease are acral blistering in infancy and childhood, 
progressive poikiloderma, skin atrophy, photosensitivity [159] and periodontal inflammation 
[160] (see figure 14). Furthermore, a predisposition to squamous cell carcinomas, already at 
very young age, has also been reported [159]. Besides the predisposition to squamous cell 
carcinomas and a potential secondary infection Kindler Syndrome per se does not reduce 
the life expectancy of patients.  
If present, blister formation occurs close or at the dermal/epidermal junction, separated by 
the BM (seen figure 15). In contrast to dystrophic epidermolysis bullosa, Kindler Syndrome 
shows multiple planes of split within the basal keratinocytes and/or in the lamina lucida, as 
well as extensive reduplication of the lamina densa [161,162,163].  In addition, skin biopsies 
frequently show hyperkeratosis, epidermal atrophy, hyper- and hypo-pigmentation and 
telangiectasiae [164]. The clinical course heavily depends on the age of the patient. A large 
heterogeneity in the appearance and also disappearance of symptoms is characteristic for 
this disease. 
 
Figure 15: H&E staining of a sun exposed skin biopsy taken from a seven year old Kindler 
Syndrome patient. The picture shows vacuolar alteration of the basal keratinocytes and early 
cleft formation. In addition, sparse lymphocytic dermal infiltrate can be observed.  [165].  
 
Initially mutations or abnormal deposition of the extracellular matrix component collagen VII 
have been hypothesised as cause of Kindler Syndrome [166] but could be excluded by 
linkage and mutation studies [161,167]. Alternatively, it has been proposed that Kindler 
Syndrome is primarily an apoptotic skin disorder [168], which could not be confirmed in more 
recent reports [169]. 
Finally, the identification of mutations in the human FERMT1 gene coding for Kindlin-1 as 
cause of Kindler Syndrome, advanced the understanding and diagnostics of this disease 
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[152,153]. Using DNA sequencing and specific antibodies raised against the C-terminus of 
human Kindlin-1 it is now possible to diagnose Kindler Syndrome. Currently more than 30 
mutations in the FERMT1 gene have been identified. Interestingly, however, it was not 
possible to correlate the severity of this disease or the occurrence of specific symptoms with 
a specific mutations in the Kindlin-1 gene [160]. Very recently, three cases revealed a 
correlation between N-terminal mutations in Kindlin-1 and the appearance of UC 
[170,171,172], indicating that Kindlin-1 could have an important role in other epithelia, too. 
The identification of Kindlin-1 as part of the integrin actin connection allowed the conclusion 
that Kindler Syndrome is the first skin blistering disease caused by detachment of the actin 
cytoskeleton from the basal cell membrane. Nevertheless, it is unknown to which extend the 
perturbed actin linkage contributes to the symptoms of Kindler Syndrome.  Certainly, the loss 
of this mechanical linkage can explain the skin blistering observed, but it already fails to 
explain why the patients loose this feature when they become older. In addition, many other 
prominent features like the poikiloderma cannot be explained by an altered actin linkage, 
suggesting additional functions of Kindlin-1 in keratinocytes and maybe also melanocytes. 
Kindlins in integrin signalling 
 
Figure 16: Kindlin interaction partners. Kindlin-1 has been shown to interact with β1 and β3 
integrin cytoplasmic tails.  Kindlin-2 interacts with ILK and Migfilin. Migfilin in addition 
interacts with Filamins, providing a linkage to the actin cytoskeleton. Kindlin and actin 
interaction via ILK is mediated via binding of ILK to parvins. (modified from [30]) 
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The first member of the Kindlin family that was functionally characterised was Kindlin-2. Tu 
and co-workers showed that Kindlin-2 localises to FAs, where it binds a LIM domain-
containing adaptor protein, called Migfilin [173] (see figure 16). This is of special interest as 
Migfilin was shown to interact with Filamin A and B, which in turn are important in the 
assembly of the actin cytoskeleton [174,175]. Thereby the Kindlin-2/Migfilin/Filamin complex 
provides a novel link from the integrins to the actin cytoskeleton. Similar like UNC-112, 
Kindlin-2 has been suggested to bind ILK, which provides an additional link via Paxillin 
and/or Parvin to the actin cytoskeleton [30,122]. RNAi-mediated depletion of Kindlin-2 in 
HeLa and C2C12 cells resulted in impaired cell spreading and an altered organisation of the 
actin cytoskeleton. Unlike in C. elegans, these cells were still able to cluster integrins into FA 
and to recruit FA components like paxillin [173]. More recently it has been reported that 
Kindlin-2 can interact via its PTB domain in the F3 subdomain of the FERM domain with the 
cytoplasmic tails of β1 and β3 integrins. The exact interaction site within the β integrin was 
not determined. However, the authors excluded that Kindlin-2 binds to the same site as Talin, 
which contains a highly homologous FERM domain [44]. Furthermore Shi et al. could show 
that overexpression of EGFP-Kindlin-2 but not of a mutant form, unable to bind to β integrin 
cytoplasmic tails, leads to an increased activation of β3 integrins. In addition, overexpression 
of Kindlin-2 leads to increased cytoskeletal strengthening and a higher number of FAs [44]. 
In line with these observations, Kindlin-1 has been shown to interact with the cytoplasmic 
tails of β1 and β3 integrins too [43]. Interestingly, it was shown to bind the same NPXY motif 
within β1 and β3 integrin cytoplasmic tails as Talin does. Despite the identical binding sites 
overexpression of Kindlin-1 did not increase activation of β3 integrin [176]. Thus, there are 
conflicting findings in the literature regarding the mode of action of Kindlin-1 and Kindlin-2. 
This reflects either differences between these two proteins or different experimental 
handlings. Nevertheless, depletion of Kindlin-1 using RNAi impairs cell spreading of 
keratinocytes [43,176]. Furthermore, Kindlin-1 but not Kindlin-2 is transcriptionally 
upregulated upon TGF-β treatment and translocates from FAs to so called “membrane 
ruffles” [43]. 
Thus Kindlin-1 and Kindlin-2, although they share a common protein structure and are both 
components of cell matrix adhesions, seem to fulfil non redundant functions within FAs and 
to function in different cellular compartments when released from FAs. This notion is further 
supported by a recent report that described a nuclear localisation of Kindlin-2 in normal and 
neoplastic smooth muscle cells of the myometrium [177]. Although a potential function of 
Kindlin-2 within the nucleus is purely speculative, the Kindlin-2 binding partner Migfilin has 
also been shown to translocate to the nucleus and to function as a transcriptional co-
activator with CSX/NKX2-5 in cardiac differentiation [178]. This suggests that Kindlin-2 
together with Migfilin might act as a co-regulator of transcription. The important role of 
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Kindlin-2 has been further highlighted by a mouse line harbouring a gene trap insertion in the 
Kindlin-2 gene. Homozygous mice for this insertion were reported to die before E 7.5 [179]. 
Very little is known about the function of Kindlin-3. One report showed that overexpression of 
Kindlin-3 suppresses NF-κB activity via inhibition of nuclear translocation, which in turn leads 
to apoptosis [180]. Conversely, depleting Kindlin-3 using RNAi activates the NF-κB pathway 
and attenuates TNF-α induced apoptosis [180]. 
 30
Paper Summaries 
 Paper Summaries 
The Kindlins: subcellular localization and expression during murine 
development. 
Ussar S, Wang HV, Linder S, Fässler R, Moser M 
 
In this publication we show the murine expression pattern and subcellular localisation of all 
three Kindlin proteins. We show that Kindlin-1 is predominantly expressed in epithelia of 
different organs with highest expression in the intestinal epithelium. Kindlin-3 has a very 
restricted expression pattern and is exclusively found in the haematopoietic system. During 
embryonic development Kindlin-3 mRNA and protein was predominantly detected in the 
foetal liver, where the haematopoietic stem cells, B-cells and megakaryocytes, from which 
platelets arise, reside. In contrast to Kindlin-1 and -3, Kindlin-2 was widely expressed, 
already from the earliest embryonic stage (E7.5) investigated on, with highest expression in 
skeletal and smooth muscle. Using EGFP-tagged cDNA constructs we could show that 
Kindlin-1 and Kindlin-2 localize to cell-matrix adhesions, while Kindlin-3 is unable to do so in 
non-haematopoietic cells. Kindlin-3 localises to specialized matrix adhesion sites, called 
podosomes, in cells like macrophages or dendritic cells. Additionally we could show that 
Kindlin-2 translocates to cell-cell contacts upon differentiation of keratinocytes. 
Taken together we could show that (i) Kindlins are expressed already from very early 
embryonic development on, (ii) there is expression of at least one Kindlin in every cell type, 
while epithelia express both Kindlin-1 and Kindlin-2 and (iii) Kindlins are part of integrin 
containing cell-matrix adhesion sites and in case of Kindlin-2 additionally of cell-cell contacts. 
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Paper Summaries 
Kindlin-2 controls bidirectional signalling of integrins 
Montanez E*, Ussar S*, Schifferer M, Bosl M, Zent R, Moser M, Fässler R 
* equal contribution 
 
This publication identifies Kindlin-2 as an important regulator of integrin function. Mice 
deficient for Kindlin-2 die at the peri-implantation stage at around E5.5-6.5. ES cells, derived 
from these mice show severe adhesion defects and a lack of integrin activation in 
comparison to wild-type ES cells, expressing Kindlin-2 but no other Kindlin. We show that 
Kindlin-2 directly interacts with the membrane distal NXXY motif in β1 and β3 integrins via its 
PTB domain. In addition we can show that Kindlin-2 acts synergistically with Talin on integrin 
activation as overexpression of Kindlin-2 and Talin significantly increases integrin activation 
in comparison to Talin overexpression alone. To understand the embryonic lethality of 
Kindlin-2 deficient mice we used EBs. EBs deficient for Kindlin-2 showed (i) severe adhesion 
defects of the outermost cell layer (endoderm) and the epiblast to the underlying abnormally 
appearing BM, (ii) a delay in cavitation and (iii) an increased unorganized apoptosis. Isolated 
endoderm cells  from Kindlin-2 deficient EBs showed an inability of adhere and spread, while 
treatment of these cells with Mn2+, that forces integrins in an active conformation uncoupled 
from intracellular signals, restored the ability of the cells to adhere. However Kindlin-2 
deficient Mn2+ treated cells were still unable to spread due to an inability to recruit necessary 
proteins like ILK and thus to from mature FAs. These data showed that despite the function 
of Kindlin-2 in integrin activation, it is a crucial regulator of signal transduction upon ligand 
binding of integrins (outside-in signalling). 
In summary we show that Kindlin-2 is an important element of both integrin inside-out and 
outside-in signalling and that deficiency of Kindlin-2 results in very early embryonic lethality. 
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Integrin-linked kinase: integrin's mysterious partner 
Grashoff C, Thievessen I, Lorenz K, Ussar S, and Fässler R 
 
Here we review the functional properties of Integrin Linked Kinase (ILK). The review 
addresses the cell biological properties and the function of ILK in vivo. ILK is recruited to 
integrin adhesion as a ternary complex together with PINCH and parvin family members 
through other interaction partners like paxillin and Kindlins. 
ILK has two proposed functions. First, it is a central binding platform to regulate the actin 
cytoskeleton. This is evidenced by defective cell spreading, FA formation, cell adhesion and 
ECM assembly, upon loss of ILK. Second, ILK has been shown to regulate cell proliferation 
which has been proposed to rely on its putative serine/ threonine kinase activity to 
phosphorylate GSK3β and PKB/Akt. 
ILK deficiency causes embryonic lethality in C. elegans and peri-implantation lethality in 
mice, but none of the observed phenotypes could be attributed to its kinase activity. 
Additionally conditional ILK deletion in chondrocytes also did not result in altered GSK3β or 
PKB/Akt phosphorylation. 
Taken together, ILK is an important regulator of actin organisation during development and in 
adult tissue, its kinase activity, however, remains controversial. 
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Kindlin-3 is essential for integrin activation and platelet 
aggregation. 
Moser M, Nieswandt B, Ussar S, Pozgajova M, Fässler R 
 
This publication identifies Kindlin-3 as an important regulator of platelet function. We 
demonstrate that Kindlin-3 deficient mice develop bleedings already during embryonic 
development which causes lethality early after birth. Analysis of platelets derived from 
Kindlin-3 deficient foetal liver chimeras show an inability of these platelets to activate αIIbβ3 
integrin, therefore fail to bind fibrinogen, causing an inability to form thrombi.  We show that 
Kindlin-3 directly interacts with the membrane distal NXXY and a TT motif of β1 and β3 
integrins via its PTB domain. Using a macrophage cell line we could demonstrate that 
overexpression of Kindlin-3 increases the ability of these cells to bind an RGD motif 
containing fibronectin fragment, due to an increase in active integrins. This increased integrin 
activity, however, was dependent on the ability of Kindlin-3 to interact with the β integrin 
subunit, as a mutant form, unable to bind integrins, did not lead to increased fibronectin 
binding. In addition we could demonstrate that Kindlin-3 does not solely play a role in integrin 
activation (inside-out signalling) but also in signal transduction upon integrin ligand 
interaction (outside-in signalling). Therefore integrins on Kindlin-3 deficient platelets were 
activated using Mn2+ and allowed to adhere and spread on fibrinogen. Kindlin-3 deficient 
platelets were able to adhere to fibrinogen upon Mn2+ treatment, but did not spread and form 
lamellipodia, indicating that Kindlin-3 has an additional role in outside-in signalling. 
 
In summary we conclude, that Kindlin-3 is an important regulator of integrin affinity in 
haematopoietic cells, especially platelets. 
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SILAC-mouse for quantitative proteomics uncovers Kindlin-3 as an 
essential factor for red blood cell function 
Kruger M*, Moser M*, Ussar S, Thievessen I, Luber C,  A, Forner F, Schmidt S, Zanivan S, 
Fässler R, Mann M 
*equal contribution 
 
This publication describes the establishment of stable isotope labelling by amino acids in cell 
culture (SILAC) applied to whole mice. Using a special diet, in which normal 12C6-lysine (light) 
was replaced with 13C6-lysine (heavy), we were able to breed mice that were completely 
labelled with the heavy amino acid. This allowed the quantitative analysis of whole 
proteomes by mass-spectrometry. Labelling of mice with this diet had not effect on weight, 
fertility or litter size. Combination of this method with mouse genetics enabled us to show that 
platelets deficient for β1 integrin had comparable proteomes with the exception of β1 and its 
dimerisation partners, α2 and α6 integrin. In a second approach we analyzed β-parvin 
deficient hearts and could show that β-parvin deficiency is compensated by upregulation of 
α-parvin. Analysis of Kindlin-3 deficient erythrocytes revealed a severe anaemia, caused by 
structural alterations of erythrocytes. SILAC labelling of mice was applied to discover that 
Kindlin-3 deficient erythrocytes had an almost complete absence of ankyrin-1, band 4.1, 
adducin-2, and dematin in their membrane fractions, while other membrane skeleton proteins 
like α/β spectrin and band-3 were not changed. 
In summary we could show that mice can be completely labelled with 13C6-lysine allowing a 
quantitative proteome comparison. This method was used to show that Kindlin-3 deficiency 
in erythrocytes affects their shape and contributes to their severe anaemia. 
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Leukocyte Adhesion Deficiency-III (LAD-III) is caused by mutations 
in the adhesion protein Kindlin-3, * equal contribution 
Svensson L*, Howarth K*, McDowall A, Patzak I, Evans R, Ussar S, Metin A, Fried M, 
Tomlinson I,Hogg N 
*equal contribution 
  
Here we describe that mutations in the human Kindlin-3 cause LAD-III. Previously mutations 
in the Rap1-GEF, CalDAG-GEF1, have been described to cause LAD-III. Indeed, 
homozygosity mapping of two Turkish patients revealed a previously described C/A base 
exchange in the CalDAG-GEF1 gene (chr11:64.25-64.27Mb) but no mutation could be found 
in a Maltese patient.  The CalDAG-GEF1 mutation was previously described to alter splicing 
of exon 15 to exon 16. Interestingly, real time PCR did not reveal any statistically significant 
changes in CalDAG-GEF1 expression. Furthermore, expression of wild type CalDAG-GEF1 
could not rescue the adhesion and migration defects of EBV transformed B-cells derived 
from those patients on ICAM-1 and fibronectin. 
The FERMT3 (Kindlin-3) gene is located in close proximity (chr11:63.73-63.76Mb) to the 
CalDAG-GEF1 gene and the described phenotype of LAD-III patients shows high similarities 
to Kindlin-3-/- mice. Therefore the FERMT3 gene was sequenced and an R509X stop 
mutation in the two Turkish patients and an A>G change at the splice acceptor site of exon 
14 in the Maltese patient were found.  In addition to the altered amino-acid sequence, these 
mutations diminished mRNA stability. 
Unlike the rescue experiments with wild type CalDAG-GEF1, expression of wild type Kindlin-
3 fully rescued the adhesion and migration defects of EBV transformed B-cells from those 
patients. 
In summary we could show that mutations in the human Kindlin-3 gene result in a severe 
leukocyte adhesion deficiency syndrome due to an inability of β1, β3 and also β2 integrins to 
become activated and bind their ligands. 
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Loss of Kindlin-1 causes skin atrophy and early postnatal ulcerative 
colitis 
Ussar S, Moser M, Widmaier M, Rognoni E, Harrer C, Genzel-Boroviczeny O, Fässler R 
 
Here we show that loss of Kindlin-1, known to be mutated in the human skin blistering 
disease Kindler Syndrome, in mice leads to some skin features of Kindler Syndrome, but 
predominantly to a lethal early postnatal UC. Analysis of the neonatal skin revealed a severe 
epidermal atrophy due to an almost abolished proliferation of basal keratinocytes. The 
reduction in the proliferation was progressive as at birth proliferation rates were normal but 
declined during the following days. No epidermolysis could be observed even after 
application of mild stress. Interestingly, however, keratinocytes isolated from these mice 
showed adhesion and spreading defects. This suggests that either the composition of the BM 
or the lower turnover of adhesion structures prevents epidermolysis in vivo. 
Using a detailed histological and immunochemical analysis of the murine intestine we could 
identify the colostrum to cause epithelial rupture and subsequently, upon loss of the intestinal 
barrier, a severe inflammation that shows all signs of an UC in men. Importantly, a previous 
publication reported a neonatal case of Kindler Syndrome that developed an UC prior to the 
development of skin symptoms. This finding allowed us to conclude that the murine 
phenotype indeed reflects the human presentation of a complete loss of Kindlin-1. 
Furthermore, we could identify impaired integrin activation to cause the shear induced 
epithelial detachment. We could show that direct Kindlin-1 and β integrin interaction is 
important for Talin mediated integrin activation. We provide evidence that Kindlin-1 interacts 
via its PTB domain with the membrane distal NXXY motif of β1 and β3 integrins. We 
demonstrate that Talin, previously believed to be solely sufficient to promote integrin 
activation, needs at least one Kindlin protein to activate integrins. Interestingly Kindlin-1 and 
Kindlin-2 could compensate for this function in integrin activation in vitro but not in vivo due to 
a sequestration of Kindlin-2 to cell-cell contacts in epithelia of the skin and intestine.  
In summary, we could identify null mutations in the FERMT1 gene as the cause for a severe 
neonatal UC in mice and man that is triggered by defective integrin activation in the intestinal 
epithelium. 
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Paper Summaries 
Colocalization of kindlin-1, kindlin-2 and migfilin at keratinocyte 
focal contacts and relevance to the pathophysiology of Kindler 
syndrome 
Lai-Cheong JE, Ussar S, Arita K, Hart IR, McGrath JA 
 
In this publication we show that Kindlin-1 co-localises and complexes with Kindlin-2 and 
Migfilin at focal contact sites of human keratinocytes. Depletion of Kindlin-1 using RNAi did 
not result in altered levels or in a mislocalisation of Kindlin-2 or Migfilin. Skin biopsies taken 
from different Kindler Syndrome patients, however, revealed that several cases showed 
reduced immunolabeling of Kindlin-2 and Migfilin that seemed to correlate with the level of 
reduction of Kindlin-1 labelling. Interestingly not all Kindler Syndrome patients showed an 
absence of Kindlin-1 staining, although confirmed mutations in the FERMT1 gene. This is of 
special interest as immunostaining for Kindlin-1 is used as a diagnostic marker for Kindler 
Syndrome. Our data, however suggest that not all Kindler Syndrome patients necessarily 
need to have reduced staining intensity and that gene sequencing should be applied to 
exclude or confirm the diagnosis of Kindler Syndrome. Furthermore we could identify and 
describe the first potential Kindlin-1 interaction partners. To test whether these interactions 
are direct and which function these interactions fulfil will be interesting tasks. 
Taken together we could identify Kindler Syndrome patients that show normal Kindlin-1 
protein expression or despite a reduction in Kindlin-1 immunoreactivity also a reduction in 
Kindlin-2 and Migfilin. 
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Expression of truncated kindlin-1 leads to abnormal adhesion and 
migration of keratinocytes 
Has C, Ludwig RJ, Herz C, Kern JS, Ussar S,  Ochsendorf FR, Kaufmann R, Schumann H, 
Kohlhase J, Bruckner-Tuderman L 
 
This case report describes a 27 year old Kindler Syndrome patient that showed a 
homozygous splice site mutation at the first position of intron 13 c.1718+1G>A. The patient 
presented a severe form of Kindler Syndrome with skin blistering, skin atrophy, poikiloderma 
and fragility of the oral mucosa, diarrhoea and anal bleeding. Protein and mRNA analysis 
revealed that both protein and mRNA were present. The described mutation however 
resulted in a truncated Kindlin-1 protein, lacking the terminal part of the FERM domain, 
essential for Kindlin and β integrin interaction. Atrophic skin areas showed a reduction of 
proliferating keratinocytes. In vitro analysis of keratinocytes derived from the patient 
revealed, in line with previous reports from other Kindler Syndrome patient derived 
keratinocytes, deficits in proliferation and adhesion to fibronectin and laminin-332. In addition 
altered cell morphology and deficits in an in vitro wound closure assay could be observed. 
Taken together we could add an additional mutation affecting splicing of exon 13 to the 
known list of 31 mutations within the FERMT1 gene that results in all classical symptoms of 
Kindler Syndrome. 
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The three Kindlins are a novel family of focal adhesion proteins. The Kindlin-1 (URP1) gene is
mutated in Kindler syndrome, the first skin blistering disease affecting actin attachment in
basal keratinocytes. Kindlin-2 (Mig-2), the best studied member of this family, binds ILK and
Migfilin, which links Kindlin-2 to the actin cytoskeleton. Kindlin-3 is expressed in
hematopoietic cells. Here we describe the genomic organization, gene expression and
subcellular localization of murine Kindlins-1 to -3. In situ hybridizations showed that
Kindlin-1 is preferentially expressed in epithelia, and Kindlin-2 in striated and smooth
muscle cells. Kindlins-1 and -2 are both expressed in the epidermis. While both localize to
integrin-mediated adhesion sites in cultured keratinocytes Kindlin-2, but not Kindlin-1,
colocalizes with E-cadherin to cell-cell contacts in differentiated keratinocytes. Using a
Kindlin-3-specific antiserum and an EGFP-tagged Kindlin-3 construct, we could show that
Kindlin-3 is present in the F-actin surrounding ring structure of podosomes, which are
specialized adhesion structures of hematopoietic cells.
© 2006 Elsevier Inc. All rights reserved.
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Introduction
The Kindlin gene family is named after the gene mutated in
Kindler syndrome, an autosomal recessive genodermatosis in
humans [1]. Kindlin-1 is a member of a new family of focal
adhesion (FA) proteins. The family consists of three members
in mice and men. The Kindlin proteins are composed of a
centrally located FERM (Band 4.1/Ezrin/Radixin/Moesin)
domain interrupted by a pleckstrin homology (PH) domain.
The first member of this family was identified in a differential
cDNA library screen as mitogen inducible gene-2 (Mig2 now
termed Kindlin-2) [2]. The two other genes were initially
namedUnc-112 Related Protein 1 (URP1 now termedKindlin-1)
and URP2 (now termed Kindlin-3), due to their homology to
the Caenorhabditis elegans gene unc-112 [3]. Siegel et al. [5]
proposed to name the three different genes Kindlin-1 (URP1),
Kindlin-2 (Mig2) and Kindlin-3 (URP2/Mig2B [4]), which we will
also do throughout this article.
Kindlin-1 and Kindlin-2 have been shown to play an
essential role in integrin-mediated adhesion and spreading.
Both proteins localize to FAs and loss of either leads to
delayed cell spreading in different cell lines [6,7]. These
studies also showed that Kindlin-1 can interact with the
cytoplasmatic tails of β1 and β3 integrins and Kindlin-2 with
the integrin-linked kinase (ILK). Binding partners for Kindlin-
3 are not known. The ability of Kindlin-2 to bind Migfilin, a
LIM domain containing protein capable of binding Filamin,
revealed a novel linkage between integrins and the actin
cytoskeleton [7]. Whether Kindlin-1 also binds Migfilin has
not been investigated yet, although the high homology
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between Kindlin-1 and Kindlin-2 makes such a binding
activity very likely [8].
Genetic studies have so far been performed in humans and
C. elegans. Null mutations of the Kindlin orthologue Unc-112 in
nematodes are embryonic lethal due to a paralyzed arrested
elongation at twofold (PAT) phenotype. Unc-112 localizes
together with PAT3/β-integrin and PAT4/ILK to dense bodies
andM-lines atmuscle attachment sites, which link themuscle
to the bodywall. Loss of Unc-112 impairs cell–matrix adhesion
and integrin function resulting in muscle detachment from
the body wall and severe paralysis [9].
Loss of Kindlin-1 in humans gives rise to Kindler syndrome.
Kindler syndrome patients show different skin pathologies
that undergo changes during the patients' lifetime. The
syndrome is characterized by skin atrophy and trauma-
induced skin blisters at early life. During infancy, the blistering
becomes less and instead photosensitivity and progressive
poikiloderma develops. In addition, there are indications that
Kindler Syndrome patients may be prone to squamous cell
carcinoma development [10]. Kindler Syndrome is the first
skin blistering disease resulting from defects in actin cytoske-
leton anchorage to cell matrix adhesion sites [5,11,12,13].
However, the molecular mechanism leading to the multiple
defects of Kindler Syndrome is only poorly understood and
simple actin anchorage insufficiencies cannot completely
explain the phenotype.
Several reports describe a transcriptional misregulation of
Kindlins in various types of cancer. Kindlin-1 is overexpressed
in lung and colon carcinomas, whereas Kindlins-2 and -3 were
unchanged or even reduced [3]. Kindlin-2 expression has been
shown to be elevated in leiomyomas and greatly decreased in
leiomyosarcomas [14]. Interestingly, an almost exclusive
nuclear staining of Kindlin-2 was observed in both tumors,
suggesting additional functions of Kindlin-2. This observation
is of note since Migfilin has been shown function in the
nucleus as transcriptional coactivator during cardiomyocyte
differentiation in mice [15]. Finally, increased expression of
Kindlin-3 has been reported in different kinds of B cell
lymphomas [4]. However, the molecular role of Kindlin
proteins during tumor formation is so far completely unclear.
In the present paper, we report the expression of the three
Kindlins during murine development and in adult tissues and
characterize their subcellular localization in different cell
types.
Materials and methods
Northern blotting
Total RNA was extracted with Trizol (Invitrogen) following the
manufacturer's protocol. Total RNA (8 μg) was separated on a
denaturating agarose gel and transferred to Hybond N+
membranes (Amersham). The following primers were used
to amplify the Kindlin probes:
Kindlin-1 forward: TCTGAGGTTGACGAGGTAG (Exon 6);
Kindlin-1 reverse: ACTTCATTCATACCATCAGC (Exon 9);
Kindlin-2 forward: CTAGATGACCAGTCTGAAGACG (Exon 4);
Kindlin-2 reverse: TGAATCGGAGCAGCAAGGCC (Exon 6);
Kindlin-3 forward: GAGAAGGAGCCTGAAGAGGAG (Exon 4);
Kindlin-3 reverse: TAAATCGCAGCCAAAGCACATC (Exon 6).
The amplified probes were radiolabeled using the Redi-
Prime II random prime labeling kit (Amersham). Membranes
were hybridized overnight at 65°C in Church buffer, washed
and exposed for 1–8 days at −80°C with Kodak Biomax MS
screens (Kodak).
RT-PCR
Total RNA (1 μg) was used for first strand cDNA synthesis
according to the protocol of the manufacturer using Super-
Script III polymerase (Invitrogen) and random hexamer
primers. Specific cDNA fragments were amplified using the
following primers:
Kindlin-1 forward: CTACACCTTCTTTGACTTG;
Kindlin-1 reverse: AGGGATGTCAGTTATGTC.
Kindlin-2 forward: GTACCGAAGTAGACTGCAAGG;
Kindlin-2 reverse: CATACGGCATATCAAGTAGGC.
Kindlin-3 forward: AGCTGTCTCTGCTGCGTGCTC;
Kindlin-3 reverse: ATACCTTGCTGCATGAGGCAC.
Radioactive in situ hybridization
33P-UTP-labeled sense and antisense riboprobes were gener-
ated by in vitro transcription from linearized vectors contain-
ing Kindlins-1/-2/-3-specific cDNA fragments (see Northern
Blotting). Paraffin sections from mouse embryos at different
embryonic stages were dewaxed, rehydrated and hybridized
as previously described [16].
Antibody production and affinity purification
A Kindlin-3-specific peptide (EPEEEVHDLTKVVLA; aa 156–170)
was coupled to Imject Maleimide Activated mcKLH (Pierce)
and used to immunize rabbits. The antiserum was subse-
quently affinity purified using a commercial kit (SulfoLink Kit,
Pierce Biotechnology Inc., Rockford, IL, USA). High affinity
antibodies were eluted from the columnusing 100mMGlycine
buffer, pH 2.7 and then dialyzed against phosphate-buffered
saline (PBS).
Western blotting
Both cells and tissues from adult C57BL/6 mice were homo-
genized in lysis buffer (1% Triton X-100, 50 mM Tris–Cl pH 7.4,
300 mM NaCl, 5 mM EDTA and protease inhibitors (Roche)).
Equal amounts of total protein (about 20 μg) per lane were
separated on a 10% polyacrylamide gel and transferred to
PVDF membranes (Millipore). Kindlin-3 (1:1000), tubulin
(1:5000), GAPDH antibodies (1:5000; Chemicon) were used
together with the appropriate secondary antibody (1:50000 in
5% bovine serum albumin (BSA); Biorad).
Constructs
All Kindlin cDNAs were cloned into the pEGFP-C1 vector
(Clontech). A partial Kindlin-1 cDNA was obtained from Image
3143E X P E R I M E N T A L C E L L R E S E A R C H 3 1 2 ( 2 0 0 6 ) 3 1 4 2 – 3 1 5 1
clone 3157716. The missing N-terminal part was amplified
from epidermal cDNA by PCR using CAGGTCGAC-
CATCTGCCTGGGCCACAATG as forward primer and CAAGT-
CAAAGAAGGTGTAG as reverse primer. Kindlin-2 full-length
cDNA was obtained from Image clone 3596509. Kindlin-3
was cloned by amplifying a 558 bp fragment from the N-
terminus (CAGGTCGACATGGCGGGTATGAAGACAG; AGAA-
GTGTGCTGGCATGC) containing the start codon combined
with the residual nucleotides from the Image clone 4187161.
Final expression constructs were confirmed by sequencing.
Immunostaining
Paraffin sections were dewaxed, rehydrated and endogenous
peroxidase was blocked by incubating the slides for 20 min in
2.5ml H2O2/75mlmethanol. Blockingwas performed for 1 h in
PBS supplemented with 10% goat serum and 1% BSA.
Subsequently, the Kindlin-3 antibody (1:500) was incubated
at 4°C over night. Sectionswere incubatedwith a 1:200 dilution
of biotinylated anti-rabbit secondary antibody for one hour
and transferred to ABC solution (Vector Laboratories) for an
additional 30 min. Secondary antibody was detected with
diaminobenzidine (DAB). Counterstaining of the sections was
performed with methylene green and sections were mounted
with Entellan.
Immunohistochemistry
Cells were grown on fibronectin (5 μg/ml, Calbiochem) coated
glass cover slips, fixed with PBS supplemented with 4%
paraformaldehyde (PFA) and 3% sucrose, permeabilized with
0.25% Triton X-100 in PBS for 10min, blocked in PBS containing
3% BSA and 5% goat serum for 1 h. Cells were immunostained
for paxillin (monoclonal antibodies, BD Transduction), α-
actinin (monoclonal antibodies, Sigma), vinculin (monoclonal
antibodies, Sigma) and TRITC-labeled phalloidin (1:500; Sigma)
to visualize F-actin. Alexa647 and Cy3-conjugated secondary
antibodies were purchased from Molecular Probes. Stained
cells were mounted in Elvanol and pictures were taken with a
Leica DMRA2 microscope and a Hamamatsu camera.
Transfections
Immortalized wild-type mouse embryonic fibroblasts, mouse
keratinocytes, primary cardiomyocytes and dendritic cells
were transfected with the EGFP-Kindlin-1, EGFP-Kindlin-2 and
EGFP-Kindlin-3 cDNA constructs using Lipofectamine 2000
(Invitrogen) following the manufacturer's instructions.
Cell culture
Primary wild-type macrophages and dendritic cells were
derived from bone marrow of 5-day-old mice and cultured
on bacterial petri dishes for 7 days in DMEM, supplemented
with glutamine, 10% FCS, Pen/Strep (all Invitrogen), M-CSF (to
derive macrophages) or GM-CSF (to generate dendritic cells).
Both cytokines were derived from a hybridoma supernatant.
The supernatant was used in a 1:10 dilution.
Immortalized newborn mouse keratinocytes were main-
tained in MEM supplemented with 5 μg/ml insulin (Sigma),
10 ng/ml EGF (Roche), 10 μg/ml transferrin (Sigma), 10 μM
phosphoethanolamine (Sigma), 10 μM ethanolamine, 0.36 μg/
ml hydrocortisone (Calbiochem), glutamine (Invitrogen), Pen/
Strep (Invitrogen), 45 μM CaCl2 and 8% chelated FCS. For
differentiation keratinocytes were cultured in growthmedium
containing 1 mM CaCl2 over night. Immortalized mouse
embryonic kidney fibroblasts were maintained in DMEM
supplemented with 10% FCS.
Isolation and culture of neonatal mouse cardiomyocytes
Cardiomyocytes were isolated fromhearts of P1 newbornmice
by treatment with 0.4 mg/ml collagenase II (Worthington,
Freehold, NJ) and 1 mg/ml pancreatin (Sigma) in ADS buffer
(116 mM NaCl, 0.8 mM NaH2PO4, 1 g/l glucose, 5.4 mM KCl,
0.8 mM MgSO4 and 20 mM 2,3-butanedione monoxime in
20 mM HEPES, pH 7.35) for 10 min at 37°C. Fresh enzyme
solution (0.3ml/heart) was added and tissuewas incubated for
8min. The supernatant containing dispersed cardiac cells was
transferred to a new tube containing 1 ml FCS (per heart) and
centrifuged at low speed (80×g, 6 min), resuspended in 2 ml
FCS and kept at 37°C. The remaining tissue fragments were
incubated with fresh enzyme solution (0.3 ml/heart) as above
for additional 5 times. Cell suspensions were pooled and
centrifuged at low speed (80×g, 6 min) and resuspended in
4 ml ADS buffer.
Cells were grown on glass coverslips coated with fibro-
nectin (10 μg/ml) at a cell density of 3.0×105 cells/35-mm
culture dish in plating medium (67% DMEM, 17% M199
medium, 10% horse serum, 5% FCS, 1% Pen/Strep and
4 mM glutamine). Cells were incubated at 37°C in a 5% CO2
humidified incubator. The next day the plating medium was
replaced with maintenance medium (75% DMEM, 23.5% M199
medium, 0.5% horse serum, 1% Pen/Strep, 4 mM glutamine
and 0.1 mM phenylephrine).
MAC sorting of primary T and B cells
A whole spleen from an adult C57BL/6 mouse was strained to
obtain a single cell suspension. 3×107 cells were incubated in
300 μl PBS with 3 μl FITC conjugated B220 (PharMingen) and
CD3 (eBioscience) antibodies for 10 min at 4°C. Cells were
washed with PBS and incubated with 30 μl anti-FITC MACS-
beads (Miltenyi Biotec) for 10 min, washed with PBS, isolated
in a magnetic field and eluted from beads, following the
manufacturer's recommendations.
Results and discussion
Genomic organization of the murine Kindlin gene family
All three murine Kindlin genes were identified in a genomic
search of the Ensembl database using the human Kindlin
cDNAs. The chromosomal localization of the three human and
murine Kindlin genes is shown in Table 1. The human as well
as the murine Kindlin genes are composed of 15 exons with
the translation start site in exon 2. The murine Kindlin-1 gene
spans 38.5 kb resulting in a transcript of approximately 4.6 kb.
Themurine Kindlin-2 gene has a length of 70 kb and gives rise
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to a 3.2 kb transcript. Kindlin-3 represents the smallest gene
with 19.8 kb encoding a 2.5 kb mRNA.
Kindlin protein structure
Translation of the murine cDNAs results in proteins of 637 aa
(Kindlin-1), 680 aa (Kindlin-2) and 655 aa (Kindlin-3), respec-
tively. A sequence alignment between the three murine
Kindlin proteins revealed that Kindlins-1 and -2 are most
closely related, sharing 60% identity and 74% similarity, while
Kindlin-3 is more distantly related sharing 53% identity and
69% similarity to Kindlin-1 and 49% identity and 67% similarity
to Kindlin-2.
Kindlin proteins have a unique domain architecture. They
are composed of a centrally located FERM domain interrupted
by a PH domain [6]. FERM domains are found in a number of
proteins linking the membrane to the cytoskeleton [17].
Among these proteins, the FERM domain of talin is most
homologous to the Kindlin FERM domains. In vitro assays
have shown an interaction between Kindlin-1 and the
cytoplasmatic tails of β1 and β3 integrins [6]. Therefore, it
has been proposed that Kindlins bind to β1 and β3 integrins
with a similar mechanism as it has been described for talin
[18,19].
The second common domain within Kindlins is the PH
domain. Although PH domains are known to mediate binding
to phosphatidylinositol phosphates [20], the function and
specificity of this domain have not been further characterized
in Kindlin proteins.
A nuclear localization signal (NLS), amino acids 55–72, is
exclusively present in Kindlin-2 only. In accordance with this
finding, nuclear localization of Kindlin-2 has been reported in
leiomyosarcomas and leiomyomas. Furthermore, the Kindlin-
2 interacting proteinMigfilin can localize to the nucleus. There
it functions as a coactivator for the CSX/NKX2-5 transcription
factor to promote cardiomyocyte differentiation [14].
Taken together, Kindlin proteins are typical adaptor
proteins with two domains known to mediate membrane
association. However, both the molecular regulation of
Table 1 – Genomic localization of the human and murine
Kindlin genes
Mouse Human
Kindlin-1 2F2 20p12.3
Kindlin-2 14B 14q22.1
Kindlin-3 19A 11q13.1
Fig. 1 – Expression pattern of Kindlins-1/-2/-3. (A) Northern blot from different tissues. Total RNAwas extracted from organs of
2-week-old C57BL/6 mice. Staining of ribosomal RNA with ethidium bromide was used to control loading. (B) Skin from adult
C57BL/6 mice was separated into epidermis and dermis by trypsin digestion and total RNA was reverse transcribed to detect
differential expression of Kindlin-1 and Kindlin-2 in epidermis, dermis andwhole skin. (C) Total RNA from 2-week-old C57BL/6
mice was reverse transcribed into cDNA and expression of the three Kindlins was checked by RT-PCR. GAPDH was used as
loading control. (D) Total RNA was extracted from total embryos at different embryonic stages. RT-PCR was performed for all
three Kindlinswith cDNAderived from the total RNA. GAPDHwas used to show equal loading. Sk.muscle: skeletalmuscle; Sm.
Int.: small intestine; Epi: epidermis.
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Kindlin proteins and the specific binding of certain interactors
to individual Kindlin proteins are only poorly understood.
Expression patterns of murine Kindlin-1 to -3 in adult tissues
and during embryonic development
The tissue distribution of the murine Kindlin genes was
analyzed bymultiple tissue Northern blots and RT-PCR of total
RNA from 2-week-oldmice using specific cDNA fragments and
primer pairs (Fig. 1A). The specificity of the cDNA probes was
confirmed in a Southern blot containing all three murine
Kindlin cDNAs (data not shown).
Kindlin-1 transcripts were detected in bladder and colon
and at lower expression levels in kidney, skin, small intestine,
stomach and thymus with Northern blot assays. RT-PCR
revealed additional weak Kindlin-1 expression in ovary and
uterus. Recently, a larger splice variant of Kindlin-1 was
detected in human intestine [5]. This isoform is generated by
including intron 7 into the coding sequence and was recently
found in a thymus cDNA (AK_030947). This alternative splicing
event gives rise to a 5.2 kb transcript, a premature translation
stop, and a short protein isoform of 352 amino acids. Using
primer pairs located in exon 6 and intron 7 we could detect the
long transcript in kidney, colon and small intestine (data not
shown). The existence of this isoform became also apparent in
our Northern blots, which revealed a second, approximately
5.2 kb large transcript in colon and small intestine (Fig. 2A).
Since no antibody against the N-terminus of Kindlin-1 is
currently available, it remains to be seen whether this
transcript is translated and if so, which function this short
Kindlin-1 protein might fulfil.
Since there is a strong interest in a detailed expression
analysis of Kindlin-1 in skin, we separated epidermis from
dermis. RT-PCR analysis indicated strong expression of
Kindlin-1 in the epidermis, and much weaker expression in
the dermis (Fig. 1B). Whether the dermal expression is indeed
derived from dermal cells or alternatively from hair follicle
keratinocytes is unclear. Interestingly, Kindlin-2 is inversely
expressed, with higher expression levels in the dermis than in
the epidermis (Fig. 1B). This finding is particularly interesting,
since Kindlin-2 seems not to compensate for the loss of
Kindlin-1 in Kindler Syndrome. Whether this is due to the
distinct expression in different cell layers of the skin or
because of differences in the subcellular localization of both
proteins within the keratinocytes needs to be addressed in the
future.
Northern blot and RT-PCR analyses confirmed Kindlin-2
expression in all tissues analyzed. The levels differed between
tissues and were high in heart, lung, skeletal muscle, kidney,
bladder and stomach. In contrast to the broad expression
pattern of Kindlin-2, Kindlin-3 showed a restricted expression
pattern with signals in lung, spleen, thymus and very low in
lymph nodes (Fig. 1A). RT-PCR confirmed a strong Kindlin-3
expression in hematopoietic tissues and much lower in other
tissues, which may be due to contamination of these tissues
by blood cells (Fig. 1C).
Expression of Kindlin genes during embryonic develop-
ment was tested by RT-PCR from RNA samples derived from
E7.5 to 18.5 embryos. All Kindlin genes are expressed
throughout the analyzed time points, although Kindlin-3
expression was low at E7.5 and increases until E13.5 (Fig. 1D).
To determine the distribution of the Kindlin mRNAs during
mouse development, we performed radioactive in situ hybrid-
izations on mouse embryo sections from different develop-
mental stages.
The same probes that were used for Northern blot
experiments were subcloned into pBluescript to derive sense
and antisense transcripts. As expected from the RT-PCR and
Fig. 2 – Radioactive in situ hybridizations on E13 and E15mouse embryo sections reveal Kindlin-1 expression in the developing
gut epithelium (arrowhead in panel A) and epithelium of the oral cavity and tongue at E13 (arrowheads in panel C). Consecutive
sections hybridized with the sense probe indicate signal specificity (B, D). At E15, Kindlin-1 expression is found in the
oesophageal epithelium (E) and gut epithelium (F).
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Northern blot analyses, Kindlin-1 expression was hardly
detected in the embryo. Weak signals could be detected in
the epithelium of the gut from E12.5 onwards, as well as in the
oral epithelium and oesophagus. Control hybridizations with
the sense probe revealed no signal in these organs (Fig. 2). All
attempts to detect Kindlin-1 in other embryonic or adult
tissues were unsuccessful.
In contrast, Kindlin-2 expression was seen in many organs
with strongest expression in the not sooth but smoothmuscle
cell layer of a number of organs including the developing gut,
bladder, oesophagus and blood vessels (Fig. 3). Strong expres-
sion was also found in striated muscle such as tongue and
heart. In agreement with Northern blot and RT-PCR data,
Kindlin-3 expression was restricted to hematopoietic organs
such as the fetal liver and thymus. Interestingly, between
E12.5 and E16.5 Kindlin-3 signals were detectable throughout
the whole liver with strong signals in large multinucleated
cells that most likely represent megakaryocytes (Figs. 4A–F).
Weak staining was detected in the thymus (Figs. 4G, H). Based
on the restricted expression of Kindlin-3 in adult hemato-
poietic tissues, the uniform signal in the embryonic liver was
likely derived from lymphoid progenitor cells rather than
from hepatocytes. In line with this notion, neither Northern
blot nor RT-PCR revealed Kindlin-3 expression in adult liver
(Figs. 1A and C).
Fig. 3 – In situ hybridizations reveal Kindlin-2 expression in
all three muscle types. Kindlin-2 is expressed in the smooth
muscle layer of the developing gut at E12 (A), E13 (B) and E15
(C). In addition, Kindlin-2 expression is found in the smooth
muscle layers surrounding the oesophagus (E), large vessels
(arrowhead in panel E), around the bronchial epithelium of
the lung (E), in the bladder and hindgut (both F). Expression in
skeletal muscle is seen in the tongue and the diaphragm
(D,E). A weaker signal is detected in cardiac muscle (E).
b, bladder; g, gut; h, heart; hg, hindgut; l, lung; m, skeletal
muscle; o, oesophagus; t, tongue.
Fig. 4 – In situ hybridizations on sagittal sections of murine
embryos at E12 (A, B), E13 (C, D), and E15 (E–H). Panels A, C, E,
and G show brightfield views of panels B, D, F, and G,
respectively. Kindlin-3 expression is mainly restricted to the
developing liver with particularly strong signals in large
multinucleated cells, most likely representing
megakaryocytes (A–F). (G,H) Kindlin-3 is also expressed in
thymus at E15. g, gut; k, kidney; li, liver; lu, lung; st, stomach;
t, thymus.
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Altogether these data indicate that Kindlin-1 expression is
confined to epithelial cells of the skin and gut, Kindlin-2
expression is broad with high expression in striated and
smooth muscle cells and Kindlin-3 expression is restricted to
hematopoietic tissues.
Kindlin-3 is expressed in different hematopoietic cell types and
is localized to podosomes
To date, the Kindlin-3 protein has not been investigated in any
study. Therefore we generated a rabbit polyclonal antiserum
against Kindlin-3 (see Materials and methods). The affinity
purified antibody reacted with an approximately 100 kDa
protein from mouse embryonic fibroblasts transfected with
EGFP-tagged murine Kindlin-3 cDNA. As a control, cell lysates
from fibroblasts transfected with EGFP-Kindlin-1 or -2 con-
structs showed no crossreactivity with the Kindlin-3 antibody
(Fig. 5A). The anti-Kindlin-3 antibody was then used to
immunoblot lysates derived from multiple organs of adult
C57BL/6 mice. In accordance with the RNA data Kindlin-3
protein could be detected in spleen, thymus, lymph node and
lung (Fig. 5B).
Due to this very broad expression pattern of Kindlin-3
within hematopoietic tissues, we addressed the expression in
different hematopoietic cell types. Western Blots from MACS
sorted T and B cells and in vitro differentiated macrophages,
immature and mature dendritic cells were performed. Inter-
estingly, Kindlin-3 was expressed in all these hematopoietic
cell types at similar levels and seems not to be restricted to a
specific hematopoietic lineage (Fig. 5C). Since Northern blot
and RT-PCR analyses revealed weak expression of Kindlins-1
and -2 in spleen and thymus, we investigated expression of
both genes in different hematopoietic cell types by RT-PCR.
Interestingly, both Kindlins-1 and -2 are expressed in T cells
and very weak in B cells (Fig. 5D).
Furthermore, the anti-Kindlin-3 antibody was used for
immunohistochemical stainings of mouse embryo sections.
The Kindlin-3 protein was observed in the developing liver
with particularly high signals in megakaryocytes (Fig. 5E),
confirming our in situ hybridization data (Figs. 4A–F).
To investigate the subcellular localization of Kindlin-3, we
first overexpressed EGFP-tagged Kindlin-3 in murine fibro-
blasts. Unexpectedly, we could not observe any specific
localization to FA but rather a diffuse cytoplasmatic staining
Fig. 5 – Hematopoietic expression pattern and typical subcellular localization of Kindlin-3. (A) Western blot of NIH3T3 cells
transfected with EGFP-Kindlins-1/-2/-3 with the Kindlin-3 antibody. A GFP antibody was used to control loading. (B) Western
blot of different mouse tissues from adult C57BL/6 probed with the Kindlin-3 antibody. Tubulin was used to control loading. (C)
Western blot for Kindlin-3 from different hematopoietic cell types (DC: dendritic cells). GAPDH was used to control loading. (D)
RT-PCR for Kindlin-1 and Kindlin-2 from different hematopoietic cell types. GAPDH was used to control loading. (E)
Immunostaining of E14.5 embryo sections with Kindlin-3 antibody (Li: liver). (E′) Higher magnification of the liver.
(F) EGFP-Kindlin-3 colocalizes with vinculin in podosomes of cultured dendritic cells.
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Fig. 6 – Subcellular localization of Kindlin-1 and Kindlin-2. (A) Mouse embryonic fibroblasts (MEFs) were seeded onto
fibronectin and transiently transfected with EGFP-Kindlin-1 and EGFP-Kindlin-2, respectively. 24 h after transfection cells were
costained for paxillin and F-actin. Arrowheads indicate focal adhesion sites. Arrows indicate colocalization with F-actin.
(B) Spontaneously immortalized mouse keratinocytes were transiently transfected with EGFP-Kindlin-1. Cells were costained
for paxillin and F-actin. EGFP-Kindlin-2 transfected cells were differentiated with 1 mM CaCl2 overnight, and costained for
E-cadherin and F-actin. Arrowheads show colocalization of EGFP-Kindlin-2 and E-cadherin at cell–cell contacts. (C) Primary
mouse cardiomyocytes were transfected with EGFP-Kindlin-2 and after fixation costained with α-actinin.
3149E X P E R I M E N T A L C E L L R E S E A R C H 3 1 2 ( 2 0 0 6 ) 3 1 4 2 – 3 1 5 1
(data not shown). This indicates that either Kindlin-3 differs in
its localization from the other two family members or cannot
compete with the endogenous Kindlin-2 for FA recruitment in
these cells. Kindlin-1 and Kindlin-3 expression could not be
detected in these cells by RT-PCR (data not shown). Therefore,
we used immunofluorescence stainings of in vitro differen-
tiated macrophages and dendritic cells. In contrast to fibro-
blasts or epithelial cells, hematopoietic cells do not form
classical FA. Instead, they form podosomes, adhesion struc-
tures characterized by a core of F-actin and actin-associated
proteins surrounded by a ring consisting of plaque proteins
such as talin or vinculin (reviewed in [21] and [22]). Coimmu-
nofluorescence stainings with phalloidin revealed that Kin-
dlin-3 colocalizes to podosomes (data not shown). Therefore, a
more detailed analysis of Kindlin-3 localization within podo-
somes was performed. Transfection of immature dendritic
cells with EGFP-Kindlin-3 and subsequent staining for vinculin
(Fig. 5F) and talin (data not shown) revealed Kindlin-3
localization to the actin surrounding ring of podosomes.
Altogether these data show that Kindlin-3 is present in
hematopoietic adhesion complexes and expressed inmultiple
hematopoietic cell lineages.
Kindlins-1 and -2 localize to different cell adhesion sites
Previous studies have localized human Kindlin-1 and Kindlin-
2 to FAs. Using EGFP-tagged cDNA constructs transiently
transfected into mouse embryonic fibroblasts, we tested the
localization of murine Kindlins. Transfection of neither
Kindlin constructs nor the EGFP control affected cell morphol-
ogy during cell spreading when compared to untransfected
cells (data not shown).
Kindlin-1 colocalized with paxillin to focal complexes and
FAs (Fig. 6A). A similar staining pattern was also observed for
Kindlin-2 suggesting that Kindlins-1 and -2 are recruited to
newly formed focal contacts, andhencemayplay an important
role during the assembly of the cell–matrix adhesion complex.
In addition to the integrin-containing adhesion structures,
Kindlin-2 also localized to actin stress fibers. Altogether these
data indicate that all three Kindlin proteins localize to specific
cell–matrix adhesion sites in vitro.
Our in situ hybridizations suggested a preferential expression
of Kindlin-1 in epithelial cells and Kindlin-2 in striated and
smooth muscle cells in vivo. Therefore we investigated the
localization of Kindlins-1 and -2 in immortalized mouse kerati-
nocytes and of Kindlin-2 in addition in primary cardiomyocytes.
Keratinocytes transfected with EGFP-Kindlin-1 revealed
fluorescent labeling of paxillin-positive FAs and phalloidin-
positive actin stress fibers (Fig. 6B). A similar staining pattern
could be observed for Kindlin-2 (data not shown). However,
cells transfected with EGFP-Kindlin-1 often revealed a strong
perinuclear and a weak filamentous signal that failed to
colocalize with F-actin. Whether these signals are a conse-
quence of Kindlin-1 overexpression or indeed represent an
additional subcellular localization of Kindlin-1 outside of FAs
remains to be addressed. Furthermore, we investigated the
localization of Kindlins-1 and -2 in calcium differentiated
keratinocytes. Surprisingly, we could not observe localization
of EGFP-Kindlin-1 to cell–cell contacts, as previously assumed
[8] (data not shown). In contrast, EGFP-Kindlin-2 colocalized
with E-cadherin to cell–cell contacts (Fig. 6B). This result is the
first indication that Kindlins-1 and -2 can localize to different
subcellular compartments. It could explain why Kindlin-2
cannot compensate for Kindlin-1 loss in Kindler Syndrome.
Unfortunately, no Kindlin-1 or -2-specific antibodies are
available, which would be required to investigate the sub-
cellular localization in vivo.
To test the localization of Kindlin-2 in muscle cells, we
isolated primary cardiomyocytes from newborn mice and
transfected them with EGFP-tagged Kindlin-2. Kindlin-2
colocalized with α-actinin to Z-discs of cardiomyocytes (Fig.
6C). This observation implies that Kindlin-2 like UNC-112
plays an important role in the organization of cell–matrix
adhesion sites in muscle cells.
In summary, our analyses revealed that all three Kindlins
are expressed during early development, but expression of
each isoform is restricted to certain tissues and cell types. This
is most evident for Kindlin-3, which is exclusively expressed
in cells of hematopoietic origin. The expression pattern of
Kindlins-1 and -2 show a partial overlap, although with a
preference for Kindlin-1 expression in epithelial cells of the
skin and the gastrointestinal tract and Kindlin-2 in striated
and smoothmuscle cells. Kindlins-1 and -2-specific antibodies
will be important tools to investigate their subcellular
localization in more detail in vivo. This is medically relevant,
since our analyses demonstrate that Kindlin-2 is expressed in
the epidermis but can apparently not compensate for the loss
of Kindlin-1 expression in Kindler syndrome patients. This
observation is in line with our in vitro data indicating that in
contrast to Kindlin-1, Kindlin-2 localizes to cell–cell contacts
of differentiated keratinocytes and might therefore be less
involved in the cell–matrix adhesion of keratinocytes. Identi-
fication of novel Kindlin binding partners will be one
important aim to understand the cellular functions of Kindlin
proteins. Additionally, Kindlin-deficient mice could give
important insights into the function of this gene family during
development and disease.
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Control of integrin activation is required for cell adhe-
sion and ligand-induced signaling. Here we report that
loss of the focal adhesion protein Kindlin-2 in mice re-
sults in peri-implantation lethality caused by severe de-
tachment of the endoderm and epiblast from the base-
ment membrane. We found that Kindlin-2-deficient cells
were unable to activate their integrins and that Kindlin-2
is required for talin-induced integrin activation. Further-
more, we demonstrate that Kindlin-2 is required for in-
tegrin outside-in signaling to enable firm adhesion and
spreading. Our findings provide evidence that Kindlin-2
is a novel and essential element of bidirectional integrin
signaling.
Supplemental material is available at http://www.genesdev.org.
Received January 3, 2008; revised version accepted March 10,
2008.
The establishment and maintenance of cell–extracellu-
lar matrix (ECM) and cell–cell interactions are essential
for the development of multicellular organisms. These
interactions are mediated via membrane-associated pro-
teins that firmly bind to ECM proteins or cell counter-
receptors. The integrins, consisting of at least 24 mem-
bers, represent the largest and most important family of
cell–ECM receptors in vertebrates (Hynes 2002). Inte-
grins are heterodimeric glycoproteins composed of  and
 subunits. Each subunit consists of a large extracellular
domain, a transmembrane domain, and a short cytoplas-
mic domain. Integrins are bidirectional signaling mol-
ecules. They regulate their affinity for ligand (integrin
activation) by direct interactions of the -subunit cyto-
plasmic tails with the cytoskeletal protein talin (inside-
out signaling) (Calderwood et al. 1999, 2002; Wegener et
al. 2007). Following ligand binding, integrins transduce
signals into cells (outside-in signaling) by recruiting sig-
naling and adaptor proteins to the cytoplasmic tails of
the  and/or  subunits, which results in actin reorgani-
zation and modulation of various intracellular signaling
pathways (Hynes 2002).
Kindlins are a novel family of adaptor proteins that are
recruited to integrin-containing adhesion sites, termed
focal adhesions (FAs) (Rogalski et al. 2000; Tu et al. 2003;
Weinstein et al. 2003; Ussar et al. 2006). The Kindlin
family consists of three members, termed Kindlin-1/
Unc-112-Related Protein 1 (URP1), which is expressed in
epithelial cells; Kindlin-2/Mig-2, which is ubiquitously
expressed; and Kindlin-3/URP2, whose expression is re-
stricted to hematopoietic cells. The structural hallmark
of Kindlins is a FERM (Band 4.1/Ezrin/Radixin/Moesin)
domain that was shown to associate with the 1-integrin
subunit cytoplasmic tails (Kloeker et al. 2004; Shi et al.
2007).
Kindlin-1 is the founding member of the Kindlin family.
Mutations in the Kindlin-1 gene lead to Kindler syndrome
in humans, which is characterized by skin blistering (Jo-
bard et al. 2003; Siegel et al. 2003). The defect in Kindler
patients suggested a role of Kindlin-1 in integrin–ECM
adhesion in vivo. This assumption has been corroborated
further in siRNA-mediated depletion studies of Kindlins
in different cell lines and genetic analyses of the Kindlin-2
ortholog in Caenorhabditis elegans. Knockdown experi-
ments in mammalian cells showed that Kindlin-1 and
Kindlin-2 are essential for integrin-mediated cell–ECM
adhesion and spreading (Tu et al. 2003; Kloeker et al. 2004).
Absent expression of UNC-112, the nematode ortholog
of the mammalian Kindlins, gives rise to a PAT (para-
lyzed, arrested elongation at twofold) phenotype. The
embryonic lethality of UNC-112 mutants is caused by
an abrogated integrin function leading to pronounced
muscle cell rounding and detachment. An identical phe-
notype is also observed in nematodes lacking the expres-
sion of PAT-3/ integrin or PAT-4/ILK and, consistent
with this observation, UNC-112/Kindlin was shown to
be required for the proper spatial localization of PAT-3/
integrin and PAT-4/ILK to cell–ECM adhesion sites (Ro-
galski et al. 2000; Mackinnon et al. 2002).
To address the role of Kindlin-2 in vivo, we generated
mice, embryonic stem cells (ESCs), and embryoid bodies
(EBs) lacking Kindlin-2 expression. We found that Kind-
lin-2 is required for integrin activation. The conse-
quences of impaired integrin activation in Kindlin-2-de-
ficient mice are severe endoderm and epiblast detach-
ments, which arrest development at the peri-implantation
stage.
Results and Discussion
Loss of Kindlin-2 leads to peri-implantation lethality
and impaired integrin activation
To investigate Kindlin-2 function, we disrupted the
Kindlin-2 gene in mice (Supplemental Fig. 1). Mice with
a heterozygous Kindlin-2-null mutation (Kindlin-2+/−)
were viable and normal (data not shown). Among 166
newborn offspring from Kindlin-2+/− intercrosses, 67%
were Kindlin-2+/− and 33% were wild type. Timed mating
of Kindlin-2+/− intercrosses revealed that Kindlin-2−/− em-
bryos were missing at embryonic day 7.5 (E7.5), and his-
tology of implantation chambers at E6.5 showed that
74% of the embryos were normally developed (presump-
tive wild type or Kindlin-2+/−) and 26% were severely
[Keywords: Integrin activation; Kindlin-2; adhesion; mouse develop-
ment; embryonic stem cells]
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misshapen or already partially resorbed (putative Kind-
lin-2−/−) (Fig. 1A). These results suggest that ablation of
Kindlin-2 leads to lethality at the peri-implantation
stage.
To analyze the function of Kindlin-2 in vitro, we es-
tablished wild-type and Kindlin-2−/− ESCs. While Kind-
lin-2−/− ESCs were readily obtained and showed a normal
proliferation rate, their colonies barely adhered to the
feeder layer and were less compact than wild-type ESC
colonies (Fig. 1B). Western blot analysis revealed that
Kindlin-2 is the only Kindlin expressed in ESCs and its
expression was lost in Kindlin-2−/− ESCs (Fig. 1C; data
not shown). To test whether the poor adhesion of Kind-
lin-2−/− ESC colonies to the feeder layer is caused by
impaired adhesion to ECM proteins deposited by feeder
cells, we performed adhesion assays on defined ECM
substrates. They revealed that wild-type ESCs readily ad-
hered to laminin-111 (LN111), laminin-332 (LN332), or
fibronectin (FN), while Kindlin-2−/− ESCs showed strongly
reduced adhesion to these substrates (Fig. 1D).
To exclude impaired integrin expression as the reason
for the severe adhesion defects of Kindlin-2−/− ESCs, the
expression levels of major ESC integrins were deter-
mined by flow cytometry and were found to be similar to
wild-type ESCs (Fig. 1E). Next we tested whether dimin-
ished integrin-binding affinity (activation) is responsible
for the adhesion defect. To this end, we compared the
binding of a fluorescently labeled FN fragment contain-
ing the central cell-binding domain for v and 51 in-
tegrins (FNIII7-10) to wild-type and Kindlin-2−/− ESCs.
Interestingly, the binding of FNIII7-10 to Kindlin-2−/−
ESCs was strongly reduced when compared with wild-
type ESCs (Fig. 1F). The antibody 9EG7, which specifi-
cally recognizes activated mouse 1 integrins, also failed
to bind Kindlin-2−/− ESCs (Fig. 1G). When cellular acti-
vation of integrins was bypassed by the addition of
MnCl2, a powerful activator of integrins (Chen et al. 2003),
wild-type as well as Kindlin-2−/− ESCs bound significant
amounts of FNIII7-10 fragment (Fig. 1F). Collectively,
these findings show that loss of Kindlin-2 prevents inte-
grin activation.
Kindlin-2–integrin interaction enhances
talin-mediated integrin activation
It is currently believed that talin binding to -integrin
tails is necessary and sufficient to trigger the activation
of integrins (Calderwood et al. 1999, 2002; Wegener et al.
2007). Talin levels, however, were not decreased in Kind-
lin-2−/− ESCs (Fig. 1C), indicating that Kindlin-2 does not
control integrin activation by regulating talin levels. To
test whether Kindlin-2 controls integrin activation by
binding to the  tails, we performed pull-down assays
with GST-tagged 1- and 3-integrin cytoplasmic tails.
We found that Kindlin-2 in wild-type ESC lysates bound
the 1- and 3-integrin tails. Moreover, substitutions of
the tyrosine (Y) to alanine (A) in the proximal NPxY
motifs of the 1 and 3 tails (1Y788A; 3Y747A),
known to abrogate talin binding (Calderwood et al.
2002), did not diminish Kindlin-2 association. However,
mutation of the distal NxxY motifs (1Y800A; 3Y759A),
which is known to be dispensable for talin binding but
required for integrin activation (Xi et al. 2003), com-
pletely abolished the interaction with Kindlin-2 (Fig.
2A). To test whether the interaction between -integrin
tails and Kindlin-2 is direct, pull-down assays were per-
formed with purified GST-tagged Kindlin-2 phosphoty-
rosine-binding (PTB) domain and recombinant His-tagged
1-integrin cytoplasmic tail. They demonstrated that
the Kindlin-2 PTB domain was able to interact with 1-
integrin cytoplasmatic tails and that this interaction was
eliminated by mutating the PTB domain (QW614/615AA)
of Kindlin-2 (Fig. 2B). Together, these results indicate that,
despite the sequence similarities between the FERM do-
mains of talin and Kindlin-2, these proteins bind distinct
sites within the 1- and 3-integrin tails.
Since Kindlin-2 can directly bind 1- and 3-integrin
tails and is essential for ESC adhesion and binding to
ECM substrates, we hypothesized that a potential role of
Kindlin-2 could be to regulate integrin affinity for ligands.
To confirm this hypothesis, we overexpressed Kindlin-2 in
CHO cells engineered to express the inactive form of the
Figure 1. Peri-implantation lethality and impaired integrin activa-
tion in ESCs in the absence of Kindlin-2 expression. (A) Hematoxilin
and eosin staining of an E6.5 control and presumptive Kindlin-2−/−
implantation chamber. TUNEL staining (green) and FN staining
(red) show apoptosis and disturbed matrix deposition in Kindlin-2−/−
embryos. Nuclei are counterstained with DAPI (blue). (B) Bright-
field pictures of wild-type and Kindlin-2−/− ESCs lines seeded on
feeder cells. (C) Western Blot for Kindlin-2 and talin in wild-type and
two independent Kindlin-2−/− ESCs lines. (D) Adhesion assay of
wild-type and Kindlin-2−/− ESCs on different ECM substrates. (E)
Integrin surface expression of wild-type (blue), Kindlin-2−/− (light
and dark green), and 1-integrin−/− (red) ESC lines. A background
control is shown in gray. (F) Binding of FNIII7-10 to wild-type and
Kindlin-2−/− ESCs in the presence and absence of MnCl2. (G) 9EG7
binding on wild-type (blue) and Kindlin-2−/− (green) ESC lines. A
background control is shown in red. (d) Decidua; (epc) ectoplacental
cone; (ee) extraembryonic ectoderm; (e) ectoderm; (m) mesoderm.
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human platelet integrin IIb3 (O’Toole et al. 1994). As
shown previously, overexpression of the talin FERM do-
main is sufficient to activate the IIb3 integrin (Fig. 2C;
Calderwood et al. 2002). Interestingly, overexpression of
Kindlin-2 did not significantly change integrin activation
when compared with EGFP-transfected cells. However, ex-
pression of the talin FERM domain together with Kindlin-2
resulted in a synergistic effect on IIb3-integrin activa-
tion. These results clearly demonstrate that Kindlin-2 acts
in concert with talin to trigger the activation of 3 integrins.
Kindlin-2−/− EBs show severe endoderm
and epiblast detachments
To investigate whether the peri-implantation de-
fect of Kindlin-2−/− embryos is caused by an inte-
grin activation defect, we generated EBs from wild-
type and Kindlin-2−/− ESCs (Li et al. 2003; Mon-
tanez et al. 2007). When wild-type and Kindlin-
2−/− ESCs were cultured in suspension for 2–4 d,
they developed into simple EBs consisting of an
outer layer of primitive endoderm cells and a core
of undifferentiated ESCs. By day 4–6 in suspen-
sion, wild-type EBs developed into cystic EBs
consisting of an outer layer of cubical-shaped en-
doderm cells, an inner layer of columnar pseu-
dostratified epithelial cells (called epiblast or primi-
tive ectoderm), a thin and continuous basement
membrane (BM) between epiblast and endoderm,
and a central cavity (Fig. 3A–C). Immunostaining
with 9EG7 antibody revealed that endoderm and
epiblast cells expressed activated integrins adja-
cent to their BM (Fig. 3D). In contrast, Kindlin-
2−/− EBs were severely abnormal. About half of
Kindlin-2−/− simple EBs did not develop further
and degenerated. They consisted of a compact ag-
gregate of ESCs covered by a discontinuous, spot-
ted BM and detached endoderm. Despite evidence
of scattered apoptotic cells, they lacked discern-
able cavities. This phenotype is similar to that
described in 1-integrin−/− EBs, which arrested
their development at the same stage of differen-
tiation, showing defects in LN-1 secretion and
impaired cavitation (Aumailley et al. 2000; Li et
al. 2002). The remaining half of the Kindlin-2−/−
EBs formed an epiblast layer with poorly devel-
oped cavities and BMs and varying degrees of en-
doderm and epiblast detachment (Fig. 3A–C). The
absence of 9EG7 staining at the basal sites of en-
doderm and epiblast cells indicates that 1 inte-
grins of Kindlin-2−/− EBs were expressed in an in-
active conformation (Fig. 3D). The abnormal BM
contained all major proteins including LN-1
(Supplemental Fig. 2A,B), suggesting that loss of
Kindlin-2 does not impair expression and secre-
tion of BM proteins. We reported previously that
Kindlin-2 colocalizes with E-cadherin at cell–cell
junctions (Ussar et al. 2006). Interestingly, however,
Kindlin-2−/− EBs showed a normal E-cadherin distri-
bution and developed normal cell–cell junctions
(Supplemental Fig. 3; data not shown), indicating that
they are not required for the establishment of cell
junctional complexes in EBs. Together, these findings
show that loss of Kindlin-2 expression impairs the
activity of integrins in developing EBs, resulting in
severe cell–ECM adhesion defects, abnormal BM de-
positions, abnormal cavity formation, and impaired cell sur-
vival.
Kindlin-2 is required for actin polarization, cell
spreading, and ILK localization into FAs
In endoderm and epiblast cells from wild-type EBs, F-
actin predominantly accumulated at E-cadherin-positive
adherens junctions to form the characteristic apical F-
actin belt. In contrast, BM-attached endoderm and epi-
blast cells of Kindlin-2−/− EBs showed in addition to the
apical F-actin belt a prominent F-actin accumulation at
Figure 3. Kindlin-2 EBs show endoderm and epiblast detachment and dimin-
ished integrin activation. (A) Micrographs of methylene blue-stained sections of
4- and 6-d-old wild-type and Kindlin-2−/− EBs. (B) Cryosections of wild-type and
Kindlin-2−/− EBs were stained with an antibody specific for LN-1 chain (green)
and fluorescently labeled phalloidin to visualize F-actin (red). Nuclei are coun-
terstained with DAPI (blue). (C) TUNEL staining (green), LN-1 chain (red), and
nuclei (blue) of 6-d-old wild-type and Kindlin-2−/− EBs. (D) Six-day-old wild-type
and Kindlin-2−/− EBs stained with LN-1 chain (green) and 9EG7 (red) antibodies.
Nuclei are counterstained with DAPI (blue). (epi) Epiblast; (end) endoderm.
Figure 2. Kindlin-2 interacts with integrin tails and is required for integrin
activation. (A) GST pull-down assay from ESC lysates with wild-type and mu-
tant GST-tagged 1- and 3-integrin cytoplasmic tails. (B) Pull-down assays with
the recombinant GST-tagged wild-type and mutant (QW614/615AA) PTB do-
main of Kindlin-2 and the recombinant His-tagged 1-integrin cytoplasmatic
tail. (C) IIb3-integrin activation in CHO cells transfected with EGFP, EGFP-
Kindlin-2, EGFP-Talin head, and EGFP-Kindlin-2 together with the Talin head.
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their basal sites, indicating that loss of Kindlin-2 affects
F-actin polarization (Fig. 4A). To determine the mecha-
nism by which Kindlin-2 depletion affects actin reorga-
nization, we isolated endoderm cells from wild-type and
Kindlin-2−/− EBs and plated them on FN. Endoderm cells
from wild-type EBs readily adhered to FN, spread, and
formed multiple FAs. In contrast, loss of Kindlin-2 ex-
pression abrogated adhesion and spreading to FN (Fig.
4B). To determine if this difference in the phenotype was
only due to lack of integrin activation, the Kindlin-2−/−
endoderm cells were treated with MnCl2 (Cluzel et al.
2005) and then plated on FN for 3 h. Under these condi-
tions, Kindlin-2−/− cells developed only a few FA-like
structures containing talin and paxillin and were still
incapable of spreading (Fig. 4B). In nematodes, the ortho-
log of Kindlin called Unc-112 was shown to bind and
recruit ILK to integrin adhesion sites (Mackinnon et al.
2002). ILK forms a complex together with the adaptor
proteins PINCH and parvin that regulates cell spreading
and actin cytoskeleton organization (Legate et al. 2006).
Interestingly, ILK was either absent from the FA-like
structures in Kindlin-2−/− cells (Fig. 4C) or did not prop-
erly colocalize with other FA proteins (Fig. 4B). Western
blot analysis revealed normal ILK levels in Kindlin-2−/−
endoderm cells, and immunoprecipitation assays with
lysates from fibroblasts showed that Kindlin-2 interacts
with ILK (Fig. 4D,E). These results indicate that Kind-
lin-2 is dispensable for ILK stability but required for ILK
localization into integrin-containing adhesion sites. This
observation together with the impaired FA formation and
spreading suggest that Kindlin-2 is required for integrin
inside-out as well as for integrin outside-in signaling.
The results of our study show that Kindlin-2 is a novel
and essential component for integrin inside-out and out-
side-in signaling, and its absence results in a peri-im-
plantation lethality in mice. We found that loss of Kind-
lin-2 severely impairs activation of 1 and 3 integrins
and that, following Mn2+ treatment Kindlin-2−/− endo-
derm cells fail to form multiple FAs
and were incapable of spreading.
Bidirectional integrin signaling
requires interactions between the
cytoplasmatic domains of the inte-
grins and intracellular signaling
molecules. It is currently believed
that the interaction between the
membrane-proximal NPxY motif
of the integrin  cytoplasmatic do-
main and talin is necessary and
sufficient for integrin activation
(Calderwood et al. 2002). Using con-
ditional gene ablation, it was shown
recently that talin is indeed essen-
tial for integrin activation in vivo
(Nieswandt et al. 2007; Petrich et
al. 2007). In contrast to the previ-
ous assumptions, however, our
findings indicate that talin is not
sufficient for triggering the activa-
tion of integrins, at least in ESCs,
primitive endoderm, and epiblast,
which clearly require Kindlin-2 for
this process. In line with this ob-
servation, loss of Kindlin-3 was
also found to compromise integrin
activation on platelets, rendering
them incapable of binding integrin ligands such as fi-
brinogen or collagen despite the expression of normal
levels of talin (Moser et al. 2008). Future studies are now
needed to investigate whether all cell types require Kind-
lins for integrin activation; whether the entire Kindlin
family, including Kindlin-1, can trigger integrin activa-
tion; and to what extent the different Kindlins can com-
pensate each other.
Interestingly, it has been shown previously that the
membrane-distal NxxY motif of the 3-integrin cyto-
plasmatic domain is required for bidirectional integrin
signaling, although the binding partner for the distal
NxxY motif remained elusive (Xi et al. 2003). In our pull-
down studies, we found that Kindlin-2 bound specifi-
cally the membrane-distal NxxY motif since the substi-
tution of Y759 to an A residue eliminated the interaction
of Kindlin-2 with the integrin tail. Therefore, we propose
that Kindlin-2 mediates integrin activation (1) through a
direct interaction of the PTB site in the F3 subdomain of
Kindlin-2 and the distal NxxY motif of the 1- and 3-
integrin cytoplasmic domains, and (2) in cooperation
with talin, which binds the proximal NPxY motif of in-
tegrin tails. The close proximity of the two NP/XxY mo-
tifs raises questions about the hierarchy of their binding
to the -integrin tails and the specific roles of Kindlin-2
and talin in integrin activation. Future studies examin-
ing how and at which step of integrin activation Kind-
lin-2 and talin cooperate will be instrumental to our un-
derstanding of how these receptors become activated. Fi-
nally, we also found that elimination of Kindlin-2 also
prevents the formation of multiple FAs, recruitment of
ILK to integrin adhesion sites, and cell spreading. Hence,
Kindlin-2 also seems to be involved in integrin outside-
in signaling. A similar double function has been assigned
to talin, since thrombin treatment of talin-deficient
platelets failed to trigger their spreading on immobilized
fibrinogen (Nieswandt et al. 2007). In analogy to talin,
Kindlin-2 fulfils an important requirement of a bidirec-
Figure 4. Impaired cell spreading of Kindlin-2−/− endoderm cells. (A) Cryosections of 6-d-old
wild-type and Kindlin-2−/− EBs stained with LN-1 chain antibody (green) and fluorescently la-
beled phalloidin to visualize F-actin (red). Nuclei are counterstained with DAPI (blue). (B) Immu-
nofluorescence staining for talin (red) and ILK (green) of wild-type and Kindlin-2−/− endoderm cells
seeded of FN in the presence or absence of MnCl2. (C) Immunofluorescence staining for paxillin
(red) and ILK (green) of wild-type and Kindlin-2−/− endoderm cells seeded of FN in the presence of
MnCl2. (D) Western blot analysis of ILK in wild-type and Kindlin-2
−/− endoderm cells. (E) Coim-
munoprecipitation of ILK and Kindlin-2 from ILKfl/fl and ILK−/− fibroblasts.
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tional signaling relay for integrins: Upon integrin activa-
tion and cell adhesion, Kindlin-2 remains in focal com-
plexes and FAs (Ussar et al. 2006) and is thus optimally
positioned to transduce signals from the integrin tail to
downstream effectors.
Materials and methods
Generation of Kindlin-2-deficient mice
A 417-base-pair fragment was amplified from mouse genomic DNA using
the primers (fwd) TTCTTCAGGGTGTAGCTACTGG and (rev) CACCC
CTAGAAAGACAGAAATAG, and was used to screen a PAC (phage arti-
ficial chromosome) library (BACPAC Resource Center) and as an external
probe for ESC genotyping. The PAC clone 638-M21 Mouse PAC (RPCI21)
was used to generate the Kindlin-2 knockout construct. To abolish Kind-
lin-2 gene function, an IRES--galactosidase cassette followed by a PGK
neomycin resistance cassette was inserted into exon 2.
Antibodies and TUNEL staining
The following antibodies were used: rat antibody against 1 integrin,
clone MB1.2 (Chemicon); rat antibody against 1 integrin, 9EG7 epitope
(BD Bioscience); mouse antibody against talin (Sigma); rabbit antibody
against LN-1 chain (a gift from Rupert Timpl); rat antibody against LN-1
chain (Chemicon); rabbit antibody against GAPDH (Calbiochem); rabbit
antibody against ILK (Cell Signaling Technology); mouse antibody against
paxillin (Transduction Laboratories); Cy3- and FITC-conjugated antibod-
ies specific for mouse IgG, rabbit IgG, and rat IgG (Jackson Immuno-
chemicals Laboratories, Inc.) were used as secondary antibodies. TRITC-
conjugated phalloidin was used to detect F-actin (Molecular Probes). A
Kindlin-2-specific polyclonal antibody was produced in rabbits (Ussar et
al. 2006).
Apoptosis in embryos and EB sections was analyzed with the In situ
Cell Death Detection Kit, POD (TUNEL technology; Roche).
ESC adhesion assay
ESCs were trypsinized and plated on cell tissue culture dishes for 30 min
to remove the feeder cells. ESCs were then plated onto 96-well plates
coated with FN, LN, or collagen IV at 1 × 105 cells per well. After 45 min
of incubation, cells were lysed in a substrate buffer (7.5 mM NPAG
[Sigma], 0.1 M Na citrate at pH 5, 0.5% Triton X-100) overnight at 37°C.
Stop buffer (50 mM glycine at pH 10.4, 5 mM EDTA) was added and OD
405 was recorded.
FNIII7-10 binding and flow cytometry
FNIII7-10 binding and flow cytometry assays were performed as de-
scribed previously (Czuchra et al. 2006). The human FNIII7-10 fragment
was subcloned into pET15b plasmid (Invitrogen), expressed and purified
from Escherichia coli, and directly labeled with Alexa Fluor 647 carbox-
ylic acid via a succinimidyl ester (Invitrogen).
Generation of EBs and isolation of endoderm cells
EBs from wild-type and Kindlin-2−/− ESCs were generated as described
(Montanez et al. 2007). To isolate endoderm cells, wild-type and Kindlin-
2−/− EBs were collected in a 15-mL conical tube and shaken, and the EBs
were allowed to settle down by gravity for 10 min at room temperature.
The supernatant containing the detached endoderm cells was carefully
aspirated and transferred into a fresh 15-mL conical tube. The process
was repeated two times to ensure complete removal of EBs. The resulting
suspension with endoderm cells was transferred into a FN-coated (10 µg/
mL) tissue culture dish.
SDS-PAGE and immunoblotting
Cells were lysed in lysis buffer (in 150 mM NaCl, 50 mM Tris at pH 7.4,
1 mM EDTA, 1% Triton X-100 supplemented with protein inhibitors
[Roche] and phosphatase inhibitors [Sigma]), homogenized in sample
buffer, and boiled for 5 min. Cell lysates were resolved by SDS-PAGE
gels. Proteins were then electrophoretically transferred from gels onto
nitrocellulose membranes, followed by incubation with antibodies. For
antibody detection, a blotting ECL detection kit (Millipore Corporation)
was used.
GST pull-downs
The 1A- and 3-integrin cytoplasmic domains and their mutant forms
were expressed as GST fusion proteins in BL21 cells. ESCs were lysed in
lysis buffer (50 mM Tris at pH 7.4, 150 mM NaCl, 1 mM EDTA, 1%
Triton X-100 and proteinase [Roche] and phosphatase inhibitors [Sigma]).
Six-hundred micrograms of lysate were incubated overnight with 5 µg of
the indicated GST constructs. The complexes were precipitated with GST
beads, subsequently washed and resuspended in LDS Sample buffer (Invit-
rogen), and used for SDS-PAGE.
For direct protein–protein interaction assay, recombinant GST-tagged
Kindlin-2-F3 domain (GST-K2F3) and a mutated form (QW614/615AA)
were expressed in BL21 cells. His-tagged 1-integrin cytoplasmatic tails
were expressed in BL21 cells upon 1 mM IPTG induction and purified
under denaturing conditions. Five micrograms of GST-K2F3 or QW614/
615AA were incubated with His-tagged 1-integrin cytoplasmatic tails
bound to Ni2+-coated beads for 2 h in buffer D (50 mM NaCl, 10 mM PIPES,
150 mM sucrose, 0.1% Triton X-100 at pH 6.8, containing protease in-
hibitor cocktails [Roche]). After washing in buffer D, bound proteins were
analyzed by SDS-PAGE and Western blotting.
IIb3-integrin activation assay
CHO cells stably expressing human IIb3 integrin were transiently trans-
fected with 2 µg of the indicated EGFP-tagged cDNAs using Lipofectamine
2000 following the manufacturer’s instructions. Double-transfected cells
were transfected with 2 µg of each plasmid. Twenty-four hours after
transfection, cells were trypsinized and incubated with the mouse mono-
clonal antibody PAC-1 (BD) in Tyrode’s buffer (pH 7.35) for 40 min at
room temperature. Cells were washed and stained with a secondary anti-
mouse IgM Alexa 647-labeled antibody (Invitrogen) for 20 min on ice.
PAC-1 binding was measured with a FACSCalibur (BD), gating for living
cells, using propidium iodide exclusion. Data evaluation was performed
with the FlowJoe software. Statistical analysis was performed with five
independent experiments using the t-test.
Coimmunoprecipitation
ILKfl/fl and ILK−/− fibroblast cells were lysed in lysis buffer, and 1 mg of
each cell lysate was incubated with an anti-ILK mouse monoclonal an-
tibody (BD Bioscience) for 1 h on ice. Bound protein complexes were
bound to protein A beads (Sigma) for 1 h, subsequently washed in lysis
buffer containing 0.1% Triton X-100, resuspended in LDS sample buffer
(Invitrogen), and used for SDS-PAGE.
Histological analysis, inmunostaining, and electron microscopy
Immunohistochemistry of embryos and immunofluorescence studies of
EBs were performed as described previously (Montanez et al. 2007).
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Paper III 
Integrin-linked kinase: integrin’s mysterious partner
Carsten Grashoff, Ingo Thievessen, Katrin Lorenz, Siegfried Ussar and
Reinhard Fa¨ssler1
Integrin-mediated cell adhesion regulates a vast number
of biological processes including migration, survival and
proliferation of cells. It is therefore not surprising that defects in
integrin function are often rate-limiting for development and
profoundly affect the progression of several diseases. The
functions of integrins are mediated through the recruitment of
cytoplasmic plaque proteins. One of these is integrin-linked
kinase, which connects integrins to the actin cytoskeleton and
transduces signals through integrins to the extracellular matrix
and from integrins to various subcellular compartments.
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Abbreviations
aPIX PAK-interactive exchange factor-a
BM basement membrane
CH calponin homology
CPI-17 protein-kinase-C-dependent phosphatase inhibitor
of 17 kDa
Dock180 180-kDa protein downstream of CRK
EB embryoid body
ECM extracellular matrix
EMT epithelial-to-mesenchymal transition
FA focal adhesions
GSK-3 glycogen synthase kinase 3
ILK integrin-linked kinase
ILKAP ILK-associated phosphatase
Mig-2 mitogen inducible gene-2
MLC myosin light chain
PAK p21-activated serine/threonine kinase
PDK 3-phosphoinositide-dependent kinase
PH pleckstrin homology
PHI-1 phosphatase holoenzyme inhibitor 1
PI3K phosphatidylinositol-3-kinase
PINCH particularly interesting new cysteine-histidine-rich protein
PIP3 phosphoinositol trisphosphate
PTEN protein tyrosine phosphatase and tensin homolog
Introduction
Cell adhesion is mediated by multiprotein complexes
composed of adhesion receptors, extracellular matrix
(ECM) proteins and cytoplasmic plaque proteins. The
cell adhesion receptors determine the speciﬁcity of the
cell–cell or the cell–ECM interaction and recruit cyto-
plasmic plaque proteins to the cell adhesion site. The
cytoplasmic plaque proteins transduce signals initiated
by the adhesion receptor, link the adhesion receptors to
the cytoskeleton and regulate the functional properties of
the adhesion receptors themselves.
Integrins are a large family of adhesion receptors com-
prising >20 members that mediate highly dynamic cell–
cell and cell–ECM interactions. The association and the
release of integrin–ligand interactions are achieved by the
ability of integrins to adopt different conformations. The
active conformation is triggered by intracellular signals
and cytoskeleton assembly and results in ligand binding,
integrin clustering and recruitment of cytoplasmic plaque
proteins into integrin attachment sites called focal adhe-
sions (FAs) [1,2]. One protein that plays a central role in
integrin activation and signaling is integrin-linked kinase
(ILK) [3]. ILK is composed of three structurally distinct
domains: three ankyrin repeats near the N terminus (a
fourth ankyrin repeat was identiﬁed in human ILK but
lacks well-conserved residues), a short linker sequence,
and a kinase domain at the C terminus. The linker
domain, together with sequences from the N terminus
of the kinase domain, shares some similarities with pleck-
strin homology (PH) domains (Figure 1).
In the present review we will discuss the functional
properties of ILK, which are governed by ILK’s interac-
tion partners and kinase activity. The ﬁrst part of this
review summarizes biochemical and cell biological stu-
dies of ILK and the second part deals with in vivo
experiments from invertebrates and mice.
Cell biology and biochemistry of ILK
Overexpression of ILK as well as loss or reduction of ILK
expression in cells profoundly affects their morphology
and function. The most striking changes are impaired
cell spreading, abnormal cell adhesion to and assembly
of ECM proteins, delayed formation of FAs and altered
cell proliferation [3–6,7]. How can these defects be
explained? Important hints have come from the identi-
ﬁcation of ILK binding partners (Table 1), from their
mode of interaction with ILK and from the identiﬁcation
of substrates for the ILK kinase domain (Table 2).
ILK —a platform for actin regulatory proteins
Almost all adaptor proteins that bind either directly or
indirectly to ILK regulate the actin cytoskeleton and
www.sciencedirect.com Current Opinion in Cell Biology 2004, 16:565–571
hence could be responsible for the shape change and FA
dysfunction associated with altered ILK expression (Fig-
ure 1). Pinch (‘particularly interesting new cysteine-his-
tidine-rich protein’) was the ﬁrst interactor to be
identiﬁed [8]. Pinch-2, a Pinch homologue, was subse-
quently identiﬁed in mice and humans [9,10]. They are
both composed of ﬁve LIM domains and a nuclear
localization signal (NLS) at the C terminus. The ﬁrst
LIM domain binds the ﬁrst ankyrin repeat of ILK. The
interaction has been well-characterized using structural
[11], biochemical and cell biological approaches [8,9].
The fourth LIM domain of Pinch-1 was shown to bind
with very low afﬁnity to the SH2/SH3 adaptor protein
Nck2, which in turn interacts with growth factor receptors
and recruits a large number of proteins, including actin
modulators such as Dock180 (180-kDa protein down-
stream of CRK) and the p21-activated serine/threonine
kinase (PAK) [8,12,13]. Whether Pinch-1 interacts with
Nck2 in vivo is not clear. Since mice and cells lacking
Nck2 are normal [14] but mice lacking Pinch-1 die during
implantation (F Stanchi and R Fa¨ssler, unpublished) this
interaction does not seem to be crucial for Pinch-1 func-
tion. It has been shown that Pinch-2 can translocate into
the nucleus [9]. Its role there, however, is unclear.
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Figure 1
ILK binds Pinch and parvin and this ternary complex subsequently locates to the plasma membrane through the interaction with the cytoplasmic
domain of activated b1 and b3 integrin subunits as well as unknown FAs component(s). Binding to phospholipids results in the activation of
the kinase function of ILK, which in turn leads to the phosphorylation of GSK3b and PKB/Akt. Finally, ILK can recruit several adaptor proteins,
which are able to regulate actin dynamics or actin attachment to FAs. The molecules presented in Figure 1 are not drawn to scale. AKT, protein
kinase B/Akt; RTK, receptor tyrosine kinase; WASP, Wiskott-Aldrich syndrome protein.
Table 1
ILK interacting proteins, the location of their binding site on
ILK and the method(s) used to confirm their interaction.
Interactor Domain Detection Reference
b1 integrin C terminus Y2H/IP [3]
b3 integrin C terminus IP [3,61]
ILKAP N terminus Y2H/IP [62]
Mig-2/Kindlin-2 C terminus Y2H [21]
a-parvin C terminus Y2H/IP [18]
b-parvin C terminus Y2H/IP [19]
paxillin C terminus IP [15]
Pinch-1 N terminus Y2H/IP/CC [8,11]
Pinch-2 N terminus IP [9]
PIP3 PH — [26]
CC, co-crystallization; IP, co-immunopreciptiation; Y2H,
yeast-two-hybrid assay
Table 2
Putative targets of the ILK kinase activity and the amino
acid residue(s) phosphorylated by ILK.
Target Phosphorylation site Reference
ILK (Ser343) [35,40]
b1 integrin (Ser785) [3]
b3 integrin — [61]
b-parvin — [19]
GSK-3b (Ser9) [26,62]
PKB/Akt (Ser473) [26]
MLC-20 (Thr18/Ser19) [42]
MYPT-1 (Thr695, Thr495/Thr709) [43,44]
CPI-17 (Thr38) [45]
PHI-1 (Thr57) [45]
MYPT1, myosin phosphatase target subunit isoform 1.
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A search for paxillin binding proteins showed that the
kinase domain of ILK contains sequences resembling a
paxillin binding subdomain (PBS) motif, which ﬁrmly
binds paxillin [15]. The ILK–paxillin interaction is neces-
sary but not sufﬁcient to recruit ILK into FAs, where the
complex may modulate the function of other paxillin
binding proteins such as vinculin,a-actinin, talin andFAK.
Several laboratories have simultaneously shown that par-
vins, a new family of F-actin binding proteins, bind the
kinase domain of ILK [16–19]. The parvins comprise
three members (a-parvin or actopaxin or CH-ILK bind-
ing protein; b-parvin or afﬁxin; and g-parvin) and are
composed of two calponin homology (CH) domains that
bind ILK, paxillin and F-actin. b-parvin was shown to
interact with the guanine nucleotide exchange factor a-
PIX (PAK-interactive exchange factor-a), which may
activate Rac1 and Cdc42 [20]. Parvins are found in FAs
and apparently do not colocalize to stress ﬁbers [16,17].
An important future task will be to map the binding sites
of ILK, paxillin and F-actin on the CH domains and to
test whether their binding occurs simultaneously or is
mutually exclusive.
A recent paper identiﬁed an additional ILK binding
partner in Caenorhabditis elegans, termed UNC-112
[21]. UNC-112 contains a FERM domain [22] and is
important for the recruitment of the ILK orthologue, Pat-
4, to muscle attachment sites. The mammalian ortholo-
gue of UNC-112, Mig-2/Kindlin-2, was shown to bind the
LIM-domain-containing adaptor protein migﬁlin, which
in turn binds ﬁlamin [23]. It will be interesting to see
whether Mig-2/Kindlin-2 also binds ILK in mammalian
cells and whether this interaction modulates the function
of ﬁlamin, which is mutated in a variety of human dis-
eases.
ILK, Pinch and parvin — a ternary complex required
for stability and focal adhesion localization
The association of ILK, Pinch and parvin into a ternary
protein complex happens before their recruitment into
FAs [24] and serves at least two purposes: it stabilizes the
individual proteins and targets the individual components
into FAs [24,25]. Loss of ILK expression in cells leads to
the degradation of Pinch and parvin and, conversely, loss
of Pinch expression diminishes ILK and parvin levels
[25]. The degradation can be prevented either by inhi-
biting the proteasome [25] or by expressing short N-
terminal fragments of ILK (the ankyrin repeats) in ILK-
deﬁcient cells (C Grashoff, R Fa¨ssler, unpublished data)
or Pinch (the ﬁrst LIM domain) in Pinch-deﬁcient cells
(F Stanchi, R Fa¨ssler, unpublished data). Their recruit-
ment into FAs, however, cannot be rescued with these
fragments. These results support the notion that ILK and
Pinch must have binding partner(s) that facilitate FA
targeting. Possible candidates for ILK targeting partners
are integrins, paxillin and Mig-2/Kindlin-2. It has been
shown that nematodes lacking b integrin fail to localize
ILK to cell attachment sites [21]. Mammalian cells may
have a similar requirement for b integrin to localize ILK,
but this has not been shown yet with cell lines lacking
either b1 or b3 or both integrin subunits. Paxillin binds
ILK via its N-terminal leucine-rich motifs and targets to
FAs via the C-terminal LIM domains. Mutation in the
paxillin binding site of ILK prevents ILK/Pinch/parvin
recruitment to FAs [15]. Mig-2/Kindlin-2 could also play a
role since the worm orthologue UNC-112 is essential for
localization of Pat-4/ILK to integrin-containing attach-
ment sites [21]. No candidate binding partners are
currently known that could promote recruitment of Pinch
into FAs.
The dependence of ILK, Pinch and parvin stability on
the formation of a ternary complex has implications for
the interpretation of overexpression experiments. Accu-
mulation of ILK in the cytoplasm of ILK-overexpressing
cells may cause a partial depletion of Pinch and parvin
from FAs, resulting in an impaired FA function. This
could explain why cells either lacking [7] or overex-
pressing ILK [3] have similar phenotypes: they both show
a rounded morphology and have decreased adhesive
properties.
The kinase activity of ILK
Despite the sequence differences between the ILK
kinase domain and other protein kinases (important resi-
dues in the activation loop of the kinase are not con-
served) the similarity was immediately recognized and
investigated [3]. Initial studies showed that GST-tagged
ILK puriﬁed from bacteria or mammalian cells could
phosphorylate serine and threonine residues in peptides
representing the b1 integrin tail, and model substrates
such as myelin basic protein [3].
ILK kinase activity took center stage when it was sug-
gested to be directly associated with cell proliferation,
tumor growth and metastasis [4,26–29]. On the one hand,
overexpression of ILK in cells results in anchorage-
independent cell cycle progression [5] and epithelial-
to-mesenchymal transition (EMT) of non-tumorigenic
as well as tumorigenic epithelial cells [4,29]. Inhibition
of ILK kinase activity, on the other hand, suppresses cell
growth in culture as well as growth of human colon
carcinoma cells in SCID mice [30]. Several lines of
experimental evidence suggest that these phenotypes
are largely attributed to enhanced ILK kinase activity
and phosphorylation of GSK3b and PKB/Akt [26], two
key enzymes involved in a diverse array of cell functions
including cell proliferation, survival and insulin responses
[31,32]. ILK-dependent phosphorylation of GSK3b in
epithelial cells downregulates GSK3b kinase activity
[26]. This in turn is associated with reduced E-cadherin
expression, enhanced AP1 activity and increased b-cate-
nin–Lef/Tcf activity [4,33], which induces the expression
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of cell-cycle-promoting genes such as cyclins and c-myc
[5,34]. The reduced E-cadherin expression could be due
to a direct effect of the b-catenin-Lef/Tcf complex on
E-cadherin gene expression [4]. Alternatively, ILK can
reduce E-cadherin levels indirectly by triggering snail
expression, which in turn represses E-cadherin gene
expression [30].
Full activation of PKB/Akt requires PIP3-dependent
phosphorylation of two residues: Thr308 and Ser473
[32]. Whereas PDK-1 (3-phosphoinositide-dependent
kinase 1) phosphorylates Thr308, ILK has been identiﬁed
as ‘PDK-2’, which phosphorylates Ser473 via a direct
interaction at the plasma membrane [26,35]. Besides
possessing a kinase activity, ILK fulﬁls other require-
ments of a PDK2, including PIP3 binding and regulation
of its activity by PI3K (phosphatidylinositol-3-kinase) or
PTEN (protein tyrosine phosphatase and tensin homo-
log) [26,27]. However, some doubts about ILK’s kinase
activity arose when it was reported that it has no Ser473
phosphorylation activity [36,37]. These doubts were
reinforced by genetic studies in invertebrates and mice
that demonstrated normal Ser473 phosphorylation in the
absence of ILK [7,21,38]. Loss-of-function mutations
of ILK in worms and ﬂies show no defects that can be
explained by impaired PKB/Akt activity, but develop
severe muscle defects that are fully rescued when differ-
ent kinase-dead versions of ILK are expressed [21,38].
Similarly, ﬁbroblasts with or without the ILK gene phos-
phorylate Ser473 to a similar extent following insulin or
PDGF stimulation [7], and neither chondrocytes nor
keratinoyctes change their steady-state Ser473 phosphor-
ylation after ILK gene ablation in vivo [39] (T Sakai and
R Fa¨ssler, unpublished). These ﬁndings convincingly
demonstrate that ILK — even if it has Ser473 phosphor-
ylation activity — is not the only PDK2. These ﬁndings,
however, do not exclude the possibility that ILK med-
iates the phosphorylation of PKB/Akt and other target
proteins in an indirect manner, for example by recruiting a
kinase or inhibiting a phosphatase [37,40]. Support for
such a notion also comes from gene ablation experiments.
Monocytes lacking ILK expression show reduced Ser473
phosphorylation [41]. Similarly, ILK-null ﬁbroblasts,
which respond normally to insulin treatment, fail to
maintain Ser473 phosphorylation levels to the same
extent as normal cells upon PDGF treatment [7].
Furthermore, they display a slightly reduced steady state
level of Ser473 phosphorylation under normal culture
conditions (T Sakai and R Fa¨ssler, unpublished).
Other targets of the ILK kinase activity (Table 2) are b-
parvin [19], the regulatory myosin light chain (MLC) [42],
and MLC phosphatase [43,44] and its regulators CPI-17
(protein-kinase-C-dependent phosphatase inhibitor of 17
kDa) and PHI-1 (phosphatase holoenzyme inhibitor 1)
[45]. The signiﬁcance of their phosphorylation, however,
is not clear.
Since ILK regulates so many essential cellular functions it
is important to settle the debate on ILK’s kinase activity.
Solving the structure of the ILK kinase domain will be
very informative, as will the analysis of mice carrying
‘kinase-dead’ versions of the ILK gene and the identiﬁ-
cation of PDK2(s). In addition to these new experimental
approaches, new reagents to probe ILK’s function will be
useful. The E359K mutation in ILK, for example, was
originally found to lack kinase activity and was therefore
used in many studies as a ‘kinase-dead’ version of ILK. It
turns out, however, that the mutation does not affect
kinase activity but rather impairs paxillin binding and FA
targeting [46]. Furthermore, a polyclonal anti-ILK anti-
serum that recognizes a 59 kDa band of unknown origin
instead of the 52 kDa sized ILK has been used in a large
number of studies and could potentially have given mis-
leading results [3,6,47].
Studies of ILK/Pinch/parvin in invertebrates
and mice
The attachment sites of the body wall muscle to the
hypodermis of C. elegans are called dense bodies and
resemble FA-like structures. They contain b-pat-3 integ-
rin (the only b integrin subunit in C. elegans), pat-4/ILK,
UNC-97/Pinch, pat-6/parvin and UNC-112/Mig-2 and
loss-of-function alleles of these proteins lead to severe
adhesion defects manifesting as muscle detachment and
embryonic lethality [21,22,48,49]. The loss-of-function
studies also reveal that b-pat-3 integrin is required to
recruit ILK to the plasma membrane [21] and that
integrins are partially mislocalized in the absence of
pat-4/ILK [21] or UNC-112/Mig-2/Kindlin-2 [22]. A
recent report showed that the Zn2+-ﬁnger-containing
transcription factor UNC-98 can bind UNC-97/Pinch
and is also required for muscle attachment to the body
wall [50]. UNC-98 shuttles between dense bodies and
the nucleus where it binds DNA and probably regulates
gene transcription. So far an ortholog of the UNC-98 gene
has not been identiﬁed in ﬂies or mammals.
Drosophila melanogaster has a similar requirement for bPS
integrins, ILK and Pinch in muscle cell attachment
[38,51]. Interestingly, loss of bPS integrin function in
ﬂies leads to detachment of ECM from the cell mem-
brane, while loss of ILK function leads to detachment of
F-actin from the plasma membrane, indicating an impor-
tant role for ILK in actin stabilization at integrin attach-
ment sites [38]. The severe muscle defect in worms or
ﬂies lacking ILK can be fully rescued by the expression
of different kinase-dead ILK transgenes, supporting the
idea that ILK functions as an important adaptor protein,
independent of its kinase activity [21,38].
The loss of ILK expression in mice leads to peri-implan-
tation lethality similar to what is seen upon loss of b1
integrin expression [7,52]. The cause of the develop-
mental arrest was studied in embryoid bodies (EBs)
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[7,53,54]; these studies showed that b1-integrin-mutant
EBs are unable to deposit a basement membrane (BM),
while ILK-null EBs produce a BM but fail to polarize the
epiblast (a primitive tissue that will give rise to all three
germ layers). Since addition of laminin to b1-integrin-null
EBs rescues the BM assembly phenotype and allows
epiblast development it is likely that b1 integrin and
ILK function independently during the peri-implantation
period [54].
Conditional loss of ILK in chondrocytes leads to skeletal
growth retardations characterized by abnormal chondro-
cyte shape and decreased proliferation in vivo [39,55], and
diminished chondrocyte spreading on ECM and reduced
stress ﬁber formation in vitro [39]. Similar, albeit more
severe, defects are also observed in mice with a chon-
drocyte-speciﬁc deletion of the b1 integrin gene [56],
indicating that b1 integrins and ILK are both required for
normal chondrocyte function. The mechanism leading to
reduced chondrocyte proliferation in the absence of ILK
expression is not understood; altered phosphorylation of
PKB/Akt or GSK-3b was excluded [39]. A conditional
deletion or reduction of ILK gene expression in macro-
phages, on the other hand, results in a strong inhibition
of the PKB/Akt-Ser473 phosphorylation associated with
apoptosis [41], indicating that ILK kinase activity might
differ depending on the cell type.
Overexpression of ILK in mammary glands of transgenic
mice leads to tumor formation [29]. Similarly, pharma-
cological inhibition of ILK in prostate carcinoma cells
causes them to proliferate much less rapidly in vivo
[57]. These ﬁndings can principally be explained by
the oncogenic activities of ILK (activation of PKB/Akt,
inhibition of GSK-3b, and stimulation of AP-1, NF-kB
and b-catenin–Lef/Tcf transcription factors) and its abil-
ity to promote tumor angiogenesis. ILK promotes blood
vessel invasion into tumors in two ways: ILK induces
HIF1a-dependent VEGF expression in tumor cells,
which in turn regulates endothelial cell migration and
proliferation in an ILK kinase-dependent manner [57].
The importance of ILK for tumor pathology is under-
scored by the fact that a large number of malignant tumors
display increased ILK levels and kinase activity [58], and
in some tumor types ILK levels correlate with tumor
grade [59,60].
Outlook
ILK has many interesting functional facets and work in
both invertebrates and mice has revealed an essential role
for ILK in development. There is a general consensus
that ILK plays a central role in the reorganization of the
F-actin cytoskeleton and its attachment to FAs. The role
of ILK as a kinase is more controversial. Since a large
number of ILK functions rely on kinase activity, includ-
ing EMT, proliferation and VEGF expression, this con-
troversy should urgently be settled. This can be assisted
by solving the structure of the ILK kinase domain, using
continued genetic approaches or the well-deﬁned anti-
bodies that have become available over the past few years.
As has already been done in ﬂies and worms, it should be
tested in mice whether point mutations in the kinase
domain of ILK impair the function of the molecule.
An important future task will be to identify the signals
that trigger assembly of the ILK/Pinch/parvin complex, to
identify the proteins that recruit the core complex into
FAs, and to establish how the core complex modulates
integrin functions and regulates actin dynamics. The
availability of cell lines and mice that lack ILK and
the progress in proteomics and live cell imaging should
together help to dissect these mechanisms and to clarify
ILK’s role in integrin-mediated cell adhesion.
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Paper IV 
Kindlin-3 is essential for integrin activation and
platelet aggregation
Markus Moser1, Bernhard Nieswandt2,3, Siegfried Ussar1, Miroslava Pozgajova2 & Reinhard Fa¨ssler1
Integrin-mediated platelet adhesion and aggregation are
essential for sealing injured blood vessels and preventing
blood loss, and excessive platelet aggregation can initiate
arterial thrombosis, causing heart attacks and stroke1. To
ensure that platelets aggregate only at injury sites, integrins
on circulating platelets exist in a low-afﬁnity state and shift
to a high-afﬁnity state (in a process known as integrin
activation or priming) after contacting a wounded vessel2.
The shift is mediated through binding of the cytoskeletal
protein Talin to the b subunit cytoplasmic tail3–5. Here we
show that platelets lacking the adhesion plaque protein
Kindlin-3 cannot activate integrins despite normal
Talin expression. As a direct consequence, Kindlin-3 deﬁciency
results in severe bleeding and resistance to arterial thrombosis.
Mechanistically, Kindlin-3 can directly bind to regions of
b-integrin tails distinct from those of Talin and trigger integrin
activation. We have therefore identiﬁed Kindlin-3 as a novel
and essential element for platelet integrin activation in
hemostasis and thrombosis.
Cellular control of integrin activation is essential for virtually all cells,
including platelets, which seal injured blood vessels and stop bleeding.
At sites of injury, the platelet receptors GPIb and GPVI bind to von
Willebrand factor (vWF) and collagen, respectively1–3, which together
with locally produced thrombin trigger activation of integrin aIIbb3
and the release of soluble platelet agonists including ADP and
thromboxane A2 (TxA2). Activated aIIbb3 integrins bind ﬁbrinogen,
vWF and ﬁbronectin, thus allowing ﬁrm platelet adhesion and platelet
aggregation. The central role of integrin activation in platelet adhesion
and aggregation sparked the search for critical integrin tail-binding
proteins that control integrin afﬁnity for ligands. Irrespective of the
platelet-activating stimulus and signaling pathways, Talin binding to
the b-integrin tails was shown to be the ﬁnal common step in aIIbb3
integrin activation and ligand binding4,6,7. Talin, a major cytoskeletal
protein at integrin adhesion sites, consists of a large C-terminal rod-
like domain and an N-terminal FERM (protein 4.1, ezrin, radixin,
moesin) domain with three subdomains: F1, F2 and F3 (ref. 8). The
phosphotyrosine-binding (PTB) subdomain in the F3 domain sequen-
tially binds to two distinct regions in the b cytoplasmic tails and is
sufﬁcient for integrin activation in vitro8,9.
In addition to Talin, other FERM domain–containing proteins,
including the Kindlins, interact with integrin b tails10. The Kindlin
protein family consist of three members (Kindlin-1, Kindlin-2 and
Kindlin-3), all of which localize to integrin adhesion sites11–13. In
contrast to the widely expressed Kindlin-1 and Kindlin-2, Kindlin-3 is
restricted to hematopoietic cells and is particularly abundant in
megakaryocytes and platelets12. The structural hallmark of Kindlins
is a FERM domain whose F2 subdomain is split by a pleckstrin
homology (PH) domain. In a comparison of FERM-domain proteins,
the F3 subdomains of Kindlins have been found to share highest
homology with the F3 domain of Talin10.
To address the function of Kindlin-3 in vivo, we disrupted the Kind3
(also called Fermt3) gene in mice (Supplementary Fig. 1 online). Mice
heterozygous for the Kindlin-3–null mutation (Kind3+/–) were nor-
mal, whereas mice lacking Kindlin-3 (Kind3/; Fig. 1a) died within a
week of birth and showed a pronounced osteopetrosis (unpublished
data) and severe hemorrhages in the gastrointestinal tract, skin, brain
and bladder, which were already apparent during development
(Fig. 1b and data not shown). To test whether the severe bleeding
of Kindlin-3–deﬁcient mice was due to impaired platelet production
and/or function, we generated fetal liver cell chimeras by transferring
either Kind3/ or wild-type fetal liver cells into lethally irradiated
wild-type recipient mice. Tail-bleed assays revealed that Kind3/
chimeras suffer from a pronounced hemostatic defect like that of
Kindlin-3–deﬁcient mice. After the tail-tip cut, bleeding in control
mice arrested within 10 min (mean of 5.4 ± 4.3 min), whereas
Kind3/ chimeras bled for longer than 15 min, suggesting severe
platelet dysfunction (Fig. 1c).
Kind3/ chimeras showed platelet counts similar to those of wild-
type chimeras (Fig. 1d), ruling out an essential role for Kindlin-3 in
platelet formation. Analysis of glycoprotein abundance on platelets
revealed elevated levels of the vWF receptor complex GPIb-IX in
Kindlin-3–deﬁcient as compared to wild-type platelets, whereas levels
of other glycoproteins, including GPVI, CD9, and b1 and b3 integrins,
were reduced (Supplementary Table 1 online). Thus Kindlin-3 has an
apparent yet undeﬁned role in the expression of several glycoproteins.
However, the reduced expression of integrin aIIbb3 does not account
for the hemostasis defect, as mice carrying a heterozygous null
mutation in the b3 integrin express even less aIIbb3 integrin on their
platelets (50% of wild-type) without developing a bleeding defect14.
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To determine the mechanism of the platelet defect, we performed
ex vivo platelet aggregation studies. Wild-type platelets aggregated in
response to ADP, the TxA2 analog U46619, thrombin, collagen and
the GPVI-activating collagen-related peptide (CRP), whereas none of
the agonists induced aggregation of Kind3/ platelets (Fig. 2a).
Notably, all agonists induced a comparable activation-dependent
change from discoid to spherical shape in control and Kind3/
platelets, which can be seen in aggregometry as a short decrease in
light transmission following the addition of agonists. This suggests a
selective defect in aIIbb3-dependent aggregation rather than a general
impairment of signaling pathways in Kind3/ platelets.
To test whether activation of aIIbb3 integrin is indeed abrogated in
Kind3/ platelets, we determined their ability to bind ﬁbrinogen
using ﬂow cytometry. Wild-type platelets showed robust ﬁbrinogen
binding in response to ADP, ADP plus U46619 and CRP, whereas
Kind3/ platelets failed to bind ﬁbrinogen upon agonist treatment
(Fig. 2b). The antibody JON/A-PE, which speciﬁcally detects the
activated form of mouse aIIbb3 integrin14, likewise did not bind
stimulated Kind3/ platelets (Fig. 2c). When cellular activation of
aIIbb3 integrin was bypassed by the addition of MnCl2, comparable
ﬁbrinogen binding to Kind3/ and wild-type platelets occurred
(Fig. 2b). Together, these ﬁndings indicate that loss of Kindlin-3
expression prevents energy-dependent conformational rearrangements
required for integrin-aIIbb3 activation.
Resting platelets store P-selectin in a-granules, which fuse with the
plasma membrane during agonist-induced platelet activation1. Both
CRP and thrombin induced P-selectin translocation on wild-type and
Kind3/ platelets, although a signiﬁcant reduction was consistently
observed at intermediate concentrations of thrombin (P o 0.001;
Fig. 2d). As expected, the weak agonist ADP did not induce P-selectin
surface expression in wild-type and Kind3/ platelets. Thus, although
loss of Kindlin-3 speciﬁcally disables integrin activation, it still permits
agonist-induced P-selectin translocation.
Integrin-aIIbb3 is also involved in adhesion to immobilized ligands,
including collagen-bound vWF, where it acts in concert with the
collagen-binding a2b1 integrin2,15. We analyzed the ability of Kind3/
platelets to interact with ﬁbrous collagen in a whole-blood perfusion
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Figure 2 Impaired platelet function in Kind3/ mice. (a) Platelet aggregation assay reveals impaired aggregation of Kind3/ platelets (gray lines) in
response to ADP, U46619, thrombin, CRP and collagen when compared with control platelets (black lines). Arrows denote addition of agonist. (b) Wild-type
(Kind+/+) platelets (black bars), but not Kind3/ platelets (gray bars), bind ﬁbrinogen in response to ADP (10 mM), ADP (10 mM) plus U46619 (3 mM) or
CRP (10 mg/ml). Treatment with MnCl2 (Mn2+; 3 mM) triggers comparable binding. Resting (rest.) platelets were used as a control. (c,d) Kind3/ platelets
(gray bars) show a complete block in activation of integrin-aIIbb3 after stimulation with ADP (10 mM), CRP (10 mg/ml) and different concentrations (0.001–0.1
U/ml) of thrombin (c), whereas platelet degranulation measured by the surface expression of P-selectin is largely intact after the same treatments (d). Wild-type
platelets (black bars) were used as a control. At the intermediate thrombin concentration, moderately but signiﬁcantly reduced degranulation was observed with
mutant platelets (** P o 0.01). MFI, mean ﬂuorescence intensity. (e) Kind3/ platelets in whole blood failed to form thrombi when perfused over a
collagen-coated (0.25 mg/ml) surface at a wall shear rate of 1,000 s–1. Scale bar, 30 mm. (f) Mesenteric arterioles were injured with FeCl3, and adhesion
and thrombus formation of ﬂuorescently labeled platelets were monitored by in vivo video microscopy. Representative images (left) and time to vessel
occlusion (right) are shown. Each symbol represents one individual. Scale bar, 30 mm.
Figure 1 Kindlin-3–deﬁcient animals show severe hemorrhages. (a) Western
blot analyses from spleen and platelet lysates of wild-type (Kind3 +/+),
heterozygous (Kind3+/) and Kindlin-3–deﬁcient (Kind3/) mice.
(b) E15.5 embryos reveal severe bleeding. Postnatally, Kind3/ mice
show skin (arrowhead) and intestinal (arrows) bleeding. All scale bars,
1 mm. (c) Tail-bleeding times in wild-type and Kind3/ mice.
(d) Peripheral platelet counts in wild-type and Kind3/ chimeras.
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assay. Under high- (1,000 s–1, Fig. 2e) or low-shear (150 s–1, data not
shown) ﬂow conditions, wild-type platelets adhered to the collagen
ﬁbers and rapidly built stable three-dimensional aggregates (Fig. 2e).
In contrast, Kind3/ platelets never established stable adhesions and
either detached immediately or translocated along the ﬁbers for a few
seconds, resulting in virtually no platelets attaching to the collagen-
coated surface at the end of the 4-min perfusion time (Fig. 2e).
Furthermore, agonist-stimulated Kind3/ platelets failed to bind the
monoclonal anti-b1 integrin antibody 9EG7, which speciﬁcally recog-
nizes the activated form of b1 integrins16, and also failed to adhere to
soluble, pepsin-digested collagen type I under static conditions (Sup-
plementary Fig. 2 online), a process known to be mediated exclusively
by a2b1 integrins17. Together these ﬁndings indicate that Kind3/
platelets can establish initial contacts with vWF/collagen via GPIb and
probably GPVI, but are unable to adhere ﬁrmly as a result of defective
activation of aIIbb3 and a2b1 integrins.
As platelet aggregation may lead to pathological occlusive thrombus
formation, we examined whether lack of Kindlin-3 is protective
against ischemia and infarction after mesenteric arteriole injury.
This injury was induced by ferric chloride and assessed by in vivo
ﬂuorescence microscopy. Five minutes after injury, numerous platelets
adhered ﬁrmly to the denuded vessel wall in control chimeras (5,380 ±
2,465/mm2); after approximately 10 min, the ﬁrst thrombi
were observed; and after 18–39 min, the vessels were occluded
(mean occlusion time: 27.6 ± 8.1 min; Fig. 2f). In contrast, a few
Kind3/ platelets transiently (o5 s) attached to the injured vessel
wall, but virtually none adhered ﬁrmly throughout the 40-min
observation period (50 ± 24 / mm2). Furthermore, no thrombi
formed in the injured vessels of Kind3/ chimeras, and blood ﬂow
was maintained in all vessels tested (Fig. 2f). These results conﬁrm the
ex vivo results and underscore the pivotal function of Kindlin-3 in
integrin-mediated platelet adhesion to injured vessels in vivo.
The requirement for Kindlin-3 to trigger agonist-induced integrin
activation on platelets, integrin-mediated platelet adhesion and
thrombus formation suggests that it may be a downstream target of
cellular signaling pathways that activate integrins. To test whether
Kindlin-3 is able to activate integrins, we overexpressed Kindlin-3 in
integrin-aIIbb3–overexpressing CHO cells. In these cells Kindlin-3 was
unable to trigger integrin activation, likely because the hematopoietic
Kindlin-3 is not recruited to integrin containing focal adhesions13.
Kindlin-3 overexpression in the mouse macrophage cell line RAW
264.7 (RAW), however, yielded a 2.2-fold increase in binding of the
Cy5-labeled ﬁbronectin repeat 7-10 (FN7-10), which harbors the
integrin-binding RGD motif (Fig. 3a). Enhanced green ﬂuorescent
protein (EGFP)-transfected RAW cells showed virtually no increase in
FN7-10 binding as compared to untransfected cells, whereas Talin
overexpression and treatment with Mn2+ induced a 2.5-fold increase.
Notably, overexpression of a Kindlin-3 variant with a point mutation
in the PTB-like domain (Q597A), which in Talin (R358) reduces
binding to b tails4, did not trigger FN7-10 binding. These data
indicate that Kindlin-3 is capable of activating FN binding integrins
and that this activity requires an intact PTB-like domain.
How does Kindlin-3 activate integrins? As reduced Talin expression
did not account for the defect (Fig. 3b), we investigated whether the
FERM domain of Kindlin-3, which is similar to that of Talin, might
play a direct role in integrin activation. As previously shown, recom-
binant Talin bound wild-type b1 and b3 integrin tails, and this binding
was signiﬁcantly reduced when alanine mutations were introduced
into the membrane-proximal tryptophan residue or NPxY motif
(b3W739A, b3Y747A, b1W780A and b1Y788A)18. Kindlin-3 was also
able to interact with the wild-type b1 and b3 integrin tails (Fig. 3c), in
the presence and absence of Talin1 (Supplementary Fig. 3 online),
and the F3 subdomain of Kindlin-3 was sufﬁcient for this interaction
and this interaction occurred in a direct manner (Fig. 3d). However,
speciﬁc point mutations within the b1 and b3 integrin cytoplasmic
tails revealed that the binding properties of Kindlin-3 were different
from those of Talin, as the former still bound to b3W739A, b3Y747A,
b1W780A and b1Y788A tails, although less efﬁciently than to wild-
type tails (Fig. 3e,f). Mutations to the membrane distal NxxY motif of
the b1 and b3 tails (b1Y800A, b3Y759A) and the b1TT793/794AA and
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Figure 3 Biochemical analyses of Kind3/ platelets. (a) Binding of Cy-5–
labeled ﬁbronectin III 7-10 fragments (FNIII7-10; FN) to RAW 264.7 cells
transfected with EGFP, Talin, EGFP-Kindlin-3 or EGFP-Kindlin-3(Q597A).
Binding of Cy-5–labeled ﬁbronectin III 7-10 lacking the RGD binding loop
(FNIII7-10DRGD) was used to estimate nonspeciﬁc binding, and binding in the
presence of 5 mM Mn2+ served as a positive control. Data shown are mean ±
s.e.m. of ﬁve independent experiments, normalized to FNIII7-10 binding to
EGFP-transfected cells and with the background binding of FNIII7-10DRGD
subtracted. P values were obtained by unpaired t-test. (b) Western blot analysis
of lysates from wild-type (+/+) control and Kind3/ (–/–) platelets.
(c) Pull-down experiment with His-tagged aIIb, b1 and b3 integrin tails incubated with 100 mg platelet lysate. (d) Protein-protein interaction assay of
recombinant GST–Kindlin-3 F3 domain (GST-K3F3) incubated with His-tagged aIIb and b3 integrin tails reveals direct binding between the F3 domain of
Kindlin-3 and the b3 tail. GST pull-down experiments were performed with recombinant GST-b1A (wild-type), GST-b1Y788A, GST-b1Y800A, GST-b1W780A
and GST-b1TT793/794AA (e); with GST-b3 (wild-type), GST-b3Y747A, GST-b3Y759A, GST-b3W739A and GST-b3ST752/753AA (f); and with GST-b3 (wild-
type) and GST-b3S752A (g) integrin cytoplasmic domains after incubation with 100 mg platelet lysate. GST protein and GST-aIIb were used as controls. 5%
of the platelet lysate used for the pull-down experiment is shown as input control. Bound Talin and Kindlin-3 proteins were detected by western blotting.
Coomassie blue staining showed that equal amount of GST fusion proteins were used. Shown are results from pull-down assays representative of a minimum
of seven experiments.
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b3ST752/753AA, however, abolished Kindlin-3 but not Talin binding
(Fig. 3e,f). Moreover, the b3S752P mutation found in a subset of
individuals with Glanzmann’s thrombasthenia also abolished Kindlin-
3 binding19 (Fig. 3g). These data indicate that Talin primarily requires
membrane-proximal residues for binding, whereas Kindlin-3 requires
membrane-distal residues for binding to the b1 and b3 tails.
Ligand-occupied integrins transduce signals that lead to the activa-
tion of Src family kinases, resulting in cell spreading (outside-in
signaling). We tested the role of Kindlin-3 in outside-in signaling by
analyzing the adhesion of washed control and Kind3/ platelets to
ﬁbrinogen under static conditions. As mouse platelets, in contrast to
human platelets, do not spread well on immobilized ﬁbrinogen
without cellular activation20, we performed the experiments in the
presence of 0.01 U/ml thrombin, with and without added Mn2+.
Comparable adhesion of control and Kind3/ platelets to the
ﬁbrinogen matrix occurred, conﬁrming a previous observation that
integrin-aIIbb3 activation is not required for static adhesion of platelets
to ﬁbrinogen21. However, whereas control platelets readily formed
lamellipodia and spread within 10–15 min, Kind3/ platelets only
formed ﬁlopodia, with occasional transient small lamellipodia, and
completely failed to spread for up to 45 min (Fig. 4a,b). We obtained
similar results when we carried out adhesion in the presence of
Mn2+ (Fig. 4c). Thus, Kindlin-3 is also required for integrin aIIbb3-
dependent outside-in signaling.
Our study demonstrates that Kindlin-3 is essential for platelet
integrin activation and subsequent integrin outside-in signaling.
Furthermore, we found that Kindlin-3 regulates activation of both
b3 (aIIbb3) and b1 (a2b1) integrins, suggesting that Kindlin-3, like
Talin, is a general regulator of integrin activation. We propose that this
regulatory mechanism is mediated through a direct interaction
between the PTB site of the F3 domain in Kindlin-3 and the integrin
b3 and b1 tails, including their distal NxxY motifs. Because Talin
binding requires an intact proximal NPxY motif, our ﬁndings raise
questions regarding the roles of Kindlin-3 and Talin in integrin
activation and the hierarchy of their binding to the integrin b tails.
Future studies on the structure of the Kindlin-3–integrin complex are
required to examine the relative roles of Kindlin-3 and Talin inter-
actions with integrin tails so as to fully understand how these receptors
become activated. Finally, we show that elimination of Kindlin-3
prevents the formation of pathological thrombi. As Kindlin-3 is
selectively expressed in cells of hematopoietic origin, it may serve as
a potential target for the design of therapeutics aimed at speciﬁcally
disrupting integrin activation in platelets.
METHODS
Inactivation of the Kindlin-3 gene. A BAC clone containing the Kind3
(Fermt3) gene was isolated and used to generate the targeting construct
containing an IRES-lacZ-neo cassette between exons 3 and 6. The targeting
vector was electroporated into R1 ES cells, and targeted ES-cell clones were
identiﬁed by southern blotting and injected into host blastocysts to generate
germline chimeras.
Generation of fetal liver cell chimeras. Fetal liver cells from E15 wild-type and
Kind3/ embryos were obtained by pushing the liver through a cell strainer
(Falcon). 4  106 cells were injected into the tail vein of lethally irradiated
(10 Gy) recipient C57BL/6 mice. At 3–4 weeks after transfer, platelets were
isolated from whole blood collected from the retro-orbital plexus.
Western blot analysis. Platelet lysates were subjected to a 5–15% gradient
SDS-PAGE. After blotting, PVDF membranes were probed with anti–Kindlin-3
(ref. 12), anti-Talin (Sigma) and anti-GAPDH (Chemicon).
GST fusion protein pull-down assays. The b1A and b3 integrin cyto-
plasmic domains and their mutant forms (GST-b1Y788A, GST-b1Y800A,
GST-b1W780A and GST-b1TT793/794AA; GST-b3Y747A, GST-b3Y759A,
GST-b3W739A, GST-b3ST752/753AA and GST-b3S752A) were expressed as
GST-fusion proteins in BL21 cells upon induction with 1 mM IPTG. Bacteria
were washed and lysed in buffer A (150 mM NaCl, 1 mM EDTA, 10 mM
Tris, pH 8) containing 100 mg/ml lysozyme for 15 min on ice and then
sonicated. After dialysis against buffer B (100 mM NaCl, 50 mM Tris
pH 7.5, 1% NP-40, 10% glycerol, 2 mM MgCl2), GST-fusion proteins were
bound to glutathione-Sepharose beads (Novagen), eluted in 50 mM Tris,
pH 8, 20 mM glutathione, and dialyzed against buffer C (20 mM Tris
pH 7.5, 20% glycerol, 100 mM KCl, 0.2 mM EDTA, 2 mM DTT,
10 mM b-glycerophosphate).
For GST pull-down experiments, GST fusion proteins were bound to
glutathione-Sepharose beads for 1 h at room temperature (B20 1C) in buffer
A. Fresh platelet lysates were incubated with GSTor GST-integrin cytoplasmic-
domain fusion proteins for 4 h or overnight at 4 1C. The glutathione-Sepharose
beads were washed four times with buffer A containing 1% Triton X-100 and
10 mM EDTA. Bound proteins were eluted from the beads by boiling in
Laemmli buffer (2% SDS, 10% glycerol, 5% 2-mercaptoethanol, 0.002%
bromphenol blue, 62.5 mM Tris-HCl, pH 6.8) after separation by a SDS-PAGE
and western blotting.
For direct protein-protein interaction assay, recombinant Kindlin-3 F3
domain, spanning amino acids 550–665 (GST-K3F3), was expressed in BL21
cells as described above. Histidine (His)-tagged integrin cytoplasmic tails
were expressed in BL21 bacteria upon induction with 1 mM IPTG and
puriﬁed under denaturing conditions. Ten micrograms of GST-K3F3 was
incubated with His-tagged aIIb, and b3 integrin cytoplasmic tails bound to
Ni2+-coated beads for 2 h in buffer D (50 mM NaCl, 10 mM PIPES, 150 mM
sucrose, 0.1% Triton X-100, pH 6.8) containing phosphatase and protease
inhibitor cocktails (Sigma, Roche). After being washed in buffer D, bound
proteins were analyzed by SDS-PAGE and western blotting. Loading of
Ni2+-coated beads with the recombinant integrin tails was assessed by
Coomassie Blue staining.
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Figure 4 Defective adhesion and spreading of Kind3/ platelets.
(a) Washed wild-type and Kind3/ platelets were stimulated with
0.01 U/ml thrombin and then allowed to adhere to immobilized ﬁbrinogen
for 15 min. Scale bar, 5 mm. (b) Scanning electron microscopy of wild-type
and Kind3/ platelets after thrombin stimulation and adhesion to
ﬁbrinogen for 30 min. Scale bars, 1 mm. (c) Washed platelets were allowed
to adhere to immobilized ﬁbrinogen in the presence of 3 mM Mn2+ for
30 min. Left, representative DIC images. Scale bar, 5 mm. Right, number
of lamellipodia-forming platelets (% of adherent platelets; mean ± s.d.
of four experiments per group).
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Fibronectin binding assay. RAW 264.7 cells were electroporated with 4 mg of
the indicated DNAs using a Macrophage Kit from the Amaxa system. Twenty-
four hours after transfection, cells were trypsinized, washed in FACS Tris-buffer
(24 mM Tris-HCl, pH 7.4, 137 mM NaCl and 2.7 mM KCl) and incubated for
40 min with 0.3 mM Cy5-labeled recombinant ﬁbronectin III 7-10 fragment or
FNIII 7-10DRGD fragment22. As a positive control, EGFP-transfected cells were
incubated with 5 mM Mn2+. After washing, the amount of cell-bound
ﬁbronectin fragment was measured with a FACSCalibur (Becton Dickinson).
Dead cells were excluded from FACS analysis by addition of 2.5 mg/ml
propidium iodide and gating for living (propidium iodide negative) and
EGFP-positive cells.
Chemicals. The anesthetic drugs xylazine (Rompun) and ketamine (Imalgene
1000) were purchased from Bayer and Me´rial, respectively. High-molecular-
weight heparin and human ﬁbrinogen and ADP were from Sigma and
collagen was from Kollagenreagent Horm, Nycomed. Monoclonal antibodies
conjugated to either ﬂuorescein isothiocyanate (FITC) or phycoerythrin (PE)
were from Emfret Analytics. Alexa-Fluor-488–labeled ﬁbrinogen was from
Molecular Probes.
Aggregometry. To determine platelet aggregation, light transmission was
measured using washed platelets (2  108/ml) in the presence of 70 mg/ml
human ﬁbrinogen. Transmission was recorded on a Fibrintimer 4 channel
aggregometer (APACT Laborgera¨te und Analysensysteme) over 10 min and was
expressed as arbitrary units with transmission through buffer deﬁned as
100% transmission.
Flow cytometry. Heparinized whole blood was diluted 1:20 with modiﬁed
Tyrode’s-HEPES buffer (134 mM NaCl, 0.34 mM Na2HPO4, 2.9 mM KCl,
12 mM NaHCO3, 20 mM HEPES, pH 7.0) containing 5 mM glucose, 0.35%
bovine serum albumin (BSA) and 1 mM CaCl2. For assessment of glycoprotein
expression and platelet count, blood samples were incubated with appropriate
ﬂuorophore-conjugated monoclonal antibodies for 15 min at room tempera-
ture and directly analyzed on a FACSCalibur (Becton Dickinson). Activation
studies were performed with blood samples washed twice with modiﬁed
Tyrode’s-HEPES buffer, which then were activated with the indicated agonists
or 3 mM MnCl2 for 15 min, stained with ﬂuorophore-labeled antibodies for
15 min at room temperature and directly analyzed.
Adhesion under ﬂow conditions. Rectangular coverslips (24  60 mm) were
coated with 0.25 mg/ml ﬁbrillar type I collagen (Nycomed) for 1 h at 37 1C and
blocked with 1% BSA. Perfusion of heparinized whole blood was performed as
described15. Brieﬂy, transparent ﬂow chambers with a slit depth of 50 mm,
equipped with the collagen-coated coverslips, were rinsed with HEPES buffer,
pH 7.45, and connected to a syringe ﬁlled with the anticoagulated blood.
Perfusion was carried out at room temperature using a pulse-free pump at low
(150 s–1) and high shear stress (1,000 s–1). During perfusion, microscopic
phase-contrast images were recorded in real time. Thereafter, the chambers
were rinsed by a 10-min perfusion with HEPES buffer, pH 7.45, at the same
shear stress, and phase-contrast pictures were recorded from at least ﬁve
different microscopic ﬁelds (63 objectives). Image analysis was performed
off-line using Metamorph software (Visitron). Thrombus formation results are
expressed as the mean percentage of total area covered by thrombi.
Analysis of bleeding time.Mice were anesthetized and a 3-mm segment of the
tail tip was cut off with a scalpel. Tail bleeding was monitored by gently
absorbing the bead of blood with a ﬁlter paper without contacting the wound
site. When no blood was observed on the paper after 15-s intervals, bleeding
was determined to have ceased. The experiment was stopped after 15 min.
Intravital microscopy of thrombus formation in FeCl3 injured mesenteric
arterioles.Mice 4–5 weeks old were anesthetized, and the mesentery was gently
exteriorized through a midline abdominal incision. Arterioles (35–60-mm
diameter) were visualized with a Zeiss Axiovert 200 inverted microscope
(10) equipped with a 100-W HBO ﬂuorescent lamp source and a
CoolSNAP-EZ camera (Visitron). Digital images were recorded and analyzed
off-line using Metavue software (Visitron). Injury was induced by topical
application of a 3-mm2 ﬁlter paper tip saturated with FeCl3 (20%) for 10 s.
Adhesion and aggregation of ﬂuorescently labeled platelets in arterioles were
monitored for 40 min or until complete occlusion occurred (blood ﬂow
stopped for 41 min).
Platelet spreading. Cover slips were coated overnight with 1 mg/ml human
ﬁbrinogen and then blocked for 1 h with 1% BSA in PBS. Washed platelets of
wild-type or Kind3/ mice were resuspended at a concentration of 0.5  106
platelets/ml and then further diluted 1:10 in Tyrode’s-HEPES buffer. Shortly
before platelets were seeded on the ﬁbrinogen-coated coverslip, they were acti-
vated with 0.01 U/ml thrombin. Platelets were allowed to spread for 30 min and
analyzed by differential interference contrast (DIC) microscopy. In parallel,
platelets were ﬁxed in 2.5% glutaraldehyde in Tyrode’s-HEPES buffer and
processed for scanning electron microscopy as previously described23. In another
set of experiments, washed platelets were allowed to adhere to ﬁbrinogen in the
presence of 3 mM Mn2+ without thrombin stimulation and analyzed as above.
Note: Supplementary information is available on the Nature Medicine website.
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SUMMARY
Stable isotope labeling by amino acids in cell culture
(SILAC) has become a versatile tool for quantitative,
mass spectrometry (MS)-based proteomics. Here,
we completely label micewith a diet containing either
the natural or the 13C6-substituted version of lysine.
Mice were labeled over four generations with the
heavy diet, and development, growth, and behavior
were not affected. MS analysis of incorporation
levels allowed for the determination of incorporation
rates of proteins from blood cells and organs. The F2
generation was completely labeled in all organs
tested. SILAC analysis from various organs lacking
expression of b1 integrin, b-Parvin, or the integrin
tail-binding protein Kindlin-3 conﬁrmed their ab-
sence and disclosed a structural defect of the red
blood cell membrane skeleton in Kindlin-3-deﬁcient
erythrocytes. The SILAC-mouse approach is a versa-
tile tool by which to quantitatively compare pro-
teomes from knockout mice and thereby determine
protein functions under complex in vivo conditions.
INTRODUCTION
The administration of radioactive or stable isotope tracers to
animals is a well established technique by which to investigate
the rate of protein synthesis and protein degradation. (Wolfe
and Chinkes, 2005). This technology has been used for many
decades (Schoenheimer and Rittenberg, 1935). The infusion of
stable isotopes (13C or 15N) as tracers combined with measure-
ments of 13CO2 or
15N in urinary urea or ammonia is a broadly
used technique by which to explore the amino acid ﬂux in meta-
bolic pathways (Bier, 1997; Dietz et al., 1982). Extensive incorpo-
ration of 13C or 15N stable isotopes does not result in discernable
health effects of the treated animals (Doherty and Beynon, 2006;
Gregg et al., 1973).
Mass spectrometry (MS) is not inherently quantitative, and rel-
ative protein expression changes are instead most accurately
measured by comparison of the natural form of a peptide with
its stable isotope analog (Ong and Mann, 2005). In recent years,
15N labeling has been applied to microorganisms such as yeast
(Oda et al., 1999; Pratt et al., 2002), Caenorhabditis elegans, and
Drosophila (Krijgsveld et al., 2003). Even a rat has been partially
(Wu et al., 2004) or completely 15N labeled (McClatchy et al.,
2007). In addition, nonsaturated labeling of a chicken, by using
the essential amino acid valine, allows for theMS-based analysis
of protein turnover rates in vivo (Doherty et al., 2005).
Our laboratory has previously described stable isotope label-
ing by amino acids in cell culture (SILAC) (Mann, 2006; Ong
et al., 2002), which has unique advantages for quantitative and
functional proteomics because of its inherent accuracy of quan-
titation and the ease of interpretation of MS results (Blagoev
et al., 2004; Kratchmarova et al., 2005). In a SILAC experiment,
two cell populations are generated: one in a medium that con-
tains the natural amino acid (i.e., 12C6-lysine), and the other in
a medium that contains the heavy isotope-substituted version
(i.e., 13C6-lysine). This allows for direct comparison of protein ex-
pression levels by mixing the nonlabeled ‘‘light’’ and the labeled
‘‘heavy’’ cell populations (Cox and Mann, 2007). Each peptide
appears as a pair in MS analysis with a difference in mass of
6 Da, and the relative peak intensities reﬂect the abundance
ratios. To date, SILAC labeling has been limited to cell culture
or microorganisms. To extend this powerful technique to higher
organisms, Oda and coworkers have SILAC labeled the Neuro
2A cell line to serve as an internal standard for quantitation of
a subset of peptides of the mouse brain proteome (Ishihama
et al., 2005).
In the present paper, we report the development of a mouse
SILAC diet that leads to complete labeling of the F2 generation.
We used in vivo SILAC quantitation to analyze newly synthesized
proteins from plasma and tissue samples in vivo. Furthermore,
we validated our in vivo quantitation system by comparing the
proteomes from platelets, heart, and erythrocytes from b1 integ-
rin-, b-Parvin-, and Kindlin-3-deﬁcient mice, respectively.
Integrins are heterodimeric transmembrane proteins, consist
of a and b subunits, are ubiquitously expressed, and perform
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cell-cell and cell-matrix adhesion functions. Association of the
corresponding a and b subunits is required for their stability
and transport to the plasma membrane, as single subunits are
not stable and are rapidly degraded. Integrin-mediated cell
adhesion triggers intracellular signaling pathways (outside-in
signaling) that control migration, proliferation, survival, and dif-
ferentiation of cells. Prior to ligand binding, integrins require an
energy-dependent activation step, which is triggered within the
cell (inside-out signaling) and is characterized by a profound
conformational change in both integrin subunits. Although the
mechanism(s) underlying integrin activation are far from under-
stood, it is believed that the binding of the FERM-domain-con-
taining adaptor proteins talin and Kindlin to the integrin b cyto-
plasmic domains represents the last step in the activation
pathway (Calderwood, 2004; Moser et al., 2008).
Upon activation and ligand binding, integrins recruit and as-
semble a multiprotein complex at the site of cell adhesion that
fulﬁls two major tasks: it connects the extracellular matrix with
the actin cytoskeleton, and it alters the ﬂuxes of many intracellu-
lar signaling pathways. A preformed complex consisting of the
three proteins, ILK, PINCH, and Parvin, represents an important
component of the integrin adhesion complex (Legate et al.,
2006). Parvins comprise a family of three proteins, a-, b- and
g-Parvin, that directly bind to ILK, F-actin, and other actin-asso-
ciated proteins, thereby linking the adhesion complex to the
actin cytoskeleton and controlling actin dynamics.
Kindlins have recently been identiﬁed within the integrin-medi-
ated cell adhesion complex and represent an additional family of
ILK-binding proteins (Montanez et al., 2007). They consist of
three members (Kindlin-1–3) and are named after the gene mu-
tated in Kindler syndrome, an autosomal recessive skin blister
disease in humans. Kindlin-3 expression is restricted to hemato-
poietic cells, and the highest levels are inmegakaryocytes (Ussar
et al., 2006). Inactivation of the Kindlin-3 gene in mice results in
severe anemia, which is thought to be due to a bleeding defect
caused by impaired activation of platelet integrins, defects in
platelet aggregation, and thrombus formation (Moser et al.,
2008).
To screen for potential defects in other cellular compartments
of the hematopoietic system in Kindlin-3-deﬁcient mice, we
compared their proteome with those from control mice. During
the course of these studies, we discovered a deﬁcit of structural
proteins in the plasma membrane of Kindlin-3-deﬁcient erythro-
cytes, which contributes to the severe anemia seen in Kindlin-3-
deﬁcient mice.
RESULTS
A Heavy SILAC Diet Has No Inﬂuence on Weight Gain
and Fertility
We prepared a SILAC diet by mixing 13C6-lysine or
12C6-lysine
into a customized lysine-free mouse diet to a ﬁnal concentration
of 1% (Figure 1A) according to standard mouse nutritional
requirements (Benevenga et al., 1995). The amino acid content
was subsequently checked by hydrolysis and cation exchange
chromatography (Figure S1 available online). We ﬁrst tested
whether the diet permits normal weight gain by feeding
mice with a regular diet or the SILAC diet (with 12C6-lysine or
13C6-lysine). During an observation period of 4 weeks, all animals
showed the same food consumption and a similar increase in
body weight of about 17% (Figures S2A and S2B), normal fertil-
ity, andmotor activity irrespective of the diet consumed. Further-
more, we SILAC labeled mice over four generations (see below),
indicating that the labeling is compatible with normal develop-
ment and physiology. Thus, we conclude that SILAC labeling
with a 13C6-substituted essential amino acid diet does not lead
to obvious discernable health effects in mice (Figure 1B).
SILAC Incorporation Rates Differ in Blood, Liver,
and Gut Epithelium
To track 13C6-lysine incorporation into the proteome over time,
we sampled blood each week for 4 weeks. Serum proteins
were separated on 1D gels in triplicate, in-gel digested, and
analyzed by high-resolution MS. The average relative standard
deviation of all quantiﬁed proteins was20% (Figure 1C), an ac-
curacy similar to what was seen in previous SILAC quantitation
experiments (Blagoev et al., 2004; Ong et al., 2003).
As an example of different incorporation levels, SILAC peptide
pairs of three serum proteins and one red blood cell protein are
shown in Figure 1C. For serum albumin, we observed a SILAC
ratio of 1:3.2, indicating that at least 74% of the protein had
been newly synthesized during the ﬁrstweek of feeding. Because
proteins can be synthesized from dietary amino acids as well as
from amino acids derived by protein catabolism, this value is
a lower limit for the true turnover (Beynon and Pratt, 2005). After
4 weeks, the three serum proteins were labeled to 90%. In
contrast, hemoglobin was only labeled to 57% after 4 weeks
(Figure 1C), due to the 60-day half-life of mouse erythrocytes
(Berlin et al., 1959). Additional proﬁles of blood proteins are listed
in Table S1.
Next, we measured the labeling efﬁciencies of a number of
organs after 4 weeks of feeding with the SILAC diet. Proteins
from heart showed an average protein ratio of 1:4.4 (Figure 2A;
Table S2), much lower than the serum proteins. Furthermore,
the distribution of SILAC ratios was relatively broad, reﬂecting
the different incorporation rates of individual cell types and the
‘‘contamination’’ of serum proteins in nonperfused samples.
For example, serum albumin has a similarly high incorporation
rate in blood (ratio 9) and heart (ratio 10) (Figures 1C and 2A).
In contrast to heart tissue, in which most cells are quiescent,
the intestinal epithelium regenerates within a few days (Radtke
and Clevers, 2005). Disaggregating the epithelium from the
digestive tube resulted in a more homogeneous cell pool con-
sisting of only a few cell types. As a consequence, we observed
a high SILAC ratio of 1:9.1 ± 2.1 reﬂecting a labeling efﬁciency of
more than 90% (Figure 2B), which is fully consistent with the high
proliferation rate of this tissue. For example, villin-1, a marker for
epithelial cells from the digestive system, showed a SILAC ratio
of 1:10.
Liver has a number of different physiological roles, including
carrying out metabolic functions and producing major blood
proteins. Accordingly, we observed a wide distribution of SILAC-
incorporation ratios among liver proteins. Hepatocytes are the
predominant liver cell type, and they are very rich in mitochon-
dria. To demonstrate that in vivo SILAC ratios can be measured
with subcellular resolution, we isolated mitochondria from liver
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cells (Forner et al., 2006) and compared their labeling ratios to
whole-cell lysates from the same sample (Figure 2C, black
bars). Interestingly, proteins frommitochondria showed an aver-
age SILAC ratio of 1:8.6 ± 2.4. This shows that the incorporation
rates of an organelle are more narrowly distributed and distin-
guishable from that of a whole tissue.
We next investigated several cell types of the hematopoietic
system. Platelets are cell fragments that are constantly released
bymegakaryocytes into the blood stream. They have a half-life of
7–9 days. We isolated platelets from a SILAC mouse after 4
weeks of labeling and measured incorporation levels of 86%
from 241 quantiﬁed proteins (Figure 2D). In contrast, serum albu-
min, which was also measured within the platelet sample due to
serum contamination, has a much higher incorporation level
compared to platelet proteins. Analysis of the red blood cell pro-
teome revealed a signiﬁcantly lower 13C6-lysine incorporation of
75% (Figure 2E). Thus, consideration of SILAC-incorporation
rates could aid in the determination of the origin of the same
proteins from different cellular pools via their different dynamic
incorporation rates.
To combine SILAC-mouse analysis with cell sorting to obtain
an accurately deﬁned cell population, we separated CD45R-
positive B lymphocytes from spleen by ﬂuorescence-activated
cell sorting (FACS) (Figures 2F and S3). An in-solution protein
digest was performed from lysates of 13 106 spleen cells (Table
S2F). The distribution of measured ratios was 1:5.4 ± 1.3, dem-
onstrating that FACS-sorted populations of interest can readily
be investigated in the SILAC mouse.
Figure 1. SILAC Labeling and Incorporation Rates of Blood Proteins
(A) Mice are SILAC labeled by being fed a pelleted, lysine-free diet supplemented with normal or heavy lysine.
(B) Mice on a SILAC diet cannot be visually distinguished from mice with a normal, commercial diet.
(C) Mass spectra showing SILAC pairs of a representative peptide for four blood proteins. The right-hand side shows lysine-6 incorporation over the course of
4 weeks as an average measurement of triplicates.
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Taken together, our results indicate that feeding mice with
a SILAC diet is a suitable approach to label proteins in vivo
and to follow their metabolic incorporation in any organ.
Complete SILAC-Based Labeling of F2 Mice
Although the label efﬁciency was relatively high in many tissues,
we found that extending the labeling time did not lead to com-
plete labeling. This is likely due to the recycling of internal amino
acid sources (Doherty et al., 2005). Since labeling rates above
95% are required to perform comparative and quantitative pro-
teomics by MS, we started feeding our mice over several gener-
ations with the heavy diet. Importantly, the consumption of the
heavy diet did not affect litter size (Figure S2). The F1–F4 off-
spring developed normally, gained weight within the normal
weight-gain chart (Figure S2), and showed normalmating behav-
ior. Furthermore, newborn animals of the F1 generation were
almost completely labeled, reaching 93% in blood, brain, and
liver (Figures 3 and S4). To obtain fully labeled animals to serve
as internal standards and to investigate if SILAC labeling could
be performed for many generations, we bred F2, F3, and F4
mice. These mice contained virtually no unlabeled peptides
(Figures 3B, 3C, and 5A; Table S3).
Proteome of b1 Integrin-Deﬁcient Platelets
For validation of our in vivo quantitative proteomics approach,we
analyzedandcomparedprotein lysates fromb1 integrin-deﬁcient
Figure 2. SILAC Label Incorporation into Different Cell Types and Tissues after 4 Weeks
(A–F) The panels show the relative number of proteins with the speciﬁed ratios for each proteome investigated. (A) Heart tissue. (B) Gut epithelium. (C) Incorpo-
ration into whole liver (gray bars) is compared with incorporation into liver mitochondria (black bars). (D) Platelets. (E) Erythrocytes. (F) CD45R-positive B lympho-
cytes from spleen.
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and control platelets (Nieswandt et al., 2001). We generated
b1 integrin-deﬁcient platelets by intercrossing b1 ﬂoxed mice
(b1ﬂ/ﬂ) with a transgenic mouse expressing an Mx1 promoter-
driven, interferon-inducible Cre (Mx1-Cre) (Brakebusch et al.,
2000; Kuhn et al., 1995). We treated b1ﬂ/ﬂ; Mx1-Cre mice with
synthetic double-stranded RNA (polyinosinic-polycytidylic acid,
pI-pC), which triggers endogenous interferon production and
subsequent Mx1-Cre activity. This leads to deletion of the b1 in-
tegrin gene in all hematopoietic cells, includingmegakaryocytes.
To monitor the knockout efﬁciency of b1 integrin, we compared
platelets from labeledwild-type animalswith platelet populations
from three groups of mice: (1) nonlabeled wild-type platelets; (2)
platelets from nonlabeled, non-pI-pC-induced b1ﬂ/ﬂ; Mx1-Cre
mice; and (3) platelets from nonlabeled, pI-pC-induced b1ﬂ/ﬂ;
Mx1-Cre mice (Figure 4). All mice were backcrossed on
a C57BL/6 background to reduce genetic variability.
We quantiﬁed 645 proteins in these platelets, and, as
expected, protein ratios of labeled and nonlabeled wild-type
platelets were tightly distributed, with an overall ratio of 1:1.
The quantitative MS analysis revealed complete loss of b1 integ-
rin in platelets from pI-pC-induced b1ﬂ/ﬂ; Mx1-Cre mice
(Figure 4F). The proteins with the next highest ratios were the di-
merization partners of the b1 integrin subunit, strikingly conﬁrm-
ing the sensitivity and reliability of our SILAC-mouse labeling
system (Figure 4I). In a boxplot analysis, b1, a2, and a6 integrins
were all more than ten interquartile ranges away from themedian
(Figure S5A; Table S4).The complete loss of both a subunits can
be explained by the formation of a stable integrin heterodimer
during the synthesis and transport of the complexed integrin
subunits to the plasma membrane. Without the correct b integrin
subunit, the a subunit is rapidly degraded (Hynes, 2002). In con-
trast, the loss of b1 integrin has no impact on the expression of
other integrins, such as the major platelet integrin aIIbb3.
In addition, several other proteins in b1 integrin-deﬁcient
platelets were outliers in the boxplot (Figure S5A; Table S4).
However, a second independent experiment did not verify these
proteins as being signiﬁcantly downregulated. (Figure S5C). In
contrast, the b1 integrin dimerization partners a2 and a6 integ-
rins were again strongly reduced (Figure S5).
Interestingly, the analysis of platelets from noninduced b1ﬂ/ﬂ;
Mx1-Cre mice also revealed a slight downregulation of the b1,
a2, and a6 integrin levels compared to labeled wild-type plate-
lets (Figure 4J). This effect is due to the natural, endogenous
a/b interferon production in the bone marrow causing a low
Mx1 promoter activity (Kuhn et al., 1995). The detection of this
‘‘leak’’ impressively underscores the sensitivity of our quantita-
tive proteomics approach.
b-Parvin Deﬁciency in Heart Is Compensated
by a-Parvin Induction
We next wanted to conﬁrm the applicability of our in vivo SILAC
approach to analyze the proteomes fromknockoutmice in a solid
organ. To this end, we compared the proteomes from hearts of
b-Parvin-deﬁcient mice with those of control littermates. As
a heavy standard, we used heart lysates from 2-week-old mice
of the F4 generation, which showed an overall 97.7% incorpora-
tion of 13C-lysine (Figure 5A). To test our quantitation system, we
mixed ‘‘heavy’’ and ‘‘light’’ protein lysates from wild-type hearts
in ratios of 1:1, 1:2, and 1:4. As shown in (Figure 5B), mixing of
protein lysates from different heart samples gave rise to SILAC
ratios that accurately reﬂected the lysate mixture.
b-Parvin represents the dominant Parvin isoform of the heart,
since a-Parvin is only weakly present and g-Parvin is absent from
heart tissue. b-Parvin-deﬁcient mice were generated by homol-
ogous recombination of a targeting vector in embryonic stem
(ES) cells, which lacks exons 2 and 3 of the b-Parvin gene (I.T.
and R.F., unpublished data). b-Parvin-deﬁcient mice were viable
and fertile and did not show any overt phenotype, indicating that
b-Parvin is not essential for mouse development and organ for-
mation. Mass spectrometric measurements of whole protein ly-
sates from b-Parvin-deﬁcient and control hearts of 2-week-old
animals showed a complete absence of b-Parvin in knockout an-
imals (Figures 5C and 5D). Out of 1205 proteins, only 4 proteins
showed a two-fold decrease in their abundance compared to
Figure 3. Complete Labeling of the F2 Generation
(A) Label efﬁciency of the liver of a 2-day-old mouse of the F1 generation.
(B and C) Histograms of liver proteins with the speciﬁed percent incorporation
at (B) P2 and at (C) P50 of the F2 generation. The averages of the SILAC ratios
and the corresponding percent of the SILAC labeling are displayed in the histo-
gram. The analysis encompasses 100 proteins.
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wild-type hearts (Table S5). Interestingly, lack of b-Parvin had no
dramatic consequence on the level of ILK and PINCH-1, which
are the two other components of the ILK/Pinch/Parvin complex.
The two-fold increase of a-Parvin in b-Parvin-deﬁcient hearts
suggests that the absence of an obvious phenotype is due to
compensatory upregulation of a-Parvin (Figure 5C).
Kindlin-3 Deﬁciency Disrupts the Red Blood Cell
Membrane Skeleton
Kindlin-3-deﬁcient mice die at birth and suffer from severe
bleeding, anemia, and pale skin color (Figures 7A and 7B; Moser
et al., 2008). To further validate the power of in vivo SILAC and to
obtain novel insights into Kindlin-3 function, we performed quan-
titative proteomics of platelets and erythrocytes fromKindlin-3/
mice. Platelet analysis identiﬁed Kindlin-3 as the protein with the
highest fold change of more than 1200 platelet proteins
(Figure S6A; Table S6). Interestingly, the levels of integrin aIIb
and b3 subunits were normal, suggesting that the reduced sur-
face levels found by FACS (Moser et al., 2008) were due to an im-
Figure 4. Analysis of b1 Integrin Knockout
Platelets
(A–J) (A, D, and G) Platelets from SILAC-labeled
wild-type mice were mixed with platelets from
a nonlabeled wild-type control mouse. Compari-
son of the wild-type SILAC mouse with (B, E, and
H) noninduced b1ﬂ/ﬂ; Mx1-Cre mice and with (C,
F, and I) pI-pC-induced b1ﬂ/ﬂ; Mx1-Cre mice. The
slight decrease of b1 integrin shown in (E) is due
to Cre activity induced by low endogenous inter-
feron expression. The arrows in (F) and (I) label
the reduced peak intensity of b1 and a2 integrin,
respectively. (J) Summary of quantiﬁed SILAC ra-
tios for b3, b1, a2, and a6 integrin subunits. White
bars represent the ratio between the labeled wild-
type WT(h) animal and the nonlabeled wild-type
animal, gray bars represent the SILAC ratio of
WT(h) and noninduced b1ﬂ/ﬂ, and black bars repre-
sent the SILAC ratio between WT(h) and induced
b1ﬂ/ﬂ; Mx1-Cre. The error bars show the variability
of the measured ratios.
paired integrin trafﬁcking in the absence
of Kindlin-3 (Figure S6B).
We have previously reported that Kind-
lin-3 (also known as ‘‘unc-related protein
2’’) is present in red blood cells (Pasini
et al., 2006). This was conﬁrmed by dif-
ferent SILAC-incorporation levels in
platelets (incorporation rate of 1:6.0) com-
pared to erythrocytes (incorporation rate
of 1:2.1), measured after the initial 4-week
labeling period (Figures 2, S7A, and
S7B). Furthermore, Kindlin-3 gene activity
in Ter119-positive Kindlin-3-heterozy-
gous erythroblasts was further corrobo-
rated by measuring Kindlin-3 promoter-
driven b-galactosidase reporter gene
activity with FACS (Figure S7C).
To investigate whether loss of Kindlin-3 affects erythroid cells,
we determined and quantitatively compared the proteomes from
wild-type, Kindlin-3+/, and Kindlin-3/ erythrocytes (Figure 6;
Table S7). MS conﬁrmed a 50% reduction of Kindlin-3 in hetero-
zygous and a complete absence of Kindlin-3 in Kindlin-3/
erythrocytes (Figure 6A).Out of 881 proteins identiﬁed in all 3 pro-
teomes, more than 50 were two-fold increased in Kindlin-3/
erythrocytes, andonlya few revealedamore than two-fold reduc-
tion. Interestingly, a large proportion of the upregulated proteins
was annotated to be nuclear (Table S7).
Blood smears from Kindlin-3/ embryos and P3 animals
showed a strong reduction of cells when compared to wild-
type controls and, in concordance with this proteomic ﬁnding,
manymore nucleated erythroblasts (Figures 7B and 7C). In addi-
tion, the size and shape of Kindlin-3/ erythrocytes were mark-
edly irregular.
Scanning electron microscopy showed abnormally shaped
erythrocytes with striking membrane invaginations and protu-
berances (Figure 7D). Red blood cell membrane abnormalities
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are often caused by mutations within membrane-skeleton pro-
teins, and the absence of key components can have drastic con-
sequences on the stability of the red cell membrane (Delaunay,
1995). To obtain an explanation for the structural defects, we
quantitatively compared the membrane-skeleton proteins from
total erythrocytes by using SILAC-based MS. The levels of the
most prominent skeleton proteins (e.g., a/b spectrin, ankyrin,
band 3, band 4.1, band 4.2, and actin) did not signiﬁcantly differ
between wild-type and Kindlin-3/ mice.
Next, we determined whether these proteins have formed
a stable meshwork that is connected with the erythrocyte mem-
brane. To address this question, we isolated the erythrocyte
membranes (so called red blood cell ‘‘ghosts’’) from wild-type
Figure 5. Analysis of Heart Tissue from
b-Parvin Knockout Mice
(A) 13C6-Lysine incorporation of heart tissue from
mice of the F4 generation shows a label efﬁciency
of 97.7%.
(B) Heart tissue from labeled and nonlabeled ani-
malswasmixed1:1, 1:2, and1:4. ThemeasuredSI-
LAC ratios after in-solution digestion were 0.93 ±
0.17 for the 1:1 mix, 0.58 ± 0.10 for the 1:2 mix,
and 0.26 ± 0.05 for the 1:4 mix. Approximately
300 SILAC protein ratios were used for the quanti-
ﬁcation.
(C) Heart tissue from SILAC-labeled wild-type
mice was mixed with nonlabeled b-Parvin (+/+)
and b-Parvin (/) hearts. The arrow indicates
the complete absence of b-Parvin.
(D) SILAC ratios of selected proteins.
and Kindlin-3/ mice and compared
them to ghosts from SILAC-labeled con-
trol animals (Figure 7E). Quantitative
SILAC-based analysis revealed an almost
complete absence of ankyrin-1, band 4.1,
adducin-2, and dematin (Figure 7F, right
rows; Table S8), whereas other mem-
brane-skeleton proteins, like a/b spectrin
and band 3, were not changed.
Together, these ﬁndings show that
Kindlin-3 is required for the assembly of
a subset of proteins within the red blood
cell membrane skeleton. Furthermore,
the proteomic, morphological, and func-
tional data provide a clear explanation
for the anemia that leads to postnatal
lethality.
DISCUSSION
Thus far, quantitative gene expression
comparisons in higher organisms have
been restricted to RNA analyses by gene
chip approaches. These methods have
many advantages: for example, ready
accessibility and the fact that, in principle,
almost all genes can be analyzed on one
chip. However, because of posttranscriptional regulation as
well as regulated protein degradation, these data do not neces-
sarily predict changes in protein levels within cells or tissues.
Furthermore, there are speciﬁc cell populations, such as the
platelets and erythrocytes investigated here, that are devoid of
mRNA and are therefore out of reach for these techniques.
Here, we show that SILAC, a versatile and successful method
for quantitative proteomics in cell culture-based systems or mi-
croorganisms, can be extended to mammalian model systems.
Mice can be SILAC labeled without any obvious effect on
growth, behavior, or fertility. SILAC food preparation is straight-
forward and not particularly expensive when considering other
resources required for the generation and maintenance of
Cell 134, 353–364, July 25, 2008 ª2008 Elsevier Inc. 359
knockout animals. We chose 13C6-lysine labeling, as lysine is not
converted into other amino acids. This makes endoprotease
Lys-C the preferred choice as the proteolytic enzyme. Another
interesting enzyme for SILAC mice is Lys-N, which has recently
been described as an efﬁcient enzyme for proteomics and de
novo peptide sequencing (Taouatas et al., 2008). Organs derived
from SILAC mice can serve as standards for a large number of
subsequent experiments, in which wild-type and knockout
mice are compared. Importantly, cell types such as intestinal
epithelium that are difﬁcult to study ex vivo can be analyzed by
the in vivo SILAC approach. Moreover, the SILAC mouse can
serve as a reference model at any biological scale, from the
whole organ through speciﬁc cell types down to intracellular
compartments or single proteins of interest. As an example,
we used SILAC mice to successfully study the mitochondrial
proteome, which can be extended to investigations in relevant
organs from metabolic or neurodegenerative disease models.
In studies in which a large number of mice are required—such
as in toxicology studies—labeled organ tissue could be stored
and used as an internal standard for each measurement. A la-
beled SILAC-mouse liver, for example, yields sufﬁcient internal
standard for more than 1000 measurements. Although not
shown here, phosphopeptides can also be enriched from SILAC
mice and can serve as a standard for functional and time-
resolved phosphoproteomics (Olsen et al., 2006).
We analyzed the proteomes of cells from three independent
knockout mice. In all analyses, the complete absence of the tar-
geted genes was immediately revealed by the SILAC technique.
Furthermore, heterozygous Kindlin-3 animals present the ex-
pected two-fold reduction from wild-type levels, emphasizing
the quantitative nature of our proteomic technology. This may
be particularly useful in quantifying knockdown efﬁciencies in
Figure 6. Quantitative Proteomics of Erythrocytes
from Kindlin-3/ Mice
(A) Mass spectra of a Kindlin-3 peptide SILAC pair in Kindlin-
3+/+, Kindlin-3+/, and Kindlin-3/ erythrocytes.
(B) Histogram of SILAC ratios of wild-type (white bars) and
Kindlin-3/ (gray bars) erythrocytes. The measured ratios
were grouped into ratio bins, and the y axis shows the relative
number of detected ratios per bin.
transgenic RNAi mice. The sensitivity of the
SILAC-based quantitation system became remark-
ably obvious by an observation from the b1 integrin
inactivation in platelets. Deletion of the b1 integrin
gene in hematopoietic cells is achieved by the
induction of the Mx1-Cre transgene through the
injection of pI-pC into b1 integrin ﬂoxed animals.
Even without induction of Cre, the low expression
levels of naturally expressed a/b interferon acti-
vated the Mx1 promoter and triggered b1 integrin
deletion in a few cells. Even this slight difference
in total b1 integrin expression proved sufﬁcient for
detection by the SILAC method.
Our proteomic data on platelets of b1 integrin
mice showed that, although integrins control a num-
ber of different signaling pathways, the lack of the
b1 integrin has no consequences on the levels of other proteins
in platelets, apart from its dimerization partners a2 and a6 integ-
rins. This may be due to the fact that, in resting platelets, integ-
rins are inactive and signaling into the cell is only induced upon
stimulation via molecules like thrombin or collagen (Ruggeri,
2002). Further studies with the SILAC-mouse system could
focus on activation of signaling cascades during platelet aggre-
gation by using phosphoproteomics.
To test the SILAC-based analysis in a solid organ system, we
compared the proteomes from heart of b-Parvin-deﬁcient mice
with control littermates. The complexity of a tissue, formedby dif-
ferent cell types, poses no limitation for the quantitative analysis
by MS. The interpretation of results, however, is more challeng-
ing because changes in protein levels may result from non-cell-
autonomous defects caused, for example, by altered cell-cell
communication rather than cell-autonomous defects.
To study the molecular cause of the anemia observed in Kind-
lin-3 mutants, we analyzed the consequences of this deletion on
the proteome of platelets and erythrocytes. Recently, we char-
acterized Kindlin-3 as an essential factor for the activation of
platelet integrins (Moser et al., 2008). Kindlin-3 directly binds to
the cytoplasmic tails of both b1 and b3 integrin subunits. Its ex-
pression is restricted to cells of the hematopoietic system (Ussar
et al., 2006). Our SILAC-based analysis of Kindlin-3-deﬁcient
erythrocytes revealed an increased amount of nuclear proteins,
prompting us to investigate consequences of the knockout on
this cell type. Consistent with the proteomic results, we found
an increased number of nucleated erythroblasts in blood
smears. Furthermore, Kindlin-3-deﬁcient erythrocytes are irreg-
ular in size and shape. The structural defects of the red blood
cell membrane skeleton suggested an additional function of
Kindlin-3. With the help of the SILAC method, we quantitatively
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compared the membrane-skeleton proteins of control and Kind-
lin-3-deﬁcient erythrocytes and revealed a critical role of Kindlin-
3 in the formation or stabilization of this structure. The inner sur-
face of the red blood cell membrane is laminated by a protein
network that is linked to transmembrane proteins. In humans
and mice, mutations in genes encoding ankyrin, band 3, spec-
trin, and protein 4.1 or protein 4.2 cause hereditary spherocyto-
sis or poikilocytosis, often accompanied with hemolytic anemias
(Delaunay, 1995; Peters et al., 1998; Rybicki et al., 1995; Shi
et al., 1999; Southgate et al., 1996). The dramatic reduction of
ankyrin-1, protein 4.1, and dematin in membrane preparations
from Kindlin-3-deﬁcient erythrocytes explains the severe
Figure 7. Kindlin-3-Deﬁcient Erythrocytes Show Disrupted Membrane Skeletons
(A) Kindlin-3 knockout mice are anemic.
(B) Decreased hematocrit in Kindlin-3/ mutants at embryonic day 15 and P3.
(C) Blood smears from E15 embryos and P3 wild-type and Kindlin-3/ mice reveal fewer erythrocytes and an increased number of nucleated erythroblasts.
(D) Scanning electron microscopy of wild-type and Kindlin-3/ erythrocytes. The scale bar represents 1 mm.
(E) ‘‘Ghost’’ lysates from wild-type, heterozygous, and Kindlin-3/mice were stained by Coomassie blue after SDS-PAGE. The arrows indicate the absence of
proteins within the membrane-skeleton fraction of Kindlin-3/ erythrocytes.
(F) SILAC-ratio comparison of total erythrocytes (left rows) and the membrane fraction (right row).
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malformations. Thus, loss of Kindlin-3 affects erythropoiesis by
disrupting the assembly of structural components within the
red blood cell membrane skeleton.
In summary, a direct combination of the SILAC technology for
quantitative proteomics with the large number of powerful
mouse models generated by the community is now possible.
We have demonstrated here how proteomics can be combined
with several of the powerful technologies already used in this en-
deavor. We are conﬁdent that this technology will help to eluci-
date disease processes and guide novel intervention strategies.
Data Availability
Data used for quantitation accompany this article online.
EXPERIMENTAL PROCEDURES
Materials and Reagents
13C6-Lysine (98 atom %
13C) was purchased from Silantes, Martinsried, Ger-
many. Chemicals for the ‘‘in-solution’’ and ‘‘in-gel’’ digests were purchased
from Sigma-Aldrich, and LysC was obtained from WAKO. Wild-type mice
were obtained from an in-house C57Bl/6 colony.
Knockout Mice
Transgenic mice expressing the Cre recombinase under the control of theMx1
promotor (Kuhn et al., 1995) were mated with mice carrying a ﬂoxed b1 integrin
gene (Brakebusch et al., 2000). To ensure extensive downregulation of the b1
integrin on platelets, pI-pC (250 mg per mouse) (Amersham) was injected intra-
peritoneally three times in a 2-day interval.
Kindlin-3-deﬁcient mice were generated as described byMoser et al. (2008).
A detailed description of the b-Parvin gene inactivation will be published else-
where (I.T. and R.F., unpublished data).
Food Preparation, Weight Gain, and Food Consumption
A customized lysine-free mouse diet (Harlan-Teklad, TD.99386) was com-
bined with the heavy L-13C6-lysine and the natural isotope L-lysine (Sigma) to
a ﬁnal concentration of 1%. To obtain a homogenous distribution of the amino
acid, the powder was vigorously mixed with a blender for 5 min. For the prep-
aration of food pellets, 10 g of the mixture was ﬁlled into an in-house-manu-
factured cylinder with an inner diameter of 1.5 cm and a length of 10 cm. Food
was compressed with an exactly ﬁtting pestle for 1 min. Pellets were taken out
and dried overnight at room temperature. After drying, the pellets were cut into
smaller pieces.
The lysine content was checked as described (Moore et al., 1958). Although
the hydrolysis with subsequent chromatography does not allow for the exact
determination of the amino acid contents, the supplemented lysine amount
was comparable to that in the customized diet containing the natural lysine
isotope.
For testing weight gain and food consumption, one group (n = 3 females)
was fed with a regular mouse diet, one group (n = 3 females) was fed with
the customized lysine-free diet supplemented with natural lysine (Sigma),
and one animal was fed with the diet containing the heavy isotope for lysine.
All animals were fed ad libitum and had access to water.
Food consumption was measured daily for 10 days during breeding and
weaning periods (Figure S2). The label percentage was calculated as the
mean of the heavy-labeled peptide signal divided by the sum of the light and
heavy signals.
Sample Preparation
Blood Samples
Mice were anesthetized with isoﬂuran, and 20 ml blood was taken from the
retro-orbitral plexus. Blood samples were incubated with heparin (20 U/ml),
and, after centrifugation, the supernatant was frozen in liquid nitrogen and
stored at 80C.
Tissue Harvest
After sacriﬁcing animals by cervical dislocation, tissues were dissected,
washed in phosphate-buffered saline (PBS [pH 7.4]), and frozen in liquid nitro-
gen. For protein isolation, tissues were homogenized in a buffer containing 1%
NP-40, 0.1% sodium deoxycholate, 150 mM NaCl, 1 mM EDTA, 50 mM Tris
(pH 7.5), and protease inhibitors (Complete tablets, Roche).The lysates were
centrifuged at 14,000 3 g to pellet cellular debris. A Bradford assay was per-
formed to determine protein concentrations of the supernatants.
Mitochondria Isolation
Liver tissue was quickly washed in water, then washed three times in 250 mM
sucrose, 10 mM Tris-HCl, 0.1 mM EGTA (pH 7.4) supplemented with protease
inhibitors (Roche). Crude mitochondria were isolated as described previously
(Forner et al., 2006) and were puriﬁed on a 30% Percoll density centrifugation
gradient.
Platelets were isolated by differential centrifugation steps as described by
Moebius et al. (2005).
Epithelial Cell Isolation from Gut
Small intestine was cut open and washed with PBS. The small intestine was
transferred to dissociation buffer (130 mMNaCl, 10 mM EDTA, 10 mMHEPES
[pH 7.4], 10% FCS, and 1 mM DTT) and was incubated for 45 min on a rotor at
37C. The rest of the intestine was removed, and the epithelial clumps were
collected by centrifugation at 800 rpm for 5 min and washed in PBS.
B Cell Isolation
For B cell isolation, spleen was cut into small fragments and digested with col-
lagenase and DNase, followed by the addition of EDTA. Subsequently, cells
were incubated with anti-CD45R, anti-CD3, and anti-CD49b (BD PharMingen).
B cells were selected as cells that stained positive for CD45R (B220) (Coffman,
1982) and negative for both anti-CD3 and anti-CD49b and were then sorted by
using a FACS Aria system (Becton Dickinson).
Mass Spectrometry
For protein separation, samples were loaded on a NuPAGE 4%–12% Bis-Tris
gel (Invitrogen). After staining of the gel with the Colloidal Blue Staining Kit
(Invitrogen), evenly sized gel pieces were excised from the gel and processed
for enhanced liquid chromatography-mass spectrometry (GeLC-MS).
For blood analysis, Coomassie-stained gel lanes were cut into eight pieces.
To determine incorporation ratios, we analyzed three gel pieces per lane from
heart, gut epithelia, liver, red blood cell, and platelet samples.
The gel pieces were subjected to in-gel reduction and alkylation, followed by
LysC digestion as previously described (Andersen et al., 2005; Shevchenko
et al., 1996). Finally, peptides were extracted twice by adding an equal volume
of 30% acetonitrile/0.3% triﬂuoraceticacid (TFA) in water to digest the mixture,
followed by a ﬁnal extraction with 100% acetonitrile. Extracts were evaporated
in a speedvac to remove acetonitrile and were subsequently acidiﬁed with
0.5% TFA. Samples were desalted and concentrated with StageTips and
were resuspended in 5 ml of 0.5% acetic acid/1% TFA (Rappsilber et al.,
2003). In-solution digestion of proteins was performed as described by Ong
and Mann (2006).
Reverse-phase nano-LC-MS/MS was performed by using an Agilent 1100/
1200 nanoﬂow LC system (Agilent Technologies) with a cooled, thermostated
96-well autosampler. The LC system was coupled to a 7-Tesla LTQ-FT or LTQ
Orbitrap instrument (Thermo Fisher Scientiﬁc) equipped with a nanoeletros-
pray source (Proxeon). Chromatographic separation of peptides was per-
formed in a 10 cm long 8 mm tip opening/75 mm inner diameter capillary needle
(Proxeon). The column was custom made with methanol slurry of reverse-
phase ReproSil-Pur C18-AQ 3 mm resin (Dr. Maisch, GmbH). The LysC-di-
gested peptide mixtures were autosampled at a ﬂow rate of 0.5 ml/min and
then eluted with a linear gradient at a ﬂow rate of 0.25 ml/min. The mass spec-
trometers were operated in the data-dependent mode to automatically mea-
sure MS and MS/MS. LTQ-FT full scan MS spectra (from m/z 300 to m/z
1600) were acquired with a resolution of R = 100,000 at m/z 400 (after accumu-
lation to a target value of 3,000,000 in the linear ion trap). The ﬁve most intense
ions were sequentially isolated and fragmented in the linear ion trap by using
collisionally induced dissociation at a target value of 10,000 (Olsen et al., 2004).
Raw data ﬁles were converted to Mascot generic format ﬁles with in-
house software (Raw2MSM), and Mascot (version 2.0) was used for a
database search and protein identiﬁcation. The following search
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parameters were used in all MASCOT searches: LysC digest; no missed
cleavage; carbamidomethylation of cysteine set as a ﬁxed modiﬁcation; and
oxidation of methionines and L-lysine-6 allowed as variable modiﬁcations.
The maximum allowed mass deviation for MS and MS/MS scans was 10
ppm and 0.5 Da, respectively. Only proteins that had at least two peptides
with ion scores >20 were considered for identiﬁcation and quantitation.
MSQuant (Schulze andMann, 2004) was used to verify and quantify the result-
ing SILAC-peptide pairs. All proteomic results were deposited in the publicly
accessible MAPU database (Zhang et al., 2007). A target decoy database ap-
proachwas used to identify false-positive peptides and to set threshold criteria
such that <1% false positives were included in the peptide list (Tables S1 and
S2, statistics sheet). After mass recalibration withMSQuant, the average abso-
lute mass error of all peptides was better than 3 ppm.
Samples from all mouse mutants were analyzed by the in-house-developed
software MaxQuant (Cox and Mann, 2007; Graumann et al., 2008). Brieﬂy,
MaxQuant performs a peak list, SILAC- and XIC-based quantitation, false-
positive rates (Gingras et al., 2007), and peptide identiﬁcation based on Mas-
cot search results.
All data were searched against the International Protein Index sequence da-
tabase (mouse IPI, version 3.24) (Kersey et al., 2004). Fold-change for ghost
proteins was determined from the gel slice corresponding to the expected
migration of the full-length protein.
Blood Cell Analyses
Hematocrit was measured from peripheral blood with a hematology analyzer
(Nihon Kohden).
For ‘‘ghost’’ preparation,erythrocyteswerewashed twice in0.9%NaCl, 10mM
sodium phosphate buffer (pH 7.0) before hypotonic lysis were performed in
0.25% NaCl, 10 mM sodium phosphate buffer (pH 7.0). Lysis was performed
in several rounds in hypotonic buffer until the pellet became white.
Flow Cytometry
Flow cytometric lacZ staining of hematopoietic cells was performed on
Ter119-positive bone marrow cells that have been incubated with the ﬂuores-
cent b-galactosidase substrate FDG (ﬂuorescein di-b-D-galactopyranoside)
(Sigma) as described (Montanez et al., 2007). Flow cytometry was carried
out on a Becton Dickinson FACSCalibur.
SUPPLEMENTAL DATA
Supplemental Data include seven ﬁgures and eight tables for protein identiﬁ-
cation and quantiﬁcation and are available with this article online at http://
www.cell.com/cgi/content/full/134/2/353/DC1/.
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Abstract
Integrins on leukocytes become active following “inside out” signalling through
other membrane receptors. This signalling is faulty in the Leukocyte Adhesion 
Deficiency (LAD)-III disorder. LAD-III in two Turkish patients has been 
attributed to a C>A base change postulated to alter splicing of the CalDAG-
GEF1 gene. Here we describe two further Turkish LAD-III patients containing 
the same mutation, but show that it is not responsible for the LAD-III disorder. 
We identify two independent inactivating mutations in the Kindlin-3 gene as the 
cause of LAD-III in Maltese and Turkish patients. The Kindlins bind to the 
integrin ? subunit and cooperate with the protein talin to induce an increase in 
1
integrin affinity. The mutations both cause decreased Kindlin-3 mRNA levels.
Importantly, the transfection of the patients’ lymphocytes with the wild-type 
Kindlin-3 cDNA, but not wild-type CalDAG-GEF1 cDNA, reverses the LAD-lll
defect that prevents integrin-mediated adhesion and migration.
Integrins are the major adhesion receptors of hematopoietically-derived
cells. The ability of leukocytes to use the integrins LFA-1 and ?4?1 to migrate 
across vessels and into tissues is critical for a successful immune response1,2.
The integrins on circulating leukocytes and platelets bind poorly to their
ligands, but adopt an active conformation following signals delivered through 
other membrane receptors, termed “inside-out” signalling3. The inside-out
signalling pathway(s) leads to the activation of integrins defined by increased
affinity for ligand4.  A critical step in this process consists of talin binding to the 
? integrin cytoplasmic tail causing ?? tail separation and a conformational 
change resulting in high affinity integrin5,6.
The functional importance of integrins has been highlighted by 
Leukocyte Adhesion Deficiency-1 (LAD-1) patients who characteristically have
mutations in the ?2 subunit of the leukocyte integrins7,8. This results in the
failure of ?2 integrins, LFA-1, Mac-1 and p150,95, to be expressed on 
leukocytes leading to recurrent bacterial infections. The platelet integrin ?IIb?3
initiates the process of blood clotting through binding to fibrinogen. Mutation in 
either the ? or ? subunit of ?IIb?3 causes the bleeding disorder termed 
Glanzmann thrombasthenia (GT).
An additional group of patients, termed LAD-1/variant9 or LAD-III10,
display symptoms of both LAD-1 and GT. Unlike these two disorders, the 
2
haematopoietically-derived cells of LAD-III patients express ?1, ?2 and ?3
integrin subsets at normal levels, but the integrins fail to function because of
defective “inside out” signalling. Thirteen LAD-III patients have been reported 
so far9,11-14. They vary chiefly in the timing at which problems with particular
integrin subsets are observed.
Deficiency in Rap1 activity has been reported in two LAD-III patients
and such a decrease could be caused by a defective RapGEF15.  CalDAG-
GEF1 is a RapGEF that is activated through binding of DAG and Ca2+ 16,17. The 
CalDAG-GEF1 gene, located at human chromosome 11q13.1, specifies two
proteins as a result of alternative splicing. One protein has 609 residues and is
expressed in the cytosol and a second (termed RasGRP2) has 671 residues, 
contains an additional 62 amino acid N terminal sequence and is membrane 
localized due to myristoylation and/or palmitoylation18. CalDAG-GEF1-/- mice 
mimic the LAD-III phenotype in that they display GT-like bleeding problems19
and defective function of neutrophil??1 and ?2 integrins20. Mutations in 
CalDAG-GEF1 leading to a LAD-III-like disorder are also found in three dog 
breeds21. Recently a C>A base change in a putative splice acceptor site of the 
CalDAG-GEF1 gene (exon 15 of the smaller form and exon 16 of the larger
form) has been described in two patients22. This mutation is reported to cause
a splicing problem leading to a loss of CalDAG-GEF1 mRNA and has been 
suggested to be responsible for the human LAD-III disorder.
Kindlin-3(URP2, MIG-2B) is an adhesion plaque protein that is highly 
expressed by all white blood cells23 and is also located on chromosome 
11q13.1. Recently Kindlin-3-/- mice have been characterized and found to have
a GT-like phenotype24 and leukocytes with integrin activation problems
3
(Markus Moser and Reinhard Fässler, personal communication). Kindlin-3 is
highly homologous to Kindlin-1/URP1, expressed in epithelial cells and also to 
the widely expressed Kindlin-2/Mig-223. Kindler syndrome is a human disease 
characterized by skin blistering that is caused by various loss-of-function 
mutations in Kindlin-1 leading to integrin dysfunction25,26.
The Kindlins have a FERM (protein4.1/ezrin/radixin/moesin) domain 
with F1, F2 and F3 subdomains27,28 that is most homologous to the FERM
domain of talin6. It is the F3 subdomain of talin that binds to the integrin ?
subunit cytoplasmic tail causing integrin activation5,29 and it is to the membrane 
proximal NPXY motif that it binds6,29.  A hallmark of the Kindlins is the
interruption of the F2 subdomain by a pleckstrin homology (PH) domain. 
Kindlin-3 and Kindlin-2 both bind to the ? subunit at the second membrane 
distal NPXY motif and, importantly, the integrin activation-inducing activity of
talin is enhanced by integrin-bound Kindlins24,30,31.
We describe a new LAD-III patient and analyse both CalDAG-GEF1 and 
Kindlin-3 genes in this patient and in two previously reported LAD-III patients 
and their relatives. Our two patients of Turkish origin display the previously
described C>A change in the CalDAG-GEF1 gene22, but this mutation is not 
found in a third patient of Maltese origin. We show in this study that the LAD-III 
disorder is caused by two disabling mutations in the Kindlin-3 gene.
Transfectionn of a wild-type Kindlin-3 cDNA, but not a wild-type CalDAG-GEF1 
cDNA, in the B cells of our three patients overcomes the LAD-III
adhesion/migration defect. 
4
Results
Characterization of a new LAD-III patient 
Maltese patient 112 and Turkish patient 2 (Family 5 in14) have been 
defined previously as LAD-III patients (Fig. 1a). We here characterize a new 
LAD-III patient of Turkish origin (family 3). The expression of integrins LFA-1 
(?L and ?2 subunits) and ?4?1 (?4 and ?1 subunits), that are the major 
functional integrins on T cells, were comparable between the LAD-III patient, 
normal control T cells (Fig. 1b) and both parents (data not shown). Analysis of
the same two integrin classes on neutrophils and EBV-transformed B cells also
revealed normal levels of expression (data not shown). However, when 
adhesion to LFA-1 ligand ICAM-1 and ?4?1/?5?1 ligand fibronectin was
stimulated by means of inside-out signaling that leads to integrin activation 
(phorbol ester, PdBu; Ca2+ mobiliser thapsigargin; or mAb crosslinking of the T 
cell receptor/CD3 complex)12, the T cells of the patient failed to firmly adhere 
(Fig. 1c).  In contrast, the T cells of the patient’s mother and father behaved 
similarly to unrelated normal T cells. This finding is reinforced by the 
observation that the parent’s T cells attached and spread on ICAM-1 in a 
typical LFA-1-dependent manner, in contrast to the patient’s cells that were 
unable to spread (Fig. 1d).  Thus the patient from family 3 exhibits the 
hallmarks typical of the LAD-III disorder.
Assessment of the CalDAG-GEF1 mutation
Based on the likelihood that LAD-III in our Turkish and Maltese 
pedigrees was a recessive condition caused by mutations inherited from a 
common ancestor(s), we used homozygosity mapping to indicate that the most 
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likely location of the gene responsible for the LAD-lll disorder was a region 
between 60.6Mb and 65.3Mb on chromosome 11 (Fig. 2a). The CalDAG-
GEF1 gene (chr11:64.25-64.27Mb) lies on the distal boundary of the region.
Sequence analysis of the region specifying the putative splice acceptor site of 
exon 16 of the larger form (RasGRP2) of the CalDAG-GEF1 gene revealed 
that the patients of Turkish families 2 and 3 were homozygous for the C>A
base change described by Pasvolsky and colleagues22(Fig. 2b,
Supplementary Fig. 1 online). The parents of these patients were 
heterozygous, whereas the sister of patient 2 was homozygous for the normal 
C allele. In contrast, the C>A change was not present in the Maltese patient or
her relatives (family 1). Furthermore sequencing of all 18 exons and all the 
intron/exon boundaries of the CalDAG-GEF1 gene for the 3 patients and their 
relatives yielded no further unexpected nucleotide changes (data not shown
but available on request).
The C>A mutation was reported to prevent correct splicing of the 
CalDAG-GEF1 transcript (exon 15 to exon 16), resulting in unstable CalDAG-
GEF1 mRNA22. We performed Taqman analysis on mRNA from the EBV-
transformed B cells of the three families and compared them to two normal 
EBV transformed B cell lines. All patients and their parents produced CalDAG-
GEF1 mRNA and the levels were within the range of the two normal control 
cell lines (Fig. 2c). When the mRNA from the larger alternatively spliced form 
of CalDAG-GEF1 (RasGRP2) mRNA was specifically analyzed, the patients'
levels were observed to be similar to those of their parents and the normal 
controls (Supplementary Fig. 2 online). We also investigated the levels of 
CalDAG-GEF1 protein by Western blot analysis. All LAD-III patients expressed
6
CalDAG-GEF1 proteins that were indistinguishable in both size and quantity
from the proteins present in the parent and control samples (Fig. 2d).
The effect of wild-type CalDAG-GEF1 on the migration of the LAD-III 
leukocytes
Despite not affecting protein and mRNA sizes or levels, it was possible
that the C>A change affected the function of CalDAG-GEF1. Thus we tested
whether the EBV-transformed B cells were able to undergo LFA-1-mediated
adhesion/migration on ICAM-1. The parents’ cells migrated without added 
stimulant, whereas the LAD-III patients’ cells were unable to migrate on ICAM-
1 (Fig. 3a). ?4?1/?5?1-mediated migration on fibronectin showed the same
difference (data not shown).  The same patterns were also observed in 
adhesion assays on ICAM-1 and fibronectin (data not shown).
We next investigated whether transfection of the patients’ B cells with 
wild-type CalDAG-GEF1 cDNA would overcome the migration defect of the 
LAD-III cells. We used a human CalDAG-GEF1 (RasGRP2) cDNA construct 
that included the N-terminal myristoylation domain involved in membrane
localization18.  There was no observed effect of the transfected wild-type
CalDAG-GEF1 cDNA on the migration of the LAD-III patients’ B cells (Fig. 3b)
or on their individual cell tracking patterns (data not shown). A similar negative
result was obtained by transfecting cDNA constructs of both human and 
murine cytosolic CalDAG-GEF1 cDNAs (data not shown). We next used
interference reflection microscopy (IRM) to investigate in more detail the effect 
of CalDAG-GEF1 on the LFA-1 adhesions made by migrating cells. The 
parent’s cells showed a pattern of close contact with ICAM-1, whereas the
7
LAD-III patient’s cells were only lightly attached (Fig. 3c). Quantification of the 
areas of attachment indicating the extent of integrin-mediated adhesiveness
showed that the CalDAG-GEF1-transfected LAD-III cells were similar to control 
LAD-III cells. The conclusion of these experiments was that expression of wild-
type CalDAG-GEF1, specifying either the membrane or cytosolic form, failed to 
repair the adhesion/migration defect caused by the LAD-III disorder.
LAD-III patients have mutations in Kindlin-3
Since the Kindlin-3 gene (FERMT, chr11:63.73-63.76Mb) lies within our
minimal region mapped for the LAD-III disorder (Fig. 2a), Kindlin-3-/- mice
suffer from a GT-like disorder24 and leukocytes express high levels of Kindlin-
323, we screened it for germline mutations in our three LAD-III patients and 
their immediate families. We found that the two LAD-III cases of Turkish origin 
(families 2 and 3) were homozygous for a C>T nonsense mutation (R509X) at
nucleotide 1525 in exon 12 that changes a CGA codon to a TGA stop codon 
(Fig. 4a). The parents were heterozygous for this change and the healthy
sister of family 2 was homozygous for the wild-type allele. The C>T base 
change generating the termination codon in exon 12 lies within the amino acid 
sequence coding for the C-terminal half of the FERM F2 domain and could 
thus be expected to have impact on the integrin binding F3 subdomain (Fig.
4c).
In contrast to the Turkish families, all members of the Maltese kindred 
(family 1) were homozygous for the wild-type C allele at nucleotide 1525. 
However further screening revealed a different homozygous mutation in the 
Kindlin-3 gene in the affected Maltese child. The Maltese mutation was an A>G 
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change at the splice acceptor site of exon 14 (Fig. 4b). The three other
unaffected Maltese family members were heterozygous for this change, 
whereas the Turkish patients and their relatives were all homozygous for the 
wild-type A allele at this splice acceptor site. This splicing mutation, which
affects the correct joining of Kindlin-3 exon 13 to exon 14, would also prevent 
the generation of an intact FERM F3 subdomain (Fig. 4c). Thus this mutation
would also be predicted to have implications for the binding of Kindlin-3 to 
integrin.
Effect of mutations on Kindlin-3 mRNA levels 
We next investigated the effect that these mutations had on Kindlin-3
mRNA production. mRNA levels were assessed by qRT-PCR for two regions
of the Kindlin-3 mRNA. One probe covered the sequence spanning exons 6 
and 7 and a second probe covered the region spanning exons 13 and 14. This
latter probe would measure the integrity of the mRNA in the neighbourhood of 
the exon 14 splice acceptor site mutation detected in the Maltese patient. The 
patients’ parents mRNA levels, assessed with both sets of probes, were similar
to normal controls (Fig. 5a).
The two Turkish LAD-III patients expressed substantially reduced levels 
of mRNA for both the region spanning exons 6 and 7 as well as the region 
spanning exons 13 and 14 (Fig. 5a). Therefore the mutation specifying the
termination codon at nucleotide 1525 in exon 12 in the Turkish patients results
in a decrease in the mRNA levels specifying sequences both upstream and 
downstream of the mutation. This indicates that the C>T mutation in exon 12 
affects the stability of the Kindlin-3 mRNA.
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The Maltese patient expressed mRNA spanning exons 6 and 7 at 
somewhat reduced levels, but no mRNA was detected spanning exons 13 and 
14 (see asterisk) (Fig. 5a). The lack of detection of mRNA species spanning
exon 13 and 14 in the Maltese patient strongly suggests that the intronic A>G
base change results in the disabling of the exon 14 splice acceptor site. 
It was possible to detect some low level Kindlin-3 transcripts from the 
exon 13 region in the Maltese patient. DNA sequence analysis of the PCR 
products generated only unique sequence for exon 13, but not for the 
sequence following this exon (Fig 5b). In this region, instead of unique exon 14 
sequence, as found for the parent (WT), sequence analysis revealed a number 
of low level aberrant splice products. These results are consistent with the 
mutation in the exon 14 splice acceptor site in the Maltese patient causing 
inhibition of the normal splicing connecting exon 13 and exon 14. Thus the 
mutation of the Kindlin-3 gene in the Maltese LAD-III patient is particularly
informative in terms of the function of Kindlin-3 protein in that mRNA 
specifically coding for the Kindlin-3 FERM F3 domain that is involved in binding 
to integrins is absent.
Wild-type Kindlin-3 expression repairs the LAD-III lesion in adhesion and 
migration
The role of Kindlin-3 in activation of murine integrins and their adhesion-
related functions has been demonstrated24. However there has been no 
comparable study of human Kindlin-3 and it was essential to test whether the 
defects in adhesion and migration displayed by the LAD-III patients’ cells could 
be repaired by the expression of wild-type Kindlin-3. We therefore transfected 
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EBV-transformed B cells of the three LAD-III patients with the previously 
described cDNA specifying murine GFP-Kindlin-323 that is able to reverse the 
integrin activation defect in Kindlin-3-/- cells (Markus Moser, personal
communication). The LFA-1 adhesions made by our LAD-III patients B cells 
with and without expression of murine GFP-Kindlin-3 were compared with their 
parent’s cells using IRM. As in Fig. 3c, the LAD-III cells made poor contacts 
compared with the parent’s cells (Fig. 6a). Importantly, however, expression of 
the murine GFP-Kindlin-3 cDNA in the LAD-III B cells increased adhesion to 
ICAM-1. Both IRM images and quantification of the areas of attachment 
showed that the Kindlin-3-transfected cells made adhesions equalling those 
made by the parents’ cells.
To show further that expression of wild-type Kindlin-3 was able to
overcome the LAD-III phenotype, we tested the same cells for their ability to 
undergo LFA-1-mediated migration on ICAM-1-coated surfaces. LAD-III cells
from all three families expressing GFP-Kindlin-3 migrated on ICAM-1 similarly 
to the control transfected parents’ cells, whereas this was not the case for the
GFP-transfected LAD-III cells (Fig. 6b, Supplementary Videos online). The
LAD-III B cells, expressing wild-type Kindlin-3, not only had a similar speed of 
migration as the parent’s cells, but also an identical pattern of random motility
(Fig. 6c).
Discussion
A key feature that distinguishes LAD-III or LAD-1/variant patients from 
those with other integrin deficiency syndromes is the normal expression but 
lack of function of the ?1, ?2 and ?3 integrins expressed by their leukocyte and 
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platelets. This failure to function leads to immune deficiency and bleeding 
problems as described previously32. The nature of the disabling mutation(s) 
has been a focus of interest for more than a decade since the first reports of 
these patients9,11-13.
The RapGEF, CalDAG-GEF1, is a good candidate for the LAD-III gene. 
It lies within a region of significant homology between LAD-III patients on 
chromosome 11q13.1 and the deletion of the CalDAG-GEF1 gene in mice19,20
and mutation of CalDAG-GEF1 in dogs21 causes a LAD-III-like disorder.
Pasvolsky et al postulated that a C>A change in a putative splice acceptor site 
upstream of exon 16 of the CalDAG-GEF1 gene results in low mRNA levels
and is the causative mutation responsible for the LAD-lll disorder. The 
observation that a C>A change was detected in both alleles of our two Turkish 
LAD-III patients and also in the two Turkish patients described by Pasvolsky 
and colleagues22, but not in our Maltese patient, suggests that this mutation is
exclusive to the LAD-III patients of Turkish origin. Significantly, in our Turkish 
patients, in contrast to those described by Pasvolsky et al, the presence of the 
C>A change has no impact on CalDAG-GEF1 mRNA or protein levels as they
are within the range found in the patients’ parents and normal controls.
Furthermore, in an experiment not done by Pasvolsky and colleagues, we find 
that exogenous expression of the wild type CalDAG-GEF1 gene in all three 
patients’ cells is unable to reverse the LAD-III adhesion/migration defect. 
These data strongly argue that mutation in the CalDAG-GEF1 gene is not the 
cause of human LAD-III, at least in the patients described here.
Furthermore knock down of CalDAG-GEF1 expression in human T cells
affects LFA-1-mediated adhesion to ICAM-1, but not ?4?1 adhesion to VCAM-
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1 that is PKC-dependent33. These CalDAG-GEF1 and PKC pathways also 
operate synergistically in the activation of platelet ?II?334. Thus the 
characteristics of CalDAG-GEF1 function do not conform to the hallmark of the 
LAD-III disorder in which the activity of??1, ?2 and ?3 integrin subsets are 
substantially compromised in leukocytes and platelets. 
However the association of the C>A change in CalDAG-GEF1 with 
LAD-III suggests a Turkish founder effect maintained through consanguineous 
marriage. The implication is that there is strong linkage disequilibrium between 
the CalDAG-GEF1 gene and the gene responsible for the LAD-lll syndrome.
Kindlin-3 had recently become a prime candidate for LAD-III because the gene 
is located 0.5 Mb away from CalDAG-GEF1 at chromosome 11q13.1 in the 
region of shared haplotypes in our LAD-III kindred and also because Kindlin-3-/-
mice have recently been characterized and found to display a GT-like 
phenotype24. We describe two independent disabling mutations in the Kindlin-3
gene and show that the LAD-lll phenotype can be repaired by expression of 
wild-type Kindlin-3.
We define in both Turkish patients a single homozygous mutation in 
exon 12 leading to a stop codon that destabilises Kindlin-3 mRNA. In the 
Maltese patient, there is a second independent inactivating mutation within the 
splice acceptor site associated with exon 14 of Kindlin-3 which leads to an 
absence of mRNA for exons 13/14. This is particularly informative in terms of
the LAD-III disorder as the FERM F3 subdomain of murine Kindlin-3 has been 
identified to have integrin ? subunit binding activity24 and it is this region that is 
encoded by exons 13/14 of human Kindlin-3. As the LAD-lll phenotype is
repaired by expression of murine Kindlin-3 in the patients' B cells, it is of 
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interest that there is 100% amino acid identity between the Kindlin-3 mouse 
and human F3 subdomains (data not shown). 
Finally the implication is that the binding of Kindlin-3 is a critical 
component of the sequence of events leading to integrin activation.  Kindlin-2 
and Kindlin-3 are both reported to bind to ?1 and ?3 cytoplasmic tails at the 
membrane distal NPXY motif24,30,31. This binding enhances talin binding at the 
membrane proximal NPXY site and causes a subsequent increase in integrin
affinity. Further detail of the relationship between Kindlin-3 and talin binding to
the ? subunit and the identification of any other interaction partners remains to 
be discovered. Our findings here suggest that Kindlin-3 binds not only to 
human ?1 and ?3, but also to ?2 integrins and that binding to all three integrin 
subtypes is instrumental in the generation and/or maintenance of integrin 
activity in leukocytes and platelets.
Fourteen LAD-III patients have so far been reported of which the 
majority are of Turkish origin9,11-14. The LAD-III patients exhibit very similar
symptoms, but the timing of the observed integrin subset defects can vary.
This might be explained by the nature of the Kindlin-3 mutations. Alternatively,
although we found that mutation in CalDAG-GEF1 did not explain the LAD-III 
disorder in our patients, it remains possible that either CalDAG-GEF1, or
another molecule involved in the pathway to integrin activation that includes
Kindlin-3, might be responsible for a subset of other LAD-III patients.  However
our demonstration that expression of wild-type Kindlin-3 can overcome the 
LAD-III defects in these patients by generating integrin adhesive contacts and 
integrin-mediated migration of LAD-III lymphocytes provides strong biological 
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evidence to support the assignment of Kindlin-3 as the source of disrupting 
mutations associated with the LAD-lll phenotype.
Methods
Patients
All affected children in the three families suffered from cerebral 
haemorrhages at birth. All displayed an increased leukocyte blood count 
characteristic of LAD-III patients whose leukocytes have difficulty leaving the 
circulation leading to recurrent infections during early life. Family 1: The patient
was born of non-consanguinous Maltese parents and has been characterized
previously as a LAD-III12.  Family 2: The patient is a 4 yr old Turkish boy whose
parents are first cousins. He has mental and motor retardation because of
neonatal intracranial haemorrhages that occurred at birth. He has previously
been identified as a LAD-III (Family 514). Family 3: We describe this Turkish
LAD-III patient for the first time. Consanguinity is present as the mother and
father are the grandchildren of sisters. There have been 2 sibling deaths with a 
history of delayed cord separation, hematuria, melena, petechias and severe
infection. This female patient (<1 yr old), first presented early in life with 
anemia, thrombocytopenia and leukocytosis (35-100 x 109 cells/L; neutrophilia 
and lymphocytosis in equal proportions). All features have persisted 
necessitating repeated erythrocyte transfusions. The subject had a clinical
phenotype suggestive of the severe form of LAD-1: septicemia, axillary
ulceration without pus collection, diffuse cellulitis on the right arm, delayed cord 
separation (surgical separation at day 20). Platelet aggregation tests showed 
abnormality similar to GT.
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Antibodies and other reagents 
The use of mAbs 38 (?L, CD11a), TS1/18 (?2, CD18), HP2/1 (?4,
CD49d) and (?1, CD29) have been previously reported12,35. Other Abs used 
were rabbit polyclonal anti-CalDAG-GEF1 #3752, a gift from Drs Ann Graybiel 
and Jill Crittenden; DM 1A anti-?-tubulin (Sigma-Aldrich, Dorset, UK). Full 
length ICAM-1Fc protein was prepared as previously12.
The human cytosolic Myc-CalDAG-GEF1 and membrane localised 
CalDAG-GEF1 (RasGRP2-FLAG) cDNAs were gifts from Dr John Hancock18
and the murine cytosolic CalDAG-GEF1-FLAG cDNA, a gift from Drs Ann 
Graybiel and Jill Crittenden. The murine pEGFP-Kindlin-3 DNA construct has
been described previously23.
Cells and cell transfections 
T lymphocytes were prepared and expanded in culture as previously
described12. Epstein-Barr virus transformed (EBV-transformed) B 
lymphoblastoid cells were derived from peripheral blood mononuclear cells of 
patients, their relatives and non-related controls (BS, POS) by Research Cell 
Services, Cancer Research UK using standard procedures. All cells were
maintained in RPMI-1640 with 10% FCS.
To transfect the cDNA constructs, EBV-transformed B cells were
washed in OptiMEM+GlutaMAX (Invitrogen, Paisley, UK) and electroporation 
was performed using 2x107 cells with 10 ?g per reaction of CalDAG-GEF1 or
Kindlin-3 cDNA constructs or 5 ?g of pEGFP-N1 (BD Biosciences, Oxford, UK) 
using a Gene Pulser with Capacitance Extender  (Bio-Rad UK, Hemel 
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Hemstead, UK) set at 960 ?FD and 260 mV. The DNA-transfected cells were 
maintained in RPMI 1640/10% FCS up to 24 hours. The efficiency of the 
transfection was evaluated by flow cytometry and the GFP positive cells were 
sorted using a MoFlo Cell Sorter (Beckman Coulter, CA) before use in 
migration assays. The level of cDNA construct expression was quantified by
Western blotting.
Sequencing the CalDAG-GEF1 and Kindlin-3 genes
Genomic DNA from all patients, relatives and non-related controls was
analysed for sequence alterations in all exons and intron-exon boundaries of
the CalDAG-GEF-1 and Kindlin-3 genes by direct DNA sequencing in both 
orientations. Details and PCR conditions are available from the authors.
Taqman Assays
The human CalDAG-GEF-1 and Kindlin-3 mRNA levels were quantified
using TaqMan technology. Briefly RNA was extracted from leukocytes using 
GenEluteTM Mammalian Total RNA Miniprep Kit (Sigma-Aldrich). RNA was 
reverse-transcribed using the AffinityScriptTM QPCR cDNA Synthesis Kit 
(Agilent Tech. UK Ltd., Cheshire, UK), and purified using the QIAquick PCR 
Purification Kit (Qiagen Ltd Sussex, UK). A total of 40 ng of cDNA per reaction 
was amplified using TaqMan Gene assays: for CalDaG-GEF1(RasGRP2), 
Hs00183378_m1 (exons 8-9), Hs01057123_m1 (exons 2-3); for Kindlin-3,
Hs00258828_m1 (exons 13-14) and Hs01075695_m1 (exons 6-7); and 
controls Hs99999905_m1 (GAPDH) and Hs00202782_m1 (SF3B1).
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The samples were analyzed on the ABI 7900HT Sequence Detection 
System instrument. Each sample was run in quadruplicate and expressed as a 
function of threshold cycle (Ct). The Ct values for reactions amplifying 
CalDAG-GEF-1 were corrected by the Ct value for SF3B1 or GAPDH to give 
?Ct. The difference in ?Ct values between test and control cDNA samples
allowed the relative expression of the gene to be quantified as follows: 2^-[(?Ct
test - ?Ct SF3B1/GAPDH) - (?Ct control - ?Ct SF3B1/GAPDH) (Applied 
Biosystems, Cheshire, UK). 
Flow cytometry
Leukocytes (5x105) were incubated for 20 min at 4oC in 50 ?l of 
PBS/0.2% BSA containing primary mAb at optimal dilution as described 
previously 12. Bound mAb was detected by incubation with FITC-conjugated
goat anti-mouse IgG (Sigma) for 20 min at 4oC and analysed by a FACS
Calibur flow cytometer (BD Biosciences, CA).
Cell attachment assays 
Flat-bottom Immulon-1 96 well plates were coated with 100 ?l ICAM-1Fc 
(3 ?g/ml) or fibronectin (10 ?g/ml) in PBS overnight at 4°C and blocked with 2.5
% BSA. Cells were labelled with 2.5 ?M 2’,7’-bis-(carboxyethyl)-5(6’)-
carboxyfluorescein (BCECF; Merck Chemicals, Nottingham, UK.) then washed 
into HBSS/20 mM HEPES and plated at 2 x 105 cells per  well (samples in 
triplicate). The cells were treated as indicated and incubated at 37°C for 30 
mins. Non-adherent cells were removed by gentle washing and adhesion 
quantified using a Cytofluor multiwell plate reader (PerSeptive Biosystems, 
Hertford, UK).
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Video microscopy
Either 35 mm glass bottom microwell dishes (MatTek Corp. MA) or 
ibiTreat ?-Slides VI (ibidi, Thistle Scientific, Glasgow, UK) were coated 
overnight with 3 ?g/ml ICAM-1Fc then blocked with BSA. Lymphocytes
(4x105/ml in HBSS/20 mM HEPES buffer) were allowed to settle for 10 min at
37°C, then non-attached cells removed with gentle washing. Images were 
taken with a Nikon Diaphot 300 microscope, using a 20x or 63x lens and 
AQM2001 Kinetic Acquisition Manager software (Kinetic Imaging Ltd., UK). Cells 
were tracked at 15 sec intervals using Motion Analysis software (Kinetic 
Imaging Ltd.) and the data analyzed using a Mathematica notebook (Wolfram 
Research Inc., USA) developed by Daniel Zicha (Cancer Research UK). 
Statistical analysis was carried out using the Anova test.
Interference Reflection Microscopy (IRM) 
EBV-transformed B cells were plated on ibiTreat ?-Slides coated with 3 
?g/ml ICAM-1. Images of close substrate contact of the migrating cells were 
acquired between 10-30 mins of attachment to ICAM-1 using a Zeiss Axiovert
100M Inverted confocal microscope with a 63x NA1.4 Plan-Apochromat oil 
immersion objective lens. For evaluation of adhesion status, the area of 
contact was measured using MetaMorph Offline 7.1 (n=35 cells per sample 
type).
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Figure legends 
Figure 1. LAD-III patient geneology and characterization of a new LAD-III 
patient. a. The family pedigrees of the three LAD-III patients and their families 
are shown. Families 1(Maltese) and 2(Turkish) have been reported
previously12,14; the parents in family 3 are the grandchildren of Turkish sisters. 
A double line indicates the level of known consanguinity. A forward line in the 
patient generation indicates that the individual is deceased; b. FACS analysis
showing the expression levels of the integrin subunits ?4, ?1, ?L and ?? are 
equivalent between family 3 LAD-III patient and control T lymphoblasts (control 
cells -grey fill; patient cells -dark line; representative mAb negative control-
dashed line); c. Adhesion of family 3 T lymphoblasts to LFA-1 ligand ICAM-1 
and ?4?1/?5?1 ligand fibronectin following “inside out” signalling mediated by
phorbol ester (PdBu), Ca2+ mobiliser thapsigargin (Thaps); or CD3 mAb 
crosslinking of the T cell receptor/CD3 complex (CD3XL) (n=2). d. Images of T 
lymphoblast adhesion to ICAM-1. The family 3 parent’s cells spread as 
expected, whereas the family 3 patient’s cells were lightly attached and failed 
to spread. Scale bar=10 ?m.
Figure 2. Mutation in the CalDAG-GEF1 gene and lack of effect on mRNA
and protein levels. a. Homozygosity mapping. The display from the program 
http://uk-lif-lbio02.crnet.org/~cazier01/ indicates the largest shared region of
homozygosity (chr 11: 60.6Mb to 65.3Mb Mb) present in affected individuals
(purple bars) and absent in unaffected family members from the three 
kindreds.  Data is from Affymetrix 500K SNP arrays with a mis-call tolerance of 
1%. There were no areas in the whole genome other than at centromere 
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regions with larger than 1Mb homozygosity in all three patients. In the absence 
of knowledge of allele frequencies in the almost certainly inbred populations 
under study, this relatively simple display method does not take SNP 
information content into account and hence centromeric regions (red) with low 
homozygosity are often shown falsely, as here, as being identical by descent. 
b. Alignment of the DNA sequence surrounding the C>A base change (bold) in 
the CalDAG-GEF1 gene of the LAD-III patients and their relatives (reference.
The original data is shown in Supplementary Figure 1. (reference genomic 
data from http://genome.ucsc.edu/(chr11:64,250,959-64,269,504)). c.
Quantification of CalDAG-GEF1 mRNA levels by qRT-PCR analysis of patients 
(P) and their relatives (M=mother; F=father) compared to two normal control 
EBV transformed cell lines. A 1.5 fold difference from the controls (set at 1.0) 
was considered significant (dotted line) (n=2-4 for each family); d. CalDAG-
GEF1 protein levels were similar between patients (P), relatives (M=mother, 
F=father) and control (C) as assessed by Western blotting (n=2). 
Figure 3. Migration characteristics and IRM images of LAD-III B cells 
adhered to ICAM-1 and expressing CalDAG-GEF1.  a. Parents’ cells 
randomly migrate on ICAM-1, whereas the LAD-III patients’ cells are lightly 
attached but do not migrate (representative experiment of n=3); b. LAD-III cells 
transfected with the wild type CalDAG-GEF1 or pEGFP-N1 (GFP) cDNA 
constructs compared with the migration of the pEGFP-N1-transfected parents’ 
cells. The CalDAG-GEF1 construct was without effect on migration (n=4 
independent experiments for each family); c. DIC and IRM images of the family 
3 LAD-III B cells transfected as in b. The mother’s (Parent) cells form LFA-1 
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adhesions, but the LAD-III patient’s cells expressing CalDAG-GEF-1 are 
indistinguishable from the patient’s control cells expressing GFP (n=2) Scale 
bar=10 ?m; Lower figure: quantification of the area of close contact for n=35 
cells.
Figure 4. Mutations in the Kindlin-3 gene. a. The DNA sequence around the 
location of the C>T base change in exon 12 of the Kindlin-3 (FERMT) gene in 
the Turkish (mutated) and Maltese families (reference http://genome.ucsc.edu/
chr11:63,730,782-63,747,930); C or T at this position indicated in bold; C/T 
denotes heterozygosity. The C>T mutation generates a TGA stop codon 
causing truncation of the Kindlin-3 protein and also affects Kindlin-3 mRNA 
stability. Below: the traces of the DNA sequence analysis around the mutation 
site in exon 12 for wild type (WT), a heterozygote Turkish parent (Het) and a 
homozygous mutant Turkish LAD-lll patient (LAD-lll). Y indicates the presence
of a pyrimidine (both C and T). b. The DNA sequence around the location of 
the A>G base change in the Kindlin-3 exon 14 splice acceptor site in the 
Maltese (mutated) and Turkish families is shown; A or G at this position 
indicated in bold; A/G denotes heterozygosity. This mutation leads to a splicing 
defect affecting the joining of exons 13 and 14 of the Kindlin-3 mRNA. Below:
the traces of the DNA sequence analysis around the mutation site in splice 
acceptor site of exon 14 for the wild type (WT) the heterozygote Maltese
parents (Het) and the homozygous mutant Maltese LAD-lll patient (LAD-lll); R 
indicates the presence of a purine (both A and G). More extensive original data
for (a) and (b) is shown in Supplementary Figure 3. c. Diagrammatic
representation of human Kindlin-3 protein with its PH and FERM domains. The 
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location of the exons encoding the different regions of the Kindlin-3 protein is
shown. The position of the two LAD-III mutations, one in exon 12 and the other 
affecting the join of exons 13 and 14 of the Kindlin-3 gene detailed above in (a) 
and (b), are shown by red asterisks.
Figure 5. Analysis of Kindlin-3 mRNA in LAD-III patients and their
relatives
a. Quantification of Kindlin-3 mRNA levels by qRT-PCR analysis of patients (P)
and their relatives (M=mother; F=father; S=sister) compared to two control 
EBV transformed cell lines. A 1.5 fold difference from the controls (set at 1.0) 
was considered significant (dotted line) (n=2 for each family); b. Effect of splice 
acceptor site mutation in the Maltese patient on Kindlin-3 mRNA at the 
exon13/14 junction. The ReverseTranscribed-PCR product encompassing the
mRNA sequence specifying the end of exon 13 and the start of exon 14 is
compared between parent (WT) and the Maltese LAD-lll patient (LAD-lll). The
unique DNA sequence specifying the end of exon 13 (last 7 bp) and the start of 
exon 14 (25 bp) is shown for WT. For the Maltese LAD-III patient, only the last 
7 bases of exon 13 are detectable which is consistent with an exon 14 splice
acceptor mutation.
Figure 6. Adhesion and migration characteristics of EBV-transformed B
cells expressing wild-type Kindlin-3. a. DIC and IRM images of the LAD-III B 
cells transfected with either pEGFP or Kindlin-3 cDNAs and compared with a 
parent’s B cells transfected with pEGFP. Expression of Kindlin-3 induces the
patient’s cells to form LFA-1 adhesions similar to the parent’s cells (n=2). 
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Images are accompanied by quantification of the area of close contact for n=35 
cells. Scale bar=10 ?m; b. Parents’ cells randomly migrate on ICAM-1, 
whereas the LAD-III patients’ cells are lightly attached but do not migrate; The
LAD-III cells were transfected with the wild type Kindlin-3 cDNA or pEGFP 
constructs and compared with the migration of the pEGFP-transfected parents’ 
cells. Expression of the Kindlin-3 construct increased the migration of the LAD-
III cells to that of the parent’s cells (representative experiment of n=3 for each 
family). c. The cell tracking results from an individual experiment with family 2 
LAD-III patient and father transfected as in b.
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Figure 1 The sequence of the genomic DNA surrounding the C/A base
change in CalDAG-GEF-1 (see arrow) is shown for all LAD-III patients and
their relatives.
Figure 2 Measurement of mRNA levels of the longer CalDAG-GEF1 isoform
(671 amino acids) by quantitative PCR using Taqman Gene Expression
Assay Hs01057123_m1 (CalDAG-GEF1 exons 2-3). The results are
expressed as fold difference of patients (P) and relatives (M = mother, F =
father, S = sibling) compared with two control EBV transformed B cell lines.
Figure 3 The sequence of the genomic DNA surrounding the Kindlin-3 base
changes in exon 12 and splice acceptor site associated with exon 14 is shown
for all LAD-III patients and their relatives.
Video 1 GFP-expressing LAD-III B cells (Turkish family 3) migrating on ICAM-
1. These cells have dynamic membranes but are not motile. Each frame=1/10
sec representing 15 sec real time.
Video 2 CalDAG-GEF-1 expressing LAD-III B cells (Turkish family 3)
migrating on ICAM-1. These cells have dynamic membranes, are not motile
and resemble the cells expressing only GFP (video 1). Each frame=1/10 sec
representing 15 sec real time.
Video 3 Kindlin-3- expressing LAD-III B cells (Turkish family 3) migrating on
ICAM-1. Expression of Kindlin-3 renders these cells motile almost to the same
extent as the parent’s cells in Video 4. Each frame=1/10 sec representing 15
sec real time.
Video 4 GFP-expressing B cells of the mother of family 3 migrating on ICAM-
1. Each frame=1/10 sec representing 15 sec real time.
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1
Kindler Syndrome (KS), characterized by transient skin blistering followed by
abnormal pigmentation, skin atrophy and skin cancer, is caused by mutations
in the FERMT1 gene. Although a few KS patients have been reported to also 
develop ulcerative colitis (UC), a causal link to the FERMT1 gene mutation is 
unknown. The FERMT1 gene product belongs to a family of focal adhesion 
proteins (Kindlin-1, -2, -3) that bind several ? integrin cytoplasmic domains. We 
show here that deleting Kindlin-1 in mice gives rise to skin atrophy and a lethal 
UC. The UC is triggered by defective intestinal epithelial cell integrin activation
leading to detachment of this barrier followed by a destructive inflammatory
response. The UC is not primarily dependent on an abnormal immune reaction. 
Thus, we describe the first genetic cause of UC, which is initiated by
compromised epithelial cell adhesion. 
2
Introduction
Kindler Syndrome (KS) is a rare, recessive genodermatosis caused by mutations in 
the FERMT1 gene (C20ORF42/KIND1) [1,2]. KS patients suffer from varying skin
abnormalities that occur at distinct phases of their life [3]. Skin blisters develop and
disappear after birth, followed by skin atrophy, pigmentation defects and finally skin 
cancer. The severity of the individual symptoms varies extensively among individual 
patients. FERMT1 mutations are distributed along the entire gene and can give rise
to different truncated Kindlin-1 proteins [4]. Interestingly, the different courses of the 
KS cannot be linked to mutations within specific regions of the FERMT1 gene [3] 
suggesting that additional environmental and/or genetic factors contribute to the 
disease course.
Kindlin-1 belongs to a novel family of cytoplasmic adaptor proteins consisting of three 
members (Kindlin-1-3) [5]. Kindlins are composed of a central FERM (band 4.1, 
ezrin, radixin, moesin) domain, which is disrupted by a pleckstrin homology (PH) 
domain. They localize to cell-matrix adhesion sites (also called focal adhesions, FAs) 
where they regulate integrin function. In line with the role of Kindlins in integrin 
function, keratinocytes from KS patients and Kindlin-1-depleted keratinocytes display
impaired cell adhesion and delayed cell spreading [6,7]. The mechanism how Kindlin-
1 regulates integrin function is not understood and controversial. Kindlin-2 and 
Kindlin-3 were shown to bind to the membrane distal NxxY motif of ?1 and ?3?integrin
cytoplasmic domains. This binding, in concert with talin recruitment to the membrane
proximal NPxY motif, leads to the activation (inside-out signaling) of ?1 and ?3 class
integrins enabling them to bind to their ligand. Following ligand binding, Kindlin-2 and 
Kindlin-3 stay in matrix adhesion sites where they link the ECM to the actin
cytoskeleton by recruiting ILK and Migfillin to FAs (outside-in signaling). Consistent
with this adaptor function of Kindlin-1, keratinocytes from KS patients and
keratinocytes depleted of Kindlin-1 display impaired cell adhesion and delayed cell 
spreading [6,7]. Importantly, however, Kindlin-1 was reported to have different 
properties than Kindlin-2 and -3, since it was shown to bind like talin to the proximal 
NPxY motif of ?1 integrin tails [6], 
The Kindlins have a specific expression pattern. Kindlin-1 is expressed in epithelial 
cells, while Kindlin-2 is expressed ubiquitously. They are both found at integrin 
adhesion sites and/or cadherin-based cell-cell junctions. Kindlin-3 is exclusively
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expressed in hematopoietic cells, where it controls a variety of functions ranging from 
integrin signaling in platelets [8] to stabilizing the membrane cytoskeleton in mature 
erythrocytes [9]. 
Although the FERMT1 gene is expressed in epithelial cells of almost all tissues and
organs [5], only abnormalities of the skin and the oral mucosa are associated with the 
disorder. Recently it has been reported, however, that some KS patients also 
develop ulcerative colitis (UC) [4,10,11], which together with Crohn’s disease belongs
to idiopathic inflammatory bowel disease.
UC usually occurs in the second or third decade of life, although the incidence in
pediatric patients is steadily rising [12,13]. UC is restricted to the colon and is 
characterized by superficial ulcerations of the mucosa. It is currently believed that the 
mucosal ulcerations are triggered by the release of a complex mixture of 
inflammatory mediators leading to severe inflammation and subsequent epithelial cell 
destruction [12]. In line with this paradigm a large number of murine colitis models
occur when the innate or adaptive immune response is altered [12]. Genetic linkage
analysis in man led to the identification of several susceptibility loci [14,15]. 
Importantly, however, there is still no genetic mutation assigned to the disease
etiology. In line with the UC disease course most of the KS patients develop their first 
UC symptoms in adulthood. Interestingly, however, one of them suffered from a 
severe neonatal form of UC and was diagnosed with a null mutation in the FERMT1 
gene after developing trauma-induced skin blistering later in life [10]. Since only a 
few KS patients were reported to develop intestinal symptoms, it is currently debated 
whether UC development is directly linked to FERMT1 gene mutations or secondarily 
caused by a microbial infection or an abnormal inflammatory response. 
In this study we directly investigated the role of Kindlin-1 in vivo by generating mice
carrying a constitutive null mutation in the Kindlin-1 gene. We demonstrate that 
Kindlin-1 deficient mice develop skin atrophy and a lethal UC, which results in early
postnatal lethality. The UC is caused by defective intestinal epithelial integrin
activation, which leads to severe epithelial detachment followed by a severe 
inflammatory reaction. 
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Results
Loss of Kindlin-1 leads to lethal ulcerative colitis
To unravel the consequences of loss of Kindlin-1 in vivo, we established a mouse 
strain with a disrupted Fermt1 gene, leading to a complete loss of Kindlin-1 mRNA 
and protein (Figure 1A-C). Heterozygous Kindlin-1 mice (Kindlin-1+/-) had no 
phenotype and were fertile. Kindlin-1-deficient mice (Kindlin-1-/-) were born with a 
normal Mendelian ratio (29.6% +/+; 44.1% +/-; 26.3% -/-; n = 203 at P21) and 
appeared normal at birth. Two days postnatal (P2), all Kindlin-1-/- mice analyzed so
far were dehydrated (Figure 1D), failed to thrive (Figure 1E) and died between P3-P5 
(Figure 1E). Blood glucose and triglyceride levels of Kindlin-1-/- mice were normal 
suggesting a normal absorption of nutrients in the small intestine (Supplementary 
Figure 1). Their urine showed an increased osmolarity further pointing to severe
dehydration (Figure 1F). 
The skin was assessed to determine whether skin abnormalities caused the perinatal 
lethality. Although Kindlin-1-/- mice showed features of KS like skin atrophy and
reduced keratinocyte proliferation (Figure 2A and B), adhesion of basal keratinocytes
to the basement membrane (BM) was unaltered (Figure 2A and Supplementary 
Figure 2). Histology of backskin sections from different developmental stages
revealed normal keratinocyte differentiation (Supplementary Figure 3), normal 
development of the epidermal barrier (Supplementary Figure 4A and Figure 2C and 
D), and comparable epidermal thickness at E18.5 and P0. In line with the 
progressing proliferation defect a reduction of the epidermal thickness was first 
observed at P1 (Supplementary Figure 4B). Interestingly despite the mild in vivo
phenotype, Kindlin-1-/- keratinocytes displayed severe adhesion and spreading
defects in culture (Supplementary Figure 5A and B) further indicating that Kindlin-1-/-
keratinocytes from mouse and man display similar defects [7]. 
These results indicated that another defect is responsible for their perinatal lethality.
When the stomach and the intestine of Kindlin-1-/- mice were examined, they were
swollen and filled with gas (Figure 3A) suggesting severe intestinal dysfunction might 
be the cause of death. At P2, the terminal ileum and colon were shortened and
swollen and strictures were evident in the distal colon, which are signs of acute 
inflammation (Figure 3B). By P3, when the majority of mutant mice were dying, most 
of the colonic epithelium detached (Figure 3C), became apoptotic (Supplementary 
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Figure 6) and was replaced by granulation tissue enriched with macrophage,
granulocyte and T cell infiltrates (Figure 3D). The shortened colon was neither a 
consequence of increased apoptosis, which was only seen in detached epithelium,
nor a result of reduced intestinal epithelial cell (IEC) proliferation (Supplementary 
Figure 6).
The epithelial detachment and severe inflammation extended into the ileum (Figure 
3C). In contrast, the proximal small intestine (duodenum and jejunum) had no
evidence of IEC detachment or inflammation (Figure 4). The phenotype of Kindlin-1-/-
mice for the most part phenocopied the intestinal disease observed in the patient with 
a complete loss of Kindlin-1, who developed severe neonatal UC prior to skin 
blistering becoming apparent [10]. 
Kindlin-1 is required for intestinal epithelial cell adhesion
To define the cell type affected by loss of Kindlin-1 we localized Kindlin-1 in the 
normal intestine by immunostaining. Similar to the situation in man [4], Kindlin-1 is
present throughout the cytoplasm of IECs of the colon and at the basolateral sites of
both IECs of the colon (Figure 5A) and the small intestine (Figure 5B). The anti-
Kindlin-1 polyclonal antibody produced some weak unspecific background signals in 
the intestinal mesenchyme of wild type and Kindlin-1-/- mice (Figure 5B). Kindlin-2
was exclusively found in cell-cell contacts and did not change its distribution in the 
absence of Kindlin-1 (Figure 5C and D). Focal adhesion (FA) components such as 
Talin and Migfilin as well as F-actin were expressed normally in Kindlin-1-/- colonic 
epithelium that was still adhering to the BM (Figure 5C and data not shown). 
Next we determined the time point when mutant mice began developing intestinal 
abnormalities. At E18.5 the ileum and colon of Kindlin-1-/- mice were histologically
normal and electron microscopy revealed an intact epithelium and basement 
membrane (BM) (Figure 6A). Shortly after birth (P0), wild-type and Kindlin-1-/- mice 
began to suckle and accumulated milk in their stomachs. Within 5-7 hours nursed
Kindlin-1-/- mice contained colostrum in the intestinal lumen and displayed extensive 
epithelial cell detachment (Figure 6B) but no infiltrating immune cells (Figure 6B and 
C) in the distal colon. No epithelial detachment occurred when Kindlin-1-/- mice were 
delivered by Caesarean section and incubated in a heated and humidified chamber
for up to 7 hours (Figure 6B) indicating that mechanical stress applied by stool 
caused IEC detachment. However, intestinal inflammation occurred over time in fed 
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mice  (Figure 6D) with all the signs of a classical UC [16] including a significantly
increased expression of the proinflammatory cytokines TNF-? and IL-6 and a 
reduction in goblet cell mucins (Figure 6D and E,). Although inflammation extended 
into the ileum at P3 (Figure 6B and C), the epithelial cells of the ileum were never 
detached suggesting that Kindlin-1-/- mice develop a so-called backwash ileitis
caused by stool “washed back” from the colon into the ileum [13]. These analyses
revealed that the epithelial detachment begins at P0 in the distal parts of the colon
and subsequently expands proximally. 
Kindlin-1 controls activation of integrins 
An important question is how Kindlin-1 deficiency leads to detachment of intestinal 
epithelial cells. One potential explanation could be loss of support by a disrupted BM 
as reported for skin of KS patients [1,2,3]. Moreover, it is known that BM digestion 
and epithelial detachment in inflammatory bowel disease (IBD) can be triggered via
the secretion of MMPs by epithelial and/or infiltrating immune cells [17]. This 
possibility could be excluded, since Kindlin-1-/- mice at P1 showed a continuous BM 
with all major components present, both in areas of the colon where IECs were still 
adherent as well as in areas where IECs were detached (Figure 7A). Interestingly,
also the skin of Kindlin-1-/- mice showed a normal BM distribution by immunostaining 
(Supplementary Figure 2). 
An alternative explanation for the IEC detachment could be a dysfunction of integrins,
similar to that reported for Kindlin-3-deficient platelets [8] and Kindlin-2-deficient 
primitive endoderm [18]. The normal distribution of ?1 integrin (Figure 7B) and the 
comparable levels of ?1 and ?v integrins (Figure 7C and D and data not shown) 
excluded a defect in expression and/or translocation of integrins to the plasma 
membrane. Flow cytometry of primary IECs with the monoclonal antibody 9EG7,
which recognizes an activation-associated epitope on the ?1 integrin subunit, showed
significantly reduced binding (Figure 8A) suggesting that loss of Kindlin-1 decreases 
activation (inside-out signaling) of ?1 integrins. Primary keratinocytes from Kindlin-1-/-
mice also showed normal localization (Supplementary Figure 7A) and surface 
expression of ?1 integrins (Supplementary Figure 7B). Interestingly, 9EG7 staining
revealed reduced, although not statistically significant, activation of ?1 integrins
(Supplementary Figure 7C). 
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Since it is difficult to culture and maintain primary murine IECs, we depleted Kindlin-1 
in a human colon carcinoma cell line (HT-29) using RNAi (HT-29siKind1; Figure 8B) 
to show that integrin-mediated cell adhesion and shear stress induced detachment 
were also perturbed in a colon cell line. HT-29siKind1 cells were unable to adhere to
fibronectin, showed strongly reduced adhesion to Laminin-332 and Collagen IV
(Figure 8C) and easily detached from FN upon exposure to low as well as high shear
stress (Supplementary Figure 8). The remaining adhesion to Laminin-332 and 
Collagen IV is likely mediated by other Laminin- and Collagen-binding receptors on 
colonic epithelial cells such as ?6?4 integrins and discoidin domain receptors [19,20],
which are both known to function independent of Laminin and Collagen binding ?1
integrins [21]. 
These findings indicate that (i) loss of Kindlin-1 impairs integrin activation, which 
compromises adhesion of colonic epithelial cells and finally leads to inflammation and
UC, that (ii) Kindlin-2 cannot rescue Kindlin-1 loss in colonic epithelial cells, and that 
(iii) the residual adhesion to Laminin and Collagen supports the in vivo observation
that shear is required to detach IECs Collagen IV-containing BMs in vivo.
It has been reported that Kindlin-1 associates with the membrane proximal NPxY 
motif of ?1 and ?3 integrins [6]. This observation, however, is in contrast with 
observations made with Kindlin-2 and -3, both of which bind the membrane distal 
NxxY motifs of ?1 and ?3 integrins to trigger their activation [8,18,22]. To explore the 
mechanism whereby Kindlin-1 induces integrin activation, we performed pull down 
experiments with recombinant GST-tagged cytoplasmic ? integrin tails in IEC and 
keratinocyte lysates. The results confirmed that Kindlin-1 associated with the
cytoplasmic domains of ?1 and ?3 (Figure 8D). Since substitutions of the tyrosine 
residues in the proximal NPxY motifs with alanine (?1Y788A; ?3Y747A) allowed
Kindlin-1 binding, while tyrosine to alanine substitutions in the distal NxxY motif of ?1
and ?3 integrin tails (?1Y800A; ?3Y759A) abolished Kindlin-1 binding, we conclude 
that the binding and functional properties are conserved among all Kindlins. This was 
further confirmed with direct binding assays, which showed that the recombinant His-
tagged C-terminal FERM domain of Kindlin-1 (aa 471-677) containing the
phosphotyrosine binding (PTB) motif bound GST-tagged ?1 but not the Y800A 
mutated ?1 integrin cytoplasmic tail (Figure 8E). 
It is well established that Talin can induce activation of integrins, and for a long time it 
was believed that it is sufficient for the execution of this task. This important function 
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of Talin was discovered by overexpressing Talin or its FERM domain in CHO cells.
This resulted in shifting the inactive conformation of the platelet integrin ?IIb?3 [23] 
to a  high affinity state as demonstrated by increased binding of the PAC1 antibody
recognizing activation associated epitopes on ?IIb?3 integrin. In contrast to Talin,
overexpression of Kindlin-1 failed to trigger activation of ?IIb?3 integrin in CHO cells.
Interestingly, as described for Kindlin-2 [18,22], overexpression of both the Talin
FERM domain and Kindlin-1 doubled PAC1 binding when compared with cells
expressing only the Talin FERM domain (Figure 8F). The synergism between Talin 
and Kindlin-1 depends on a Kindlin-1 and ? integrin tail interaction, as a PTB mutant 
of Kindlin-1 (QW611/612AA) failed to bind ? integrin tails (Figure 8G) and the
synergistic effect with Talin was lost. These findings suggest that Kindlin-1 is not
sufficient for integrin activation but is required for inducing Talin-mediated integrin
activation. This notion was confirmed with CHO cells, in which endogenous Kindlin-2
levels were depleted by RNAi (Figure 8H). Furthermore, overexpressing Talin failed
to induce integrin activation in these cells, but re-expression of Kindlin-1 restored this 
function (Figure 8I). 
These findings show (i) that Kindlin-1 and -2 require Talin for integrin activation, (ii)
that Talin requires Kindlins for integrin activation, and (iii) that Kindlin-1 and Kindlin-2
have redundant functions in vitro as both Kindlin-1 and -2 are recruited to FAs where 
they exert identical functions on integrin cytoplasmic tails. However, in vivo this is not 
the case as Kindlin-2 is recruited to cell-cell contacts in IECs and apparently does not 
compensate Kindlin-1 loss. 
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Discussion
In the present study we show that a null mutation in the Fermt1 gene gives rise to 
skin atrophy and an acute and fulminant, neonatal UC.  We demonstrate that, unlike
other forms of UC, the primary defect is a loss of the intestinal epithelial barrier that 
secondarily leads to inflammatory cell infiltrates and the development of all classical 
characteristics of UC. Furthermore, we show that loss of the intestinal epithelial 
barrier is caused by a severe adhesion defect of intestinal epithelial cells to the 
underlying BM, which in turn is caused by the inability of integrins to become 
activated and to bind BM components. It is possible that in addition to defective 
integrin activation and epithelial detachment, Kindlin-1 exerts other yet unidentified
functions that contribute to the phenotype in Kindlin-1-/- mice. To our knowledge, the
Kindlin-1-deficient mice represent the first animal model for UC caused by a single 
non embryonic lethal gene mutation. 
Kindler syndrome (KS) is thought to be primarily a skin disease with a disease course 
that is characterized by epidermal atrophy and followed by epidermal blistering, 
pigmentation defects and skin cancer. The complex disease syndrome is difficult to 
diagnose at the disease onset due to similarities with other forms of skin blistering 
diseases (also called epidermolysis bullosa; EB) that are caused by mutations in 
keratin and BM genes [24]. EB patients are not prone to UC, although they can 
develop gastrointestinal symptoms that are, however, restricted to the esophagus
and rectum, as both organs have a similar BM composition and keratin expression 
pattern as epidermal keratinocytes [11]. Recent case reports showed that KS may
involve more organs than only the skin, as several KS patients also suffer from 
intestinal symptoms. One patient with a severe form of KS developed a severe
postnatal UC. Interestingly, this patient was diagnosed with a null mutation in the
FERMT1 gene after developing trauma-induced skin blistering later in life [10]. In line 
with this severe UC case of KS, we found that the null mutation of the Fermt1 gene in
mice also leads to a dramatic and lethal UC very shortly after birth. Lethality is
usually not seen in KS patients, which is most likely due to the immaturity of the 
murine intestine at birth, making it more vulnerable to injury [25].
The UC of Kindlin-1-deficient mice is characterized by flat and superficial ulcerations
in the colon, as the epithelium detaches from an intact BM. The defects begin in the
rectum and extend along the entire colon finally leading to a severe pancolitis. The 
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ulcerations and epithelial cell detachments are restricted to the colon, although the
ileum shows signs of a secondary inflammation at later stages of the disease. In vitro
studies with primary IECs from Kindlin-1-/- mice and Kindlin-1-depleted HT-29 cells
showed that the cell detachment is caused by impaired activation of integrins leading
to weak adhesion of IECs to the underlying BM. The conclusion that UC is triggered
by IEC detachment rather than by a primary inflammatory defect in Kindlin-1 deficient
mice is based on the observation that epithelial cell detachment always occurred
prior to immune cell infiltration. We would therefore, argue that the detachment of 
IECs resembles an intestinal wound, which secondarily triggers a strong wound
healing response leading to immune cell infiltrates and release of a cytokine storm. In 
line with this hypothesis, epithelial cell detachment, induction of UC and inflammatory
reactions can be completely prevented when Kindlin-1 pups are delivered by 
Caesarian section and subsequently incubated in a humidified and temperature 
controlled chamber. Mechanical stress applied by the colostrum is likely inducing the 
detachment of the weakly adhering epithelial cells in the colon. The vast majority of
mouse models reported to develop colitis so far have an abnormal immune system 
[12,26]. This fact as well as the identification of several susceptibility loci in human 
patients [14,15] led to the conclusion that defects in the immune system are of 
central importance for UC development. Severe adhesion defects of IECs leading to 
a massive wound response represent a novel and alternative etiology for UC 
development.
Although adhesion is severely compromised in the colon of Kindlin-1-deficient mice, 
like KS patients they are born without skin blisters. This is in line with KS patients, 
who are also born without skin blisters even when they are delivered by the vaginal 
route but develop blisters postnatally at trauma prone sites. Interestingly, Kindlin-1 
deficient mice did not show defective adhesion of basal keratinocytes to the BM even 
after application of mild mechanical stress. The different severity of the adhesion
defect in skin and colon could be reflected by the functional properties of the distinct
set of integrins expressed in the two organs and the absence of classical
hemidesmosomes in intestinal epithelial cells [27]. 
Another pronounced skin defect in Kindlin-1-deficient mice as well as KS patients is
skin atrophy, which seems to be due to reduced proliferation of interfollicular
keratinocytes. This finding raises several questions; first, regarding the mechanism
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underlying the molecular control of cell proliferation by Kindlin-1. The mechanism is 
unknown and could result from a diminished cross talk between integrin and growth 
factor signaling. Second, it is also unclear how a molecular player that supports 
proliferation is giving rise to cancer at a later stage. It is possible that the localization 
of Kindlins in different cellular compartments, i.e. cell-matrix adhesion sites, cell-cell
adhesion sites and in certain instances in the nucleus, equips them with different 
functions that become evident at different time points in life. 
Kindlin-1 and -2 are co-expressed in epidermal cells as well as epithelial cells of the 
colon. Interestingly, we found that Kindlin-2 cannot compensate Kindlin-1 function in
vivo, neither in the colon nor in skin. Since Kindlin-2 is recruited to cell-cell adhesions 
in both mutant cell types and does not translocate to integrin adhesion sites in mutant 
intestinal and epidermal epithelial cells, it is unable to compensate for the loss of 
Kindlin-1, although both Kindlins are capable of performing the same tasks at the 
integrin tails ex vivo and in vitro [27]. Hence, a therapeutic strategy to reroute some
of the Kindlin-2 from cell-cell to the integrin adhesion sites may represent a promising 
approach to prevent ulceration in KS patients with severe UC. 
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Materials & Methods 
Mouse strains 
The Kindlin-1-/- mice were obtained by replacing the ATG-containing exon 2 with a
neomycin resistance cassette (detailed information on the cloning of the targeting 
construct can be obtained from Faessler@biochem.mpg.de). The construct was
electroporated into R1 embryonic stem (ES) cells (passage 15) and homologous
recombination was verified with Southern blots. Genomic DNA was digested with 
EcoRV, blotted and then hybridzed with a 5’ probe or digested with BglII, blotted and 
hybridized with a 3’ probe (Figure 1A). Targeted ES cells were injected into
blastocysts and transferred into foster mice. Mice were housed in a special pathogen 
free mouse facility. All animal experiments have been approved by the local
authorities.
Histology, Immunohistochemistry and Immunfluorescence stainings 
For H&E stainings intestinal segments were either PFA fixed and embedded in 
paraffin, or frozen on dry-ice in cryo-matrix (Thermo). Immunhistochemistry of 
paraffin embedded sections was carried out as previously described [5]. Sections of
8µm thickness were prepared and stained following routine protocols. Cryo sections
were fixed in 4% PFA/PBS except for the Kindlin-1 staining where sections were
fixed with 1:1 methanol/acetone at -20°C. Subsequently tissue sections were blocked
with 3% BSA/PBS, incubated with primary antibodies in a humidity chamber over 
night at 4°C, with fluorescently labeled secondary antibodies for 1h at RT and finally
mounted in Elvanol. Pictures were taken with a Leica DMIRE2 confocal microscope 
with a 100x or 63x NA 1.4 oil objective.
GST-pull downs
Recombinant GST-?1, ?1Y788A,???1Y800A, ?3, ?3Y747A,??3Y759A cytoplasmic tails 
were expressed and purified from E.coli under non denaturing conditions. 5µg of
recombinant tails were incubated with 500µg IEC lysate (in 50mM Tris pH 7.4, 
150mM NaCl, 1mM EDTA, 1% Triton-X-100) overnight. GST-constructs were 
precipitated with glutathione beads (Novagen). Subsequent western blots were 
probed for Kindlin-1 and GST. 
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Antibodies
A polyclonal peptide antibody against Kindlin-1 was raised against the peptide
YFKNKELEQGEPIEK as previously described [5]. 
The following antibodies were used at the given concentration indicated for western 
blot (W), immunoprecipitation (IP), immunfluorescence (IF), immunhistochemistry 
(IHC): Kindlin-1 (W: 1:5000, IF cells: 1:200, IF tissue: 1:1000), Kindlin-2 (W: 1:1000,
IF cells 1:200, IF tissue: 1:200), E-cadherin (Zymed, W: 1:5000), Migfilin (W: 1:5000, 
IF cells 1:100, IF tissue: 1:100), GAPDH (Chemicon; W: 1:10000), phalloidin Tritc 
(Sigma; IF cells: 1:800, IF tissue: 1:800), Mac-1 (EuroBioscience; IF tissue: 1:100), 
GR-1 (eBioscience; IF tissue: 1:100), Th1.2 (PharMingen; IF tissue: 1:100), GST 
(Novagen; W: 1:10000), His (CellSiganling; W: 1:1000), PAC1 (BD; FACS: 1:100), ?6
integrin (PharMingen; IF tissue: 1:100),  CollagenIV (a gift from Dr. Rupert Timpl; IF 
tissue: 1:100),  Laminin-332 (a gift from Dr. Monique Aumeilley;  IF tissue: 1:200), 
Perlecan (a gift from Dr. Rupert Timpl; IF tissue: 1:100), ?1 integrin (Chemicon; WB:
1:3000, IF tissue: 1:600), 9EG7 (PharMingen; FACS: 1:100), EGFP (Abcam; WB: 
1:10000), ?1 integrin (PharMingen; FACS: 1:200), ?v integrin (PharMingen; FACS: 
1:200). Keratin10 (Covance; IHC: 1:600 ), Keratin14 (Covance; IHC: 1:600 ), Loricrin 
(Covance; IHC: 1:500 ) Ki67 (Dianova; IHC: 1:50), cCaspase3 (CellSignaling, IHC: 
1:100).
Caesarean section 
Pregnant mice were sacrificed by cervical dislocation when embryos were at E18.5-
E19 of gestation. The uterus was removed and cut open. Embryos were taken out
and the umbilical cord was cut. Mice were subsequently dried and kept in an 
incubator at 37°C and high humidity. 
Real Time PCR 
Total RNA from whole colons was extracted with a PureLink Micro to Midi RNA 
extraction kit (Invitrogen) following the manufacturers instructions. cDNA was
prepared using the iScript cDNA Synthesis Kit (Biorad). Real Time PCR using a Sybr 
Green ready mix (Biorad) was performed in an iCycler (Biorad). Each sample was
measured in triplicates and values were normalized to GAPDH. Following primers 
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were used; TNF??fwd: AAAATTCGAGTGACAAGCCTGTAGC, TNF??rev:
GTGGGTGAGGAGCACGTAG. IL-6 fwd: CTATACCACTTCACAAGTCGGAGG IL-6 
rev: TGCACAACTCTTTTCTCATTTCC. RT-PCR for Kindlin-1 and GAPDH was
performed as previously described [5]. 
Isolation of IECs 
Neonatal mouse intestine was removed and flushed with 1ml PBS. The intestine was
longitudinally cut open, rinsed with PBS and incubated for 40 min. in IEC isolation
buffer (130mM NaCl, 10mM EDTA, 10mM Hepes pH 7.4, 10% FCS and 1mM DTT) 
at 37°C on a rotor. The epithelium was shaken off and pelleted by centrifugation at
2000rpm for 5 min.  For WB analysis cells were washed once with PBS and 
subsequently lysed. For flow cytometry cells were washed once with PBS and 
trypsinized with 2x trypsin (GIBCO) for 10 min. at 37°C. Trypsin was inactivated with
DMEM containing 10%FCS. A single cell suspension was prepared by passing cells
through a cell strainer (BD). 
Isolation of keratinocytes 
Primary keratinocytes were isolated from P3 mice as described previously [28]. Cells 
were cultured on a mixture of ColI (Cohesion) and 10 µg/ml FN (Invitrogen) coated 
plastic dishes in keratinocyte growth medium containing 8% chelated FCS 
(Invitrogen) and 45 µM Ca2+.
Flow cytometry
IEC’s and keratinocytes were stained with 9EG7 antibody in Tris buffered saline [29].
For the PAC1 binding assay CHO cells were stained for 40 minutes at RT as
described previously [23]. Cells were gated for viability by excluding propidium
iodide-positive cells. CHO cells transfected with EGFP-tagged constructs were 
additionally gated for highly EGFP-positive cells. Measurements were performed with 
a FACS Calibur (BD) and data evaluation was done with FlowJo software. 
Constructs
The EGFP-Kindlin-1 expression plasmid was previously described [5]. The cDNA 
encoding His-Kindin-1 C-terminus (aa 471-677) was amplified by PCR and cloned
into the pQE-70 vector (Qiagen). The Kindlin-1 PTB mutation QW611/612AA was
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introduced with a site directed mutagenesis kit (Stratagene) following the 
manufacturers recommendations. All EGFP constructs were cloned into the pEGFP-
C1 vector (Clontech) and subsequently sequenced. EGFP-Talin head was previously
described [8]. 
Cell culture
CHO and HT-29 cells were maintained in DMEM containing penicillin/streptomycin, 
non-essential amino-acids and 10% or 20% FCS, respectively (GIBCO). Cells were 
transfected with 2µg of each DNA in six well plates using Lipofectamine 2000 
following the manufacturers’ instructions (Invitrogen). 
RNAi
To deplete Kindlin-1 constitutively from HT-29 cells, an shDNA corresponding to the 
cDNA sequence GTAAGTCCTGGTTTATACA of hKindlin-1 and a control cDNA with 
the sequence AGCAGTGCATGTATGCTTC were cloned into the pSuperRetro vector 
(OligoEngine). Viral particles were prepared as described previously [30]. HT-29 cells
were infected and subsequently selected with 2mg/l puromycin. Transient knockdown 
of Kindlin-2 from CHO cells was achieved by transfection of the siRNAs; Kind2_1: 
GCCUCAAGCUCUUCUUGAUdTdT and Kind2_2:
CUCUGGACGGGAUAAGGAUdTdT, and a control siRNA (purchased from Sigma) 
using Lipofectamine 2000 (Invitrogen), following the manufacturers instructions. Cells
were harvested and assayed 24 hours after transfection. 
Adhesion assay 
The adhesion assays were performed as previously described [29], using 40000 cells
per well in serum free DMEM (HT-29) or MEM (primary keratinocytes). 
Osmolarity
Osmolarity was measured from 50µl urine using an Osmomat 030 from Gonotec. 
X-gal barrier assay 
Embryonic skin barrier formation was determined as previously described [31]. 
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Shear stress assay 
Slides with a 1µ diameter (ibidi BioDiagnostics) were coated overnight with 5µg/ml 
fibronectin and then blocked with 1% BSA. 100.000 cells were seeded onto the slides
and incubated for 2.5 hours in a cell culture incubator. Cells were subsequently
exposed to increasing amounts of shear force in two minute intervals (as indicated in
the Supplementary Figure 8) and pictures were taken every second. 
Co-Immunoprecipitation
CHO cells were transiently transfected with the indicated EGFP constructs.
Approximately 1mg of protein lysate was immunoprecipitated using the µMACS 
Epitope Tag Protein Isolation Kit for EGFP tags (Miltenyi Biotec) following the 
manufacturers instructions.
Electron microscopy 
Electron microscopy was performed as previously described [29]. 
Statistical analysis
Analyses were performed with GraphPad Prism. If not mentioned otherwise in the 
figure legends, Gaussian distribution of datasets was determined by a D’Agostino &
Pearson omnibus normality test. If samples were not Gaussian distributed a Mann-
Whitney test was performed. Gaussian distributed samples were either compared
with a one way ANOVA and a Tukey’s multiple comparison post test or an unpaired
two-tailed t-test. 
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Figure legends 
Figure 1. Loss of Kindlin-1 results in early postnatal lethality
(A) The Fermt1 gene was disrupted by replacing the ATG start codon containing
exon 2 with a neomycin resistance cassette. (B) Kindlin-1 mRNA levels were
determined by PCR from cDNAs derived from P3 kidneys. (C) Loss of Kindlin-1 
protein was confirmed by western blotting in colonic IEC lysates. (D) Pictures from
newborn (P0) and two day old mice (P2). Scale bars represent 5mm. (E) Weight
curve of Kindlin-1-/- (n=8) and control littermates (+/+; n=8; +/-; n=9) where a ?
indicates when mice died. *** indicates a P-value <0.0001. (F) Osmolarity of P2 
Kindlin-1-/- and control (+/+) urine (n=3 per genotype). Error bars show standard
deviations. *** indicates a P-value <0.0001. 
Figure 2. Atrophy and reduced proliferation in Kindlin-1-/- skin
(A) H&E stainings from P3 backskin show severe epidermal atrophy in Kindlin-1-/-
mice. The BM is indicated by a dashed line and separates the epidermis (e) from the 
dermis (d). sc: stratum corneum. Scale bar indicates 50µm. (B) Percentage of Ki67-
positive interfollicular keratinocytes at different ages. *, p<0.05; **. p<0.02 (n=7 per 
genotype). Error bars show standard errors of the mean. (C) Kindlin-2 (red; co-
stained with ?6 integrin (?6-int) in green) and E-cadherin (green, co-stained with 
Collagen IV in red) staining of P3 backskin sections. Nuclei are shown in blue. Scale 
bar indicates 10µm. (D) FITC-Lucifer yellow stain of P3 backskin overlaid with DIC. 
Lack of lucifer yellow dye penetration shows normal skin barrier in Kindlin-1-/- mice.
Scale bar indicates 50µm. 
Figure 3. Severe inflammation and epithelial detachment in Kindlin-1-/- colon 
(A) Opened abdomen with intestine from P2 mice. Arrowheads indicate air in the 
stomach and small intestine of Kindlin-1-/- mice. bl; bladder. Scale bar represents 
5mm. (B) Whole gut preparations from P2 mice. Scale bar represents 5mm. 
Arrowhead indicates a stricture in the distal colon. The caecum is highlighted with a
red circle and the colon is marked with a green line. (C) H&E staining of P3 colon and
ileum. Kindlin-1-/- mice show complete absence of colonic epithelium (e), exposure of 
the submucosa to the intestinal lumen (lu) and severe inflammation in colon and
ileum. Scale bar represents 50µm. (D) Macrophage and granulocyte infiltrations in P3 
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colon shown with Mac-1 staining in green. T-cell infiltrates in P3 colon shown with
Thy1.2 staining in green. Fibronectin (FN) is stained in red. Scale bar represents
50µm.
Figure 4. Normal duodenum and jejunum in Kindlin-1-/- mice 
H&E stainings of P1 (A) and P3 (B) duodenal and jejunal sections reveal a normal 
histology of the Kindlin-1-/- small intestine. Scale bar represents 50µm. 
Figure 5. Kindlin-1 localization in mouse intestine
(A) Immunofluorescence staining of Kindlin-1 in neonatal colon. Arrows indicate BM. 
(B) Immunofluorescence staining of P1 ileum for Kindlin-1. Arrows indicate the BM. 
(C) Immunofluorescence staining of P1 colon for Kindlin-2, Migfilin, F-actin (red), ?6
integrin (?6-int; green) and Laminin-332 (LN332; green). (D) Immunofluorescence
staining of Kindlin-2 (green) and E-cadherin (E-cad; red). All scale bars represent 
10µm.
Figure 6. Progressive ulcerative colitis in Kindlin-1-/- mice 
(A) Normal morphology of IECs and BM at E18.5. Shown are H&E stainings of the 
ileum and colon an electron microscopy pictures at 12000x magnification from the 
colon. The boxed enlargement shows the BM, e: epithelium Arrows point to the BM.
(B) Colonic IEC (e) detachment at P0 but not in mice delivered by Caesarean section 
(CS) and kept unfed for 7 hours. (C) IEC detachment but no macrophage and 
granulocyte infiltrations at P0 (Mac-1 and GR-1 in green; perlecan indicating BM in 
red). Arrows indicate IEC detachment. (D) Immune cell infiltrations in the lumen of 
the colon and floating epithelial sheets (e) in the colonic lumen at P1. PAS staining
shows reduced goblet cell mucins in Kindlin-1-/- colonic epithelium. Scale bars in A, B 
and D represent 50µm and in C 10µm. (E) Median of Real Time PCR results from 
whole colon mRNA at E18.5 (n=2 per genotype) and P1 (n=5 per genotype) for TNF-
??and IL-6. Error bars show range. The P value was determined using a Mann-
Whitney test.
Figure 7. Normal BM composition and integrin localization in P1 colon 
(A) Electron micrograph at 12000x magnification shows detachment of IECs from the 
BM at P1. Arrows point to the BM. The boxed enlargement shows the BM, e: 
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epithelium.  Cryo-sections from the colon of P1 Kindlin-1+/+ and Kindlin-1-/- mice 
stained for Collagen IV (ColIV), Laminin-332 (LN332) and Perlecan. The staining of
them shows a normal distribution and localization in Kindlin-1-/- colon. Scale bar
represents 10µm. (B) ?1 integrin staining of P1 colon. Arrows indicate the BM. Scale 
bar represents 10µm. (C) Western blot from IECs for ?1 integrin. (D) ?1 and ?v
integrin FACS profile on primary IECs.
Figure 8. Kindlin-1 association with ? integrins is required for talin-mediated
integrin activation
(A) Kindlin-1 IECs display significantly reduced 9EG7 binding (active ?1 integrin). The 
9EG7 binding was quantified by subtracting background (BG) values from mean 
fluorescence intensity (MFI) values and normalized to total ?1 integrin expression 
(n=8 mice per genotype). Error bars show standard deviations. (B) Western blot from 
HT-29 cells expressing a control siRNA or an siRNA directed against hKindlin-1 
(siKind1). (C) Adhesion assay of control and Kindlin-1-depleted HT-29 cells on the 
indicated substrates (n=5). Shown are mean values, error bars show standard errors 
of the mean (*** p<0.001) Col IV, Collagen IV; FN, fibronectin; LN332, Laminin-332;
PLL, Poly-L lysine. (D) Kindlin-1 pull-down from IEC lysates using GST-tagged
cytoplasmic ? integrin tails. (E) Direct interaction of Kindlin-1 with ?1 integrin 
cytoplasmic tails. His-tagged Kindlin-1 C-terminus was co-precipitated with GST-
tagged ?1 integrin cytoplasmic tails, but not with GST alone or an Y800A mutant form 
of ?1 integrin. (F) Quantification of ?IIb?3 integrin activation, as measured by
activation specific antibody PAC1 in CHO cells using flow cytometry (n=9). Shown 
are mean values, error bars show standard deviations. *, p<0.05; ***. p<0.0001 (G) 
Pull-down with GST-tagged cytoplasmic ?3 integrin tail from CHO cells transiently
transfected with the indicated EGFP-constructs. (H) Western blot of CHO cells 24
hours after transfection with the indicated siRNAs. (I) Quantification of ?IIb?3 integrin
activation in CHO cells transfected with the indicated cDNA constructs and/or siRNAs
(n=8). Shown are mean values, error bars show standard deviations. 
Supplementary Figure 1: Normal Triglyceride and Glucose levels in the blood 
of P3 Kindlin-1-/- mice 
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Triglyceride (n=7 per genotype) and glucose (n=5 per genotype) measurement from 
total blood at P3 are statistically insignificant in Kindlin-1-/- mice. Shown are mean 
values, error bars show standard deviations.
Supplementary Figure 2: Normal BM composition and deposition in P3 Kindlin-
1-/- backskin 
P3 backskin of wild type and Kindlin-1-/- mice was stained for the BM components
Laminin-332 (LN332), Collagen IV (ColIV) and Fibronectin (FN; red) and co-stained 
with ?6 or ?4 integrin marking (green) the basal site of basal keratinocytes. The
stainings reveal no differences in BM deposition and composition or ?6 and or ?4
integrin localization between control and Kindlin-1-/- littermates. Scale bar indicates 
30µm.
Supplementary Figure 3: Normal skin differentiation 
P3 backskin of control and Kindlin-1-/- mice was stained for epidermal differentiation 
markers Keratin14, Keratin10 and Loricrin (red) and co-stained with ?6 integrin
(green) to mark basal keratinocytes. The stainings show no difference in the 
differentiation pattern of Kindlin-1-/- keratinocytes. Scale bare indicates 10µm. 
Supplementary Figure 4: Normal skin development 
(A) Normal X-Gal staining in E17 Kindlin-1-/- embryos indicating normal barrier 
formation during development. Scale bars indicate 5mm. (B) H&E staining of back
skin from control and Kindlin-1-/- littermates of different age. In Kindlin-1-/- mice the 
epidermal (e) thickness at E18.5 and P0 is normal but clear epidermal atrophy is 
seen at P1. Scale bar indicates 50µm. (d): dermis.
Supplementary Figure 5: Altered adhesion and spreading by Kindlin-1-/-
keratinocytes
(A) Adhesion assay of control and Kindlin-1-/- keratinocytes on Col IV, Collagen IV; 
FN, fibronectin; LN332, Laminin-332; PLL, Poly-L lysine (n=3). Shown are mean 
values, error bars show SEM (* p<0.05). (B) Cell area measured upon spreading on
5µg/ml fibronectin at the indicated time-points using MetaMorph software (n=30 cells
per genotype from 3 independent experiments). Shown are mean values, error bars
show SD (*** p<0.0001) 
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Supplementary Figure 6: Normal IEC proliferation but detachment induced 
apoptosis
P1 colons form wild type and Kindlin-1-/- mice were DAB stained for cleaved
Caspases-3 to determine apoptosis and Ki67 for proliferating IECs. Apoptosis occurs 
in detached epithelium of Kindlin-1-/- mice. In areas of still adhering epithelium the
number of proliferating IECs is similar between wild type and Kindlin-1-/- mice. Scale 
bare indicates 50µm. 
Supplementary Figure 7: ?1 integrin activation in Kindlin-1-/- keratinocytes
(A) Immunofluorescence staining for ?1 integrin (green) and Laminin-332 (red) from 
P3 backskin shows normal localization of ?1 integrin in Kindlin-1-/- backskin. (B) 
Representative ?1 integrin FACS profile of freshly isolated control (blue) and Kindlin-
1-/- keratinocytes (red) shows unaltered ?1 integrin expression on basal 
keratinocytes. (C) 9EG7 FACS of freshly isolated P2 keratinocytes shows no 
significant reduction in ?1 integrin activation (n=4). 
Supplementary Figure 8: Shear induced detachment of Kindlin-1 depleted HT-
29 cells 
Control and Kindlin-1 depleted HT-29 (siKind1) cells were plated on fibronectin-
coated flow chamber slides and exposed to increasing shear forces as indicated in
the Figure. Control cells did not detach from the matrix while Kindlin-1 depleted cells
were unable to resist even low shear rates. Scale bar indicates 50µm. 
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Colocalization of Kindlin-1, Kindlin-2, and Migfilin at
Keratinocyte Focal Adhesion and Relevance to the
Pathophysiology of Kindler Syndrome
JE Lai-Cheong1,2, S Ussar3, K Arita1, IR Hart2 and JA McGrath1
Kindler syndrome (KS) results from pathogenic loss-of-function mutations in the KIND1 gene, which encodes
kindlin-1, a focal adhesion and actin cytoskeleton-related protein. How and why abnormalities in kindlin-1
disrupt keratinocyte cell biology in KS, however, is not yet known. In this study, we identified two previously
unreported binding proteins of kindlin-1: kindlin-2 and migfilin. Co-immunoprecipitation and confocal
microscopy studies show that these three proteins bind to each other and colocalize at focal adhesion in HaCaT
cells and normal human keratinocytes. Moreover, loss-of-function mutations in KIND1 result in marked
variability in kindlin-1 immunolabeling in KS skin, which is mirrored by similar changes in kindlin-2 and migfilin
immunoreactivity. Kindlin-1, however, may function independently of kindlin-2 and migfilin, as loss of kindlin-1
expression in HaCaT keratinocytes by RNA interference and in KS keratinocytes does not affect KIND2 or
FBLIM1 (migfilin) gene expression or kindlin-2 and migfilin protein localization. In addition to identifying
protein-binding partners for kindlin-1, this study also highlights that KIND1 gene expression and kindlin-1
protein labeling are not always reduced in KS, findings that are relevant to the accurate laboratory diagnosis of
this genodermatosis by skin immunohistochemistry.
Journal of Investigative Dermatology advance online publication, 5 June 2008; doi:10.1038/jid.2008.58
INTRODUCTION
Kindler syndrome (KS; OMIM173650) is a rare autosomal
recessive genodermatosis characterized by blistering in
trauma-prone sites, photosensitivity, poikiloderma, and
mucosal erosions and strictures (Kindler, 1954). The gene
responsible for KS, KIND1, was identified in 2003 (Jobard
et al., 2003; Siegel et al., 2003) and, to date, 32 different
pathogenic KIND1 mutations have been documented (see
Lai-Cheong et al., 2007 for mutation summary and Arita
et al., 2007; Mansur et al., 2007 for additional recent
mutations). The KIND1 gene encodes a 677 amino-acid
protein, kindlin-1, which is expressed mainly in basal
keratinocytes, colon, kidney, and placenta (Siegel et al.,
2003). Kindlin-1 has been shown to associate with vinculin in
the epithelial cell line PtK2 transiently transfected with
EGFP-kindlin-1 and, to some extent, with filamentous actin
(Siegel et al., 2003). Kindlin-1 forms complexes with b1- and
b3-integrin cytoplasmic tails (Kloeker et al., 2004), and a
reduction in kindlin-1 expression by RNA interference (RNAi)
in HaCaT cells results in decreased cell spreading (Kloeker
et al., 2004).
Kindlin-1 forms part of a family of kindlin proteins that
includes two other members: kindlin-2 and kindlin-3 (Siegel
et al., 2003). Kindlin-2 (also known as mitogen inducible
gene-2; Mig2) associates with actin stress fibers and thus is a
component of cell-extracellular matrix adhesion structures
(Tu et al., 2003). RNAi studies, resulting in the knockdown of
kindlin-2 expression in HeLa cells, have shown that kindlin-2
is required for the control of cell spreading, probably via
integrin-linked kinase (Tu et al., 2003). Kindlin-2 has also
been demonstrated to associate with and recruit migfilin at
cell-matrix adhesions (Tu et al., 2003). Kindlin-3 is expressed
in pulmonary and hematopoetic tissues but, thus far, has no
known binding partners (Ussar et al., 2006). Migfilin is a
novel LIM-containing protein that localizes to cell-matrix
adhesions and associates with actin via its N-terminal domain
while interacting with kindlin-2 through its C-terminal
domain (Tu et al., 2003). Like kindlin-2, migfilin is critical
for the control of cell shape (Tu et al., 2003) and has been
shown to bind to filamin and vasodilator-stimulated phos-
phoprotein (Zhang et al., 2006).
In this study, we have identified two key binding partners
of kindlin-1, namely kindlin-2 and migfilin, and demonstrate
both their tissue and cellular distribution. Furthermore, we
have shown that not every patient with KS with pathogenic
& 2008 The Society for Investigative Dermatology www.jidonline.org 1
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KIND1 mutations has reduced immunolabeling for kindlin-1,
with some individuals having normal levels of kindlin-1
expression and yet suffering from KS. These observations
provide further insight into the role of kindlin-1 in pathophy-
siology of KS.
RESULTS
Clinical features of KS patients
The clinical features of the 13 patients with KS assessed in this
study are summarized in Table 1. All these individuals have
previously determined loss-of-function mutations on both
KIND1 alleles.
Immunoblotting reveals expression of kindlin-1, kindlin-2, and
migfilin in HaCaT cells, normal human keratinocytes (NHK),
and KS keratinocytes
Western blotting showed that kindlin-1, kindlin-2, and
migfilin were expressed in both HaCaT cells, a spontaneously
immortalized human keratinocyte cell line (Boukamp et al.,
1988), and in NHK. Discrete bands of B77 kDa were noted
for both kindlin-1 (Figure 1a, lanes H and NHK) and kindlin-2
(Figure 1b, lanes H and NHK) and an B50 kDa band was
detected for migfilin (Figure 1c, lanes H and NHK) in HaCaT
and NHK lysates. Additionally, in HaCaT lysate, there was an
B74 kDa band that may correspond to the dephosphorylated
form of the kindlin-1 protein (Herz et al., 2006). In KS
keratinocyte lysate, there was loss of the B77 kDa band, a
finding that confirmed the specificity of this kindlin-1 protein
band (Figure 1a, lane KS). In the same KS lysate, however, a
different B65 kDa protein band was observed. Although the
nature of this band is currently unknown, it may correspond
to a truncated or alternatively spliced form of the protein.
Co-immunoprecipitation studies identify kindlin-1, kindlin-2,
and migfilin as potential biochemical partners
We focused on kindlin-2 and migfilin as potential kindlin-1-
binding partners, as they have previously been shown to be
components of cell-matrix adhesions as well as being
Table 1. Summary of ethnicity, clinical features, KIND1 mutations, and skin immunostaining patterns for
anti-kindlin-1, anti-kindlin-2, and anti-migfilin antibodies in 13 patients with KS
Immunolabeling
Patient
KIND1
mutations Blistering
Skin
atrophy
Poikilo-
derma
Photo-
sensitivity
Gingival
inflammation
Urethral
stenosis
Kindlin-
1
Kindlin-
2 Migfilin Reference
Indian p.C468X/
p.C468X
Y Y Y Y Y Y ± ++  Sethuraman
et al., 2005
Indian p.E516X/
p.E516X
Y Y Y N Y N ± ++  Lai-Cheong
et al., 2007
Omani p.R271X/
p.R271X
Y Y Y Y N Y + +  Siegel et al.,
2003
Omani p.W616X/
p.W616X
Y Y Y Y N Y + + + Ashton et al.,
2004
Omani p.W616X/
p.W616X
Y Y Y Y N Y + ++ + Ashton et al.,
2004
Brazilian c.676insC/
c.676insC
Y Y Y Y Y Y + ++ ± Martignago
et al., 2007
US Caucasian p.R271X/
c.1755delT
Y Y Y NK Y Y + ++  Siegel et al.,
2003
US Caucasian p.E304X/
c.1188insT
Y Y Y Y NK Y +++ +++ +++ Ashton et al.,
2004
US Caucasian p.E304X/
c.1161delA
Y Y Y Y Y Y +++ ++ ++ Ashton et al.,
2004
UK Caucasian p.E304X/
c.1909delA
Y Y Y N Y Y ++ +++ +++ Ashton et al.,
2004
UK Caucasian p.R288X/
p.R288X
Y Y Y Y NK Y +++ +++ +++ Siegel et al.,
2003
UK Caucasian p.E304X/
p.L302X
Y Y Y N Y N +++ +++ +++ Ashton et al.,
2004
Italian IVS7-1G4A/
IVS7-1G4A
Y Y Y Y Y Y +++ +++ +++ Ashton et al.,
2004
NHS WT/WT N N N N N N +++ +++ +++
N, no; NK, not known; NHS, normal human skin; Y, yes; WT, wild type.
+++, bright immunostaining; ++, slight reduction in immunoreactivity; +, marked reduction in immunostaining; ±, barely detectable immunolabeling;
, complete absence of labeling.
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Colocalization of Kindlin-1, Kindlin-2, and Migfilin
biochemically related to each other (Tu et al., 2003; Wu
2005). To determine whether these three proteins are
biochemical partners, co-immunoprecipitation was per-
formed on HaCaT cell lysates, which were precipitated
separately with anti-kindlin-1, anti-kindlin-2, and anti-migfi-
lin antibodies. When anti-kindlin-1 antibody was used to
probe the blot, an B77 kDa band was detected not only for
kindlin-1 but also for kindlin-2 and migfilin (Figure 2a).
Similar patterns of reactivity were observed when anti-
kindlin-2 antibody was used to probe the blot (Figure 2b).
In both blots, there were protein bands atB50 andB25 kDa
corresponding to the molecular weight of heavy- and light-
chain immunoglobulins, respectively. Western blotting of the
same immunoprecipitates using a rabbit polyclonal anti-
collagen VII antibody as an irrelevant antibody control
showed the absence of protein bands at B77 kDa but the
continued presence of bands corresponding to the heavy- and
light-chain immunoglobulins, respectively (Figure 2c).
Confocal microscopy studies show that kindlin-1, kindlin-2, and
migfilin colocalize at focal contacts in NHK and HaCaT cells
To determine whether kindlin-1 colocalizes with its two
biochemical partners, confocal microscopy studies were
performed on NHK individually labeled with anti-kindlin-1,
anti-kindlin-2, or anti-migfilin antibody. Focal adhesions
were revealed by double-staining the cells with anti-vinculin
antibody. In NHK, kindlin-1 showed diffuse cytoplasmic
expression and punctate nuclear localization and colocalized
with vinculin (Figure 3a). In addition, kindlin-2 and migfilin
were expressed in the cytoplasm as well as at focal adhesions
(Figures 3b and c). The independent colocalization of kindlin-1,
kindlin-2, and migfilin with vinculin suggests that all three
proteins may colocalize with each other. To assess this, con-
focal microscopy imaging was performed on HaCaT cells co-
transfected with EGFP-kindlin-1 (Figure 4a) and FLAG-migfilin
(Figure 4b) and then immunostained with anti-kindlin-2 anti-
body (Figure 4c). The merged image showed that the three
proteins colocalized at focal adhesions (Figure 4d).
Confocal microscopy studies on primary KS keratinocytes
show loss of kindlin-1 expression at focal adhesions but
presence of kindlin-2 and migfilin
To explore the pathophysiological role of kindlin-1 and its
two potential binding partners in KS, confocal microscopy
analysis was performed on primary KS keratinocytes (harbor-
ing compound heterozygous KIND1 mutations, p.E304X/p.
L302X) immunolabeled separately with anti-kindlin-1, anti-
kindlin-2, and anti-migfilin antibodies. In these KS keratino-
cytes, kindlin-1 no longer colocalized with vinculin at focal
adhesions despite cytoplasmic expression being present.
However, nuclear localization of kindlin-1 was still present
in these cells (Figure 3d). In contrast, kindlin-2 and migfilin
still colocalized with vinculin at focal adhesion (Figures 3e
and f).
Knockdown of kindlin-1 by RNAi does not alter expression
of kindlin-2 or migfilin in HaCaT cells
To understand the consequences of loss of kindlin-1
expression on kindlin-2 and migfilin, an RNAi study was
performed in HaCaT cells using kindlin-1 (k) and scrambled
control (s) small interfering RNAs (siRNAs) at a concentration
of 100 nM. A gradual reduction in kindlin-1 expression was
observed from day 2 post-transfection to almost complete
knockdown at day 8 (Figure 5a). However, the reduction of
kindlin-1 did not alter the expression of kindlin-2 (Figure 5b).
An increase in migfilin expression was noted from day 6 post-
transfection in both the scrambled and kindlin-1-transfected
HaCaT cells, as well as in the oligofectamine-transfected cells
(Figure 5c). This was confirmed by optical densitometry
analysis using ImageJ software (http://rsb.info.nih.gov/ij/),
which showed up to a fourfold increase in migfilin compared
with day 2 transfected cells (data not shown). The increase in
migfilin expression occurred in both the scrambled control
and kindlin-1-transfected cells, suggesting therefore that it is
not a consequence of kindlin-1 knockdown.
Kindlin-2 and migfilin localization is unchanged following
kindlin-1 siRNA transfection of HaCaT keratinocytes
Confocal microscopy studies performed on kindlin-1 siRNA-
treated HaCaT keratinocytes showed loss of kindlin-1 locali-
zation at focal adhesions (Figure 6a, arrows). However, diffuse
cytoplasmic staining of kindlin-1 was still seen. In contrast,
kindlin-2 and migfilin still colocalized at focal adhesions
(Figures 6b and c). In the scrambled control siRNA-treated
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Figure 1. Immunoblotting shows different expression patterns of kindlin-1
(but not kindlin-2 or migfilin) in KS or control keratinocytes. Immunoblotting
shows (a)B77 andB74 kDa protein bands matching the molecular weight of
kindlin-1 and its dephosphorylated form in HaCaT cell lysate (lane H). The
same B77 kDa band was present in lane NHK but absent in lane KS. In
addition, anB65 kDa band was seen in lane KS. (b) In lanes H, NHK, and KS,
an B77 kDa band corresponding to the molecular weight of kindlin-2 was
seen. (c) AnB50 kDa band that equates to the expected molecular weight of
migfilin was observed in lanes H, NHK, and KS. H, HaCaT cell lysate; NEG,
negative control; NHK, normal human keratinocytes; KS, Kindler syndrome.
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Figure 2. Co-immunoprecipitation studies show that kindlin-1, kindlin-2, and migfilin can bind to each other. (a) Western blotting on the immunoprecipitates
using anti-kindlin-1 antibody shows B77 kDa bands in all three lanes, indicating that kindlin-1 forms a complex with kindlin-2 and migfilin. (b) Similarly,
western blotting using anti-kindlin-2 antibody reveals B77 kDa bands in all three lanes, indicating that kindlin-2 associates with kindlin-1 and migfilin.
(c) Immunoblotting performed using rabbit polyclonal anti-collagen VII IgG antibody as irrelevant antibody control shows absence of the B77 kDa protein
band but persistence of the B50 and B25 kDa bands.
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Kindler syndrome (KS) keratinocytes (p.E304X/p.L302X)
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Figure 3. Confocal microscopy studies show different kindlin-1 localization but preserved kindlin-2 and migfilin localization in NHK and KS keratinocytes,
respectively. (a) In NHK, kindlin-1 was expressed both in the cytoplasm and near the cell periphery and colocalized with vinculin at focal adhesions.
Similarly, both (b) kindlin-2 and (c) migfilin showed cytoplasmic and peripheral distribution and colocalized with vinculin. (d) In KS keratinocytes, there
was cytoplasmic localization of kindlin-1 but kindlin-1 expression at focal adhesions was absent, as evidenced by the lack of colocalization with vinculin.
In contrast, (e) kindlin-2 and (f) migfilin subcellular localization was not affected. Bar¼20 mm.
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cells, colocalization of kindlin-1, kindlin-2, and migfilin with
vinculin at focal adhesions was still present, with no change
in the protein distribution or appearances of focal adhesions
(Figures 6d–f).
Immunofluorescence microscopy shows highly variable
kindlin-1 immunostaining in KS patients with pathogenic
KIND1 mutations
To determine the tissue distribution of kindlin-1, immuno-
fluorescence microscopy labeling was performed in both
normal and KS frozen skin sections. In normal skin sections
immunolabeled with anti-kindlin-1 antibody, there was
bright staining near the cell periphery in the basal keratino-
cytes (arrows) as well as less intense labeling throughout the
epidermis (Figure 7a). Frozen skin sections from 13 patients
with KS with pathogenic KIND1 mutations were immuno-
labeled for kindlin-1. A surprising finding was that not every
patient showed reduced or absent anti-kindlin-1 immuno-
staining. In fact, kindlin-1 labeling was markedly reduced in
seven patients (Figure 7b) and was normal or only slightly
reduced in six patients with KS (Figure 7c). The immuno-
fluorescence microscopy data are summarized in Table 1.
Immunolabeling for kindlin-2 and migfilin in KS skin mirrors
the variable kindlin-1 immunostaining patterns
Immunostaining with anti-kindlin-2 antibody on frozen
normal skin sections showed pan-epidermal membranous
labeling but with no staining along the lower pole of
basal keratinocytes in contact with the basement membrane
(Figure 7d). Anti-migfilin antibody labeling on frozen normal
skin sections showed basal epidermal staining near the cell
periphery with sparing of the rest of the epidermis (Figure 7g).
Of note, there was a reduction of immunolabeling for
kindlin-2 (Figure 7e) and also migfilin (Figure 7h) in the
seven patients with KS with reduced anti-kindlin-1 labeling.
However, in the six patients in whom kindlin-1 labeling was
normal or slightly reduced, kindlin-2 and migfilin immuno-
staining was of normal or near-normal intensity (Figures 7f
and i). Table 1 provides a summary of the immunolabeling
data.
Semi-quantitative reverse transcriptase PCR (RT-PCR) shows
variable reduction in KIND1 mRNA expression but normal
KIND2 and FBLIM1 (migfilin) mRNA levels
To begin to understand why some patients with KS have
reduced or almost normal anti-kindlin-1 immunostaining
patterns, we assessed KIND1 mRNA expression in four
patients with KS, all of whom had pathogenic KIND1
mutations determined in their genomic DNA. RT-PCR was
performed using cDNA synthesized from skin samples from
three patients with reduced or absent anti-kindlin-1 immu-
nolabeling and one patient with near-normal immunostain-
ing, respectively. The three patients harboring the following
homozygous nonsense mutations p.E516X/p.E516X,
p.W616X/p.W616X, and p.R271X/p.R271X all had reduced
anti-kindlin-1 immunolabeling and were found to have
correspondingly decreased expression of full-length KIND1
mRNA (Figure 8a, lanes 4–6). The reduction in KIND1 mRNA
in these cases is consistent with nonsense-mediated RNA
decay (Nagy and Maquat, 1998; Frischmeyer and Dietz,
1999; Holbrook et al., 2004; Maquat 2004), notwithstanding
that the mutation p.W616X occurs close to the 30 end of the
penultimate KIND1 exon (exon 14). Whole skin cDNA was
EGFP-kindlin-1 FLAG-migfilin
MergedEndogenous kindlin-2
Figure 4. Confocal microscopy shows that kindlin-1, kindlin-2, and migfilin
all colocalize at focal adhesions. (a) Kindlin-1 localizes to the ends of actin
stress fibers and also demonstrates a perinuclear distribution. (b) Migfilin is
distributed both in the cytoplasm and at the cell periphery. (c) Endogenous
kindlin-2 also localizes to the ends of actin stress fibers. (d) Merged
confocal image shows colocalization of kindlin-1, kindlin-2, and migfilin
at focal adhesions as shown by the white staining at the cell periphery
(arrows). Bar¼20 mm.
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Figure 5. Kindlin-2 and migfilin expression is not altered after RNAi-mediated
knockdown of kindlin-1 in HaCaT cells. (a) Gradual reduction of kindlin-1
expression was noted from day 2 post-transfection. (b) Expression of kindlin-2
does not seem to be altered by kindlin-1 knockdown. (c) However, there was
an increase in migfilin expression from day 6 post-transfection in the scrambled
control and kindlin-1-transfected HaCaT cells. Oligofectamine-only
(OLI)-treated HaCaT keratinocytes lysate was used as control and showed
no reduction in kindlin-1 expression. In contrast, no reduction in kindlin-1
expression was seen when the cells were treated with scrambled siRNA.
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available only from one patient with normal kindlin-1
immunostaining (harboring the compound heterozygous
mutations p.E304X/c.1909delA) who was subsequently found
to have normal expression of KIND1 mRNA (Figure 8,
lane 7). However, all four patients had normal levels of
KIND2 and FBLIM1 (migfilin) mRNA levels compared with
normal controls (Figures 8b and c) despite the individuals
in lanes 4–6 showing reduced kindlin-2 and migfilin labeling
on skin sections (cf. Figure 7e and h).
DISCUSSION
In this study, we have identified kindlin-2 and migfilin as two
novel biochemical partners of kindlin-1 by co-immuno-
precipitation supported by confocal microscopy imaging
on NHK, KS keratinocytes, as well as on transfected HaCaT
cells. Previous studies have established the colocalization of
kindlin-1 with other focal adhesion proteins such as paxillin
in various cell types including mouse embryonic fibro-
blasts (Ussar et al., 2006) and the epithelial cell line PtK2
(Siegel et al., 2003). However, our confocal microscopy
studies provide novel in vitro data regarding the localization
of kindlin-1, kindlin-2, and migfilin in both NHK and KS
keratinocytes. Additionally, we have shown that loss of
kindlin-1 in both KS keratinocytes and kindlin-1 siRNA-
transfected HaCaT cells does not seem to alter the expression
or localization of either kindlin-2 or migfilin at focal adhesions.
Our study also identifies a potential pitfall in using
immunofluorescence microscopy to assist the clinical diag-
nosis of KS. Previously, our group has reported the usefulness
of immunofluorescence microscopy on frozen skin sections
in making a rapid diagnosis of KS (Ashton et al., 2004; Fassihi
et al., 2005; Burch et al., 2006; Arita et al., 2007). Although it
remains an invaluable tool, immunostaining of a larger
number of cases now highlights that some patients with KS,
with loss-of-function KIND1 mutations confirmed by gene
sequencing, have almost normal anti-kindlin-1 immuno-
staining. Thus, positive anti-kindlin-1 immunolabeling does
not rule out a diagnosis of KS, and therefore KIND1 gene
sequencing remains the gold standard in diagnosing this
condition. An explanation for the positive anti-kindlin-1
antibody labeling may be gleaned from immunoblotting data
comparing kindlin-1 expression in NHK and KS lysates
(obtained from an individual with KS harboring compound
heterozygous KIND1 mutations, p.E304X/p.L302X). In this
individual, positive anti-kindlin-1 skin immunolabeling was
observed, which may reflect the presence of the B65 kDa
DAPI
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DAPIKindlin-1
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Migfilin
Vinculin Merged
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Figure 6. Kindlin-2 and migfilin localization remains unchanged in kindlin-1 siRNA-transfected HaCaT keratinocytes. (a) In HaCaT keratinocytes
transfected with kindlin-1 siRNA, there was no localization of kindlin-1 at focal adhesions (arrows). However, (b) kindlin-2 and (c) migfilin still colocalized
with vinculin at focal adhesions. In contrast, in the scrambled control-transfected HaCaT cells, there was no change in (d) kindlin-1, (e) kindlin-2, and
(f) migfilin subcellular localization. Bar¼20 mm.
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protein band detected by immunoblotting. Although the
nature of this band is currently unknown, it could correspond
to either a smaller kindlin-1 isoform or a truncated form of the
protein, or it could represent nonspecific antibody binding.
The immunofluorescence data also raise several key
points. First, there does not appear to be any clear correlation
between the site or nature of the mutations, immunostaining
patterns, and specific clinical features of the disease. For
instance, the patients with the homozygous nonsense
mutations p.R271X/p.R271X and p.R288X/p.R288X might
be predicted to have similar immunostaining patterns, but our
results suggest otherwise. Secondly, the seven patients with
reduced or absent anti-kindlin-1 immunostaining had similar
clinical features to those with positive immunolabeling,
observations which suggest that the low levels of kindlin-1
expression or normally expressed but defective kindlin-1
protein are insufficient to maintain normal skin integrity and
homeostasis. Thirdly, it appears that patients of Caucasian
background have more positive anti-kindlin-1 immunostaining
compared with other affected individuals (for example,
from the Middle East, South America, or Asia), suggesting
that the diverse ethnic, geographical, and environmental
Normal human skin
An
ti-
ki
nd
lin
-1
An
ti-
ki
nd
lin
-2
An
ti-
m
ig
fili
n
Homozygous mutation
p.E516X/p.E516X in KIND1
Homozygous mutation
p.R288X/p.R288X in KIND1
a b c
d e f
g h i
Figure 7. Immunofluorescence microscopy shows two patterns of labeling for kindlin-1, kindlin-2, and migfilin in KS skin. (a) Immunolabeling with
anti-kindlin-1 antibody on normal skin sections shows bright epidermal staining predominantly at the cell periphery (but also in the cytoplasm) mostly
within the basal keratinocyte layer (arrows) but with less intense pan-epidermal labeling. (b) In the KS patient with the homozygous nonsense mutation
p.E516X/p.E516X there is barely detectable staining for kindlin-1. (c) In contrast, in the KS patient with the homozygous mutation p.R288X/p.R288X there is
similar kindlin-1 immunolabeling intensity to control skin (cf. Figure 7a). (d) Anti-kindlin-2 immunostaining of normal skin sections shows pan-epidermal
membranous labeling with the absence of staining being noted along the lower pole of basal keratinocytes. (e) Marked reduction in anti-kindlin-2 antibody
immunoreactivity is seen in the patient’s skin harboring the homozygous nonsense mutation p.E516X/p.E516X. (f) Kindlin-2 antibody labeling in the
patient with the homozygous nonsense mutation p.R288X/p.R288X is similar to that in normal skin. (g) Anti-migfilin staining of normal skin sections shows
membranous and cytoplasmic labeling of the basal keratinocytes. (h) Anti-migfilin antibody labeling in the patient with homozygous nonsense mutation
p.E516X/p.E516X shows barely detectable labeling. (i) Anti-migfilin antibody labeling in the patient with the homozygous nonsense mutation p.R288X/p.R288X
is similar to that in normal skin. White dashed lines indicate the position of the dermal–epidermal junction in (b), (e), and (h). Bar¼ 50 mm.
Normal controls KS patients
KIND1 (kindlin-1)
KIND2 (kindlin-2)
FBLIM1 (migfilin)
GAPDH
p.E516X/
p.E516X
1 2 3 4 5 6 7
p.W616X/
p.W616X
p.R271X/
p.R271X
p.E304X/
c.1909delA
a
b
c
d
Figure 8. Semi-quantitative RT-PCR shows correlation between KIND1
mRNA expression and the corresponding kindlin-1 labeling patterns.
(a) Compared with the three normal controls (lanes 1–3), patients with
reduced anti-kindlin-1 immunostaining (lanes 4–6) had variably reduced
KIND1 mRNA levels, whereas the patient with normal immunolabeling of
anti-kindlin-1 (lane 7) had a normal or near-normal level of KIND1 mRNA.
(b) Patients with reduced kindlin-2 labeling (lanes 4–6), however, had no
reduction in KIND2 mRNA expression compared with normal controls
(lanes 1–3) or the patient with normal kindlin-2 immunostaining (lane 7).
(c) Similarly, there was no difference in FBLIM1 mRNA expression
in any of the patients compared with normal controls. (d) GAPDH
mRNA expression was used as loading control in these
experiments.
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backgrounds of the cases studied may also have an impact on
phenotype and expression of kindlin-1. Fourthly, although
skin immunolabeling reveals a mirror effect for kindlin-1,
kindlin-2, and migfilin immunolabeling (that is, a reduction
of kindlin-1 labeling is paralleled by a decrease in both
kindlin-2 and migfilin labeling), kindlin-2 or migfilin expres-
sion and localization were still demonstrated by immuno-
blotting and confocal microscopy, respectively.
KIND1 mRNA expression was variably reduced in the
three patients with reduced anti-kindlin-1 labeling. However,
the individual harboring the compound heterozygous muta-
tions p.E304X/c.1909delA (normal anti-kindlin-1 labeling)
had near-normal KIND1 mRNA expression. In this case, we
anticipated KIND1mRNA expression to beB50% of normal,
as the mutation c.1909delA occurs in the last exon of KIND1
and is therefore unlikely to be affected by nonsense-mediated
mRNA decay. However, KIND1 mRNA levels were normal,
suggesting that the other mutation p.E304X in exon 7 also
does not seem to affect the stability of KIND1 mRNA. No
evidence for alternative splicing of KIND1 was detected in
this individual, and thus an adequate explanation for the
near-normal mRNA levels is lacking.
The identification of kindlin-2 and migfilin as binding
partners of kindlin-1 provides new insight into the patho-
physiology of KS. First, it is evident that not all cases of KS
harbor pathogenic mutations in KIND1—perhaps B25% of
cases may result from mutations in other, as yet unidentified,
candidate genes (JAM, unpublished data). It is therefore
plausible that some individuals with KS or a KS-like geno-
dermatosis might have underlying pathogenic mutations in
KIND2 or FBLIM1. Secondly, the biochemical association
of these proteins provides new information regarding the role
of focal adhesion proteins in the pathogenesis of skin disease
and helps us understand further the pathophysiology of KS.
MATERIALS AND METHODS
Antibodies
A rabbit polyclonal anti-kindlin-1 antibody that recognizes the
last 277 amino-acid residues of kindlin-1 was kindly supplied by
Dr Mary Beckerle (Salt Lake City, OH). Rabbit polyclonal anti-
kindlin-2 and anti-migfilin antibodies were supplied by Reinhard
Fa¨ssler (Max Planck Institute of Biochemistry, Martinsried,
Germany). Alexa Fluor 488 goat anti-rabbit IgG secondary antibody
(Invitrogen, Eugene, OR) was used for immunofluorescence labeling
on skin sections. For cell immunofluorescence staining, mouse
monoclonal anti-vinculin (Sigma-Aldrich, St Louis, MO) and
anti-FLAG M2 antibodies (Sigma-Aldrich) were used. Alexa Fluor
546 goat anti-mouse IgG and Alexa Fluor 647 goat anti-rabbit
IgG secondary antibodies (Invitrogen), both highly cross-adsorbed,
were used in cell immunofluorescence microscopy.
Skin biopsies
Skin biopsies were taken for immunofluorescence microscopy
studies, tissue culture, and nucleic acid extraction after written,
informed consent was obtained from each patient, in accordance
with the Ethics Committee approval from the Guy’s and St Thomas’
Hospital. The study was conducted according to the Declaration of
Helsinki principles.
Western blotting
Keratinocytes were lysed with NuPage LDS sample buffer (Invitro-
gen, Carlsbad, CA) and 10% 2-mercaptoethanol (Sigma-Aldrich).
The lysates were then loaded and run on NuPage 4–12% bis-Tris gels
(Invitrogen) at 150V for 1.5 hours. The proteins were then transferred
onto Hybond-ECL nitrocellulose membranes (Amersham Bio-
sciences, Little Chalfont, UK) and blocked in 5% skimmed milk in
0.1% Tween-20 (Sigma-Aldrich) and Tris-buffered saline. The
membranes were then probed with anti-kindlin-1, anti-kindlin-2,
and anti-migfilin antibodies overnight at 41C. Mouse monoclonal
anti-b actin (Sigma-Aldrich) was used as loading control. Anti-rabbit
horseradish peroxidase-conjugated IgG antibody was used as
secondary antibody. Visualization of protein bands was done with
ECL western blotting detection reagents (Amersham Biosciences).
Co-immunoprecipitation
For co-immunoprecipitation, confluent HaCaT cell culture in 75 cm2
flask was lysed with 500 ml of Ripa (Radioimmunoprecipitation
assay) lysis buffer (Upstate Cell Signaling Solutions, Charlottesville,
VA) containing 5 ml of 100mM protease inhibitor cocktail set
(Merck Bioscience, Nottingham, UK) and 5 ml of 100mM sodium
orthovanadate at 41C for 5minutes. Following centrifugation, the
supernatant was precleared with Trueblot anti-rabbit Ig immuno-
precipitation beads (Insight Biotechnology Ltd, Middlesex, UK) for
30minutes at 41C. The beads were then removed by centrifugation
and the supernatant was mixed separately with anti-kindlin-1,
anti-kindlin-2, and anti-migfilin antibodies for 1 hour at 41C.
Subsequently, Trueblot anti-rabbit Ig immunoprecipitation beads
were added to the immunoprecipitates and incubated on ice for a
further hour. The beads were then collected by centrifugation and
washed three times with Ripa buffer before proceeding with western
blotting. Rabbit Trueblot HRP-conjugated anti-rabbit IgG was used
as secondary antibody (Insight Biotechnology Ltd). Visualization of
protein bands was achieved with ECL western Blotting detection
reagents.
Plasmid transfection of HaCaT cells
EGFP-kindlin-1, EGFP-kindlin-2, and FLAG-migfilin were supplied
by Professor Reinhard Fa¨ssler. EGFP-kindlin-1 and EGFP-kindlin-2
were cloned as described previously (Ussar et al., 2006). HaCaT
keratinocytes, at a seeding density of 2 105 cells per well on
13mm diameter coverslips in a 6-well plate, were transfected with
EGFP-kindlin-1 and FLAG-migfilin. Briefly, 1 mg of each plasmid was
mixed with 500ml of Optimem (Gibco, Paisley, UK) and incubated
for 5minutes at room temperature. A volume of 5 ml of oligofecta-
mine (Invitrogen) was added to 500ml optimem and the mixture was
incubated for 5minutes at room temperature. The two solutions were
then mixed, incubated for a further 20minutes at room temperature
before being added to the HaCaT keratinocytes, and incubated at
371C for 4 hours.
Cell immunofluorescence microscopy
For immunofluorescence, the fixed cells (fixation achieved using
either 4% formaldehyde for 10minutes at room temperature or an
equal mixture of methanol/acetone for 10minutes at 201C) were
blocked with 10% goat serum (Sigma-Aldrich) and 0.3% BSA in
phosphate-buffered saline by incubation with primary antibody.
Secondary antibody incubation was performed for 1 hour at room
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temperature. The coverslips containing the fixed immuno-
labeled cells were mounted with Prolong Gold AntiFade Reagent
(Invitrogen) onto Superfrost Plus slides (VWR) and analyzed with a
Zeiss Axioplan 2 Imaging confocal microscopy system.
RNA interference
Kindlin-1 expression was knocked down by RNAi using kindlin-1
siRNA (Dharmacon/Perbio, Cramlington, UK) as described previously
(Kloeker et al., 2004). Preparation of the transfectants involved incu-
bating each siRNA with Optimem for 5minutes at room temperature
before adding the mixture to an oligofectamine/Optimem solution.
The cells were incubated for 4 hours with this transfection mixture.
Immunofluorescence microscopy
Five-micrometer-thick frozen skin sections were cut from skin biopsies
obtained from 13 patients with KS in whom loss-of-function muta-
tions in KIND1 had been determined. The sections were blocked
with 10% goat serum for 30minutes followed by incubation with
the primary antibody for 30minutes at 371C. Secondary antibody
incubation was performed for 30minutes at 371C. Following
phosphate-buffered saline wash, the sections were air-dried and
mounted with Vectashield Hard Set with DAPI (Vector Laboratories,
Peterborough, UK) and viewed under a fluorescent microscope.
Extraction of total RNA from skin biopsies and cDNA synthesis
Skin biopsies were taken from patients with KS harboring
the mutations p.E516X/p.E516X, p.W616X/p.W616X, p.R271X/
p.R271X, and p.E304X/c.1909delA, and stored in RNAlater (Qiagen,
Crawley, UK) before processing. Total RNA was extracted from each
skin biopsy using the RNeasy Fibrous Tissue Mini Kit (Qiagen).
First-strand cDNA synthesis was performed with 2mg of total RNA
using SuperScript II Reverse Transcriptase (Invitrogen).
Semi-quantitative PCR analysis
First-strand cDNA was amplified by PCR in a reaction volume
consisting of 2ml of 2.5 M dNTP, 2ml forward and reverse primers,
1ml of cDNA, 10.375 ml water, 0.125 ml of Taq polymerase, 5ml Q
buffer, and 2.5 ml of 10 buffer. All PCR reagents were purchased
from Qiagen. Details of KIND1, KIND2, and FBLIM1 cDNA primers
are as follows: KIND1 forward cDNA primer: 50-TCAAACAGTGGA
ATGTAAACTGG-30; KIND1 reverse cDNA primer: 50-TACATGCTG
GGCACGTTAGG-30; KIND2 forward cDNA primer: 50-GAACAAGC
AGATAACAGC-30; KIND2 reverse cDNA primer: 50-CGGTGACCAT
TTTGATTTCCC-30; FBLIM1 forward cDNA primer: 50-AAAATCGAA
TGCATGGGAAG-30; FBLIM1 reverse cDNA primer: 50-GCAGGTTA
GGAAGGGAAACC-30. All the primer pairs were designed to
amplify a region in the 30 UTR of each gene and were purchased
from MWG (Ebelsberg, Germany). To ensure equal loading, a
housekeeping gene (GAPDH) was simultaneously amplified. The
PCR products were assessed on a 2% agarose gel.
HaCaT culture
The HaCaT cell line was grown to 70–80% confluence in DMEM
(Invitrogen) and 10% fetal bovine serum (Invitrogen).
Primary keratinocyte culture
Skin biopsies were incubated overnight at 41C with dispase I
(dilution 34U in 20ml phosphate-buffered saline) (Roche Applied
Science, Burgess Hill, UK). The detached epidermal sheet was then
incubated with a 0.05% tryspin/EDTA solution (Invitrogen) for
15minutes at 371C. The solution was subsequently filtered through a
100mm cell strainer (VWR International, Lutterworth, UK) and the
released keratinocytes were centrifuged at 1200 r.p.m. for 5minutes.
The cell pellet was resuspended in Epilife Basal Medium (Cascade
Biologics, Mansfield, UK) supplemented with Epilife Defined
Growth Supplement and Gentamicin/Amphotericin B (Cascade
Biologics) and plated in T25 flasks previously treated with Coating
Matrix (Cascade Biologics).
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Summary
Background The Kindler syndrome (KS) protein kindlin-1 is a member of a protein
complex that links cortical actin to integrins on the surface of basal keratinocytes.
Loss of kindlin-1 leads to abnormalities of cell adhesion and motility, and to skin
blistering and progressive poikiloderma as clinical symptoms.
Objectives Here we investigated a severely affected patient, disclosed the mutation
that caused the disease and delineated its biological consequences.
Methods Mutation screening of the kindlin-1 gene, KIND1 (now called FERMT1),
was performed with polymerase chain reaction (PCR) ampliﬁcation of all exons
and sequencing. Mutated kindlin-1 was characterized by reverse transcriptase
(RT)-PCR and immunoblotting, and genotype–phenotype correlations were anal-
ysed using immunohistochemical staining of skin biopsies and keratinocytes from
the patient’s skin. Cell adhesion and motility were assessed with functional tests.
Results We disclosed a splice site mutation in the ﬁrst position of intron 13 of the
FERMT1 gene, which caused skipping of exon 13. The short transcript partially
escaped nonsense-mediated mRNA decay and was translated into a truncated protein.
Conclusion A C-terminally truncated kindlin-1 in keratinocytes could not function
correctly even if it were expressed.
Kindler syndrome (KS; OMIM 173650) is a rare heritable skin
disorder with an intriguing complex phenotype, which is not
well understood. The disease begins with congenital skin blis-
tering and photosensitivity, which improve with age, and con-
tinues with progressive generalized poikiloderma.1 Additional
clinical features include chronic gingival erosions, oesophageal
and gastrointestinal involvement and an increased risk of
mucocutaneous malignancy. The disorder results from reces-
sive loss-of-function mutations of the FERMT1 gene that
encodes the protein kindlin-1, a component of focal adhesions
in epithelial cells.2,3 In vitro, loss of kindlin-1 function is asso-
ciated with abnormal cell shape, reduced cell adhesion, prolif-
eration and perturbed directed motility, presumably through a
role in integrin-associated signalling platforms.4,5
Despite rapid advances in discerning the genetic basis of
KS,6–8 the pathogenetic chain from molecular defects to the
functional tissue deﬁciencies in KS is not well understood. In
this study we describe the biological consequences of a
FERMT1 splice site mutation, which leads to reduced expres-
sion of truncated kindlin-1.
Material and methods
Patient
The clinical diagnosis of KS in the patient was based on physical
examination and personal history. Two skin biopsies were
obtained and processed for histopathological analysis, immuno-
histochemistry and cell culture. A blood sample in EDTA was
obtained from the patient after informed consent and with
approval by the ethics committee of the University of Freiburg.
FERMT1 mutation detection and reverse
transcriptase-polymerase chain reaction
Genomic DNA extracted from peripheral lymphocytes was
used for polymerase chain reaction (PCR) ampliﬁcation of
the entire coding region and exon–intron boundaries of the
FERMT1 gene, and sequencing, as described.9
Total RNA was extracted from subconﬂuent normal human
keratinocytes (NHK) and primary KS keratinocytes and reverse
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transcribed as reported.4 For ampliﬁcation of the FERMT1
cDNA, the following primers were used: KSex6F: 5¢-
ttggctagactcctcacg-3¢ and KSex9R: 5¢-gagattatctgcaagtttaggg-3¢;
KSex12F: 5¢-ctcaggtggcttccagtctc-3¢ and KSex14R: 5¢-cgg-
tggctgcatcaatttta-3¢. As a control, primers for glyceraldehyde-
3-phosphate dehydrogenase (BD Bioscience, Heidelberg,
Germany) were used.
Morphological analyses
Dermatohistopathology, immunohistochemistry and indirect
immunoﬂuorescence (IIF) staining were performed with
standard techniques.4 The following primary antibodies were
used: collagen XVII,10 Ki67, pankeratin (both from Dako,
Hamburg, Germany), ﬁlaggrin (Novocastra, Newcastle,
U.K.), BM165 to human laminin a3 chain (Dr P. Rouselle,
Lyon, France) and LH 7.2 to the NC1-domain of collagen
VII (Sigma, Taufenkirchen, Germany). The secondary
antibodies were labelled with FITC or rhodamine antimouse
or antirabbit IgG, or the AEC system (Dako). The signals
were visualized with immunoﬂuorescence (Zeiss Axio
Imager; Carl Zeiss, Jena, Germany) or light microscopy.
We used DAPI as a nuclear stain and haematoxylin as a
counterstain.
Cell culture and functional assays
Primary keratinocytes were isolated from KS and control skin
and grown in serum-free keratinocyte growth medium.4 The
morphology and shape of the cells were observed with an
Olympus CKX41 microscope (Olympus, Hamburg, Germany)
and recorded with a digital camera. Cell adhesion and in vitro
wound healing assays were performed in triplicate as
described.4 Because of the low proliferation rate of primary
keratinocytes,4 no mitomycin C was added to the culture
medium in in vitro wound healing assays.
Protein extraction and immunoblotting
Cultured cells were lysed as reported.4 Equal amounts of pro-
tein were separated by 10% SDS-PAGE and transferred to
nitrocellulose. The blots were blocked with either 10% defat-
ted milk or 3% bovine serum albumin in 0Æ01% Tween TBS
and incubated with two different afﬁnity puriﬁed antibodies
to epitopes within the N-terminal part of kindlin-1 (KS44 and
S. Ussar, unpublished data) and with b-tubulin antibodies
(Sigma) and processed as reported.4
(a) (b)
(c)
(d)
(e)
(f) (g)
(h) (i)Fig 1. Clinical presentation and morphological analysis of the patient’s
skin. (a) Extensive poikiloderma and dry skin. (b) Skin atrophy on the
dorsal aspects of the hands, ﬂexion contractures and pseudoainhum.
(c) Periodontitis with erosions and whitish deposits, teeth enamel
defects. (d) Dermatohistopathology of a skin biopsy. The frames
indicate the areas shown in panels (e)–(g). (e) Micro-blisters are
indicated by arrows. (f,g) Staining of the patient’s skin with the
proliferation marker Ki67. (h,i) Indirect immunoﬂuorescence staining
with antibodies to collagen VII (green) in the patient’s (h) and
control skin (i). Nuclei are shown in red. Bars for (f)–(i) = 50 lm.
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Results
The 27-year-old patient of Somalian origin was the only
affected member of his family. He spent the ﬁrst 20 years of
life in his homeland and the clinical diagnosis of KS was not
established until 3 years ago. Since early childhood he suffered
from skin blistering after mechanical trauma or sun exposure.
With advancing age, generalized skin dryness and focally hypo-
pigmented areas developed, and the clinical presentation
became reminiscent of a mild ichthyosis (Fig. 1a). The skin of
the hands became especially atrophic and sclerotic, which led
to ﬂexion contractures. Within the last year, pseudoainhum of
several ﬁngers developed causing functional deﬁciency and
(a)
(b)
(d)
(c)
Fig 2. Expression of kindlin-1 in the patient’s skin and keratinocytes.
(a) Reverse transcriptase-polymerase chain reaction (RT-PCR) with
total RNA from control (Co) and patient (KS) keratinocytes with
primers for FERMT1 Ex6–9 and Ex12–14, and glyceraldehyde-3-
phosphate dehydrogenase (GAPDH). In the patient’s sample a 125 bp
shorter, abnormally spliced transcript was identiﬁed with primers
spanning exons 12–14; ), negative controls without DNA; M, 100 bp
DNA ladder. (b) Direct sequencing of the RT-PCR products spanning
exons 12–14 revealed the normal transcript in the control, and
skipping of exon 13 in the patient. (c) Western blot analysis of
control (Co) and patient (KS) keratinocyte lysates with a kindlin-1
antibody (upper panels). In the control the full-length kindlin-1 and
in the patient truncated kindlin-1 of approximately 60 kDa are
indicated by arrows. b-Tubulin is shown as a loading control (lower
panels). (d) In the upper panel, the domain-structure of normal
kindlin-1 is shown. The sequence recognized by the domain-speciﬁc
antibody KS4 is depicted in pink. In the lower panel, the truncated
kindlin-1 identiﬁed in the KS patient’s keratinocytes is shown.
(a)
(b)
(c)
(d)
Fig 3. Functional analysis of Kindler Syndrome (KS) keratinocytes.
(a) Normal human keratinocytes (NHK) spread and had one broad
lamellipodium, whereas KS keratinocytes remained round or exhibited
multipolar morphology with multiple leading edges. (b) Adhesion of
KS keratinocytes was clearly reduced, as compared to NHK. (c) Phase
contrast microscopy pictures of the in vitro wound closure assays
performed with KS cells and NHK. The upper panels represent the
time point 0, and the lower panels represent the time point 10 h.
(d) The corresponding graphs showing the percentage of wound
closure in time. Black columns represent KS cells, while NHK are
represented by white columns.
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pain (Fig. 1b). The patient complained about pain and bleed-
ing of the gums during eating and brushing of the teeth
(Fig. 1c), difﬁculties in swallowing solid foods, diarrhoea
alternating with constipation, and anal bleeding.
Histopathology of a skin biopsy revealed long stretches of
ﬂattened epidermis, orthohyperkeratosis, microblistering at
the dermal–epidermal junction and pigmentary incontinence
(Fig. 1d,e). Staining with the proliferation marker Ki67 dem-
onstrated a patchy pattern in the epidermis, with a signiﬁ-
cantly reduced number of positive cells in the ﬂattened
epidermis and a high number of positive cells in nonatrophic
areas (Fig. 1f,g). Because some of the clinical features were
suggestive of an ichthyosis, ﬁlaggrin staining was performed;
it showed a normal staining pattern (not shown). IIF staining
with antibodies to collagen VII (Fig. 1h,i), collagen XVII and
laminin 332 (not shown) revealed a fragmented and branched
basement membrane zone. Keratin-positive cell bodies were
occasionally present in the upper dermis (not shown).
Mutation screening disclosed a homozygous FERMT1 muta-
tion of the ﬁrst position in intron 13, c.1718 + 1G > A. In
order to analyse the biological consequences of the mutation,
keratinocytes were cultured from the patient’s skin for RT-PCR
and protein analysis (Fig. 2). RT-PCR with primers spanning
FERMT1 exons 6–9 revealed reduced levels of the FERMT1
mRNA in KS cells (Fig. 2a). The aberrant transcript obtained
with primers for exon 12–14 resulted from skipping of exon
13 (Fig. 2b), and led to a frameshift and a premature termina-
tion codon at the second position of the abnormal sequence.
This transcript, predicted to generate a truncated kindlin-1
polypeptide of about 60 kDa, which lacks 145 amino acids in
the carboxyterminus (Fig. 2d), was identiﬁed by immunoblot-
ting with antibodies to kindlin-1 in the KS cells (Fig. 2c).
In vitro assays were used to investigate the functional
properties of KS keratinocytes. The patient’s cells did not
form colonies resembling NHK and exhibited aberrant mor-
phology (Fig. 3a). In the ﬁrst passage, 44% of KS keratino-
cytes remained round and had not spread, and 42% of the
cells exhibited multipolar morphology and multiple leading
edges. Adhesion of KS keratinocytes was clearly reduced, to
ﬁbronectin by 66% (P < 0Æ0003) and to laminin 332 by
50% (P < 0Æ001) in comparison with NHK (Fig. 3b). The
directed migration of cells was analysed by in vitro wound
closure assays. KS cells demonstrated undirected migra-
tory behaviour as they had not ﬁlled the wounded area
after 12 h, while NHK closed the wounds within 8–10 h
(Fig. 3c,d). The proliferation of KS cells was drastically
reduced; the doubling time was 7 days, while for NHK it
was 3 days (not shown).
Discussion
So far, very little is known about the molecular basis of the
clinical and biological KS phenotypes and their heterogeneity.
Our patient had several noteworthy clinical features, including
scleroatrophy of the hands, pseudoainhum, and ichthyosiform
scaling, and seems to be very severely affected as compared
with other individuals with similar mutations.7,9,11 A 30-year-
old Indian male patient, homozygous for the same mutation,
was described to be relatively mildly affected.7 A mutation of
the neighbouring nucleotide, c.1718 + 2T > C was reported
in a male newborn with blistering and dry, scaly skin.11 Yet
another mutation, IVS13)1G > A, led to aberrant splicing of
exon 14 and to typical KS symptoms.11 It is likely that in our
patient environmental factors played a major role, i.e. life in
Somalia, lack of systematic UV protection and medical care up
to young adulthood aggravated the clinical picture.
The 31 FERMT1 mutations described to date are predicted to
result in complete loss of kindlin-1 and its functions.6–8 The
fact that the present mutation in intron 13 lies close to the 3¢
end of the FERMT1 gene with 15 exons is likely to render the
nonsense-mediated RNA decay mechanisms partly inactive.12
The amount of FERMT1 mRNA was reduced to about a half.
The resulting truncated kindlin-1 polypeptide lacking the
FERM subdomain containing the talin homology region
seemed to be sensitive to proteolytic degradation, as the
intensity of the immunoblot band was about 5% of the
control. Compared to NHK, the adhesion and proliferation of
KS keratinocytes were signiﬁcantly reduced to levels similar to
those we described for kindlin-1-negative cells.4 Also KS cells
had abnormal morphology, and were not able to migrate in a
directed manner similarly to kindlin-1-null cells,4 suggesting
that kindlin-1 functions require the C-terminal domains. The
most likely explanation is that in the present case, both the
reduced amount and the truncation played a role. The deleted
145 amino acid stretch of kindlin-1, which contains the talin
homology region, is functionally important. The talin-FERM
domain mediates b integrin–talin binding.13 In the case of
kindlin-2 and -3, experimental data demonstrated that the
talin homology domain contained the b integrin-binding
site.14,15 Therefore, we hypothesize that the truncated kindlin-
1 molecule lacking the talin homology domain cannot interact
with b1 integrin, which abrogates pivotal functions of the
integrin adhesion-signalling complex.
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